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ABSTRACT 
Engineered biological systems hold great promise in providing solutions to many 
global challenges, including environmental remediation, sustainability, scalable 
manufacturing, and health and medicine. Synthetic biology is an emerging research field 
with a primary goal of making the engineering of biology more streamlined and reliable. 
Recent advances in synthetic RNA biology have led to design of RNA-based gene-
regulatory devices from assembly of functional RNA components that encode more basic 
functions, including sensing, information transmission, and actuation functions. These 
synthetic RNA control devices allow access and control information on cellular state, 
thereby advancing our ability to interact with and program biology.  
A modular ribozyme device platform was recently described to link an aptamer 
(sensor) to a hammerhead ribozyme (actuator) through a distinct sequence (information 
transmitter) capable of a strand-displacement event. The utilization of ribozyme as the 
actuator in the platform, whose mechanism of action is independent of cell-specific 
machinery, allows transport of the resultant devices to in vitro or different cellular 
environments. The broad implementation of these devices requires enabling technologies 
to support efficient generation of new functional RNA components and quantitative 
tailoring of device regulatory performance for specific cellular applications. Current 
component generation and device tailoring strategies are limited in their throughputs and 
efficiencies, and thus have hampered our ability to generate new ribozyme devices for 
cellular engineering applications. 
 To support scalable generation and tailoring of ribozyme devices, we have 
described high-throughput in vitro selection and in vivo screening strategies based on the 
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modular ribozyme device platform. We proposed a high-throughput solution-based in 
vitro selection strategy to generate new sensing functions within the device platform. A 
high-throughput and quantitative two-color FACS-based screening strategy was 
developed to complement the in vitro selection strategy by allowing efficient tailoring of 
device regulatory activities in the cellular environments. We further developed 
quantitative assays based on the surface plasmon resonance (SPR) technology to allow 
rapid measurements of the device and component activities. Together, these enabling 
strategies will offer a scalable and integrated process for the construction and 
programming of RNA control devices for broad cellular engineering applications, thus 
laying an important foundation for engineering more complex biological systems. 
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 Engineered biological systems have exciting potential in developing solutions to 
many global challenges, including environmental remediation, sustainability, scalable 
manufacturing, and health and medicine (1-4). Our ability to design and build synthetic 
biological systems is a key technology to improving the human condition. In addition, the 
redesign of biological systems can be used as an effective strategy to test, and thereby 
strengthen, our understanding of natural systems. Synthetic biology is an emerging 
research field with a primary goal of making the engineering of biology faster, less 
expensive, and more reliable. As such, core activities in synthetic biology have been 
focused on the development of foundational tools and technologies that assist in the 
design, construction, and characterization of biological systems (5,6). Recent advances in 
construction and fabrication technologies are supporting synthesis of large pieces of 
DNA including entire pathways and genomes (7). While progress has been made in the 
design of complex genetic circuits (8), current capabilities for constructing large genetic 
systems surpass our ability to design such systems. This growing ‘design gap’ has 
highlighted the need to develop methods that support the generation of new functional 
biological components and scalable design strategies for complex genetic circuits that 
will lay the foundation for integrated biological devices and systems. 
 The vast majority of genetic systems engineered to-date have utilized protein-
based transcriptional control strategies (8). However, as the examples of functional RNA 
molecules playing key roles in the behavior of natural biological systems have grown 
over the past decade, there has been growing interest in the design and implementation of 
synthetic counterparts. Researchers have taken advantage of the relative ease with which 
RNA molecules can be modeled and designed to engineer functional RNA molecules that 
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act as diverse components including sensors, regulators, controllers (ligand-responsive 
RNA regulators), and scaffolds. More recently, researchers have begun to move beyond 
molecular design and integrate these synthetic RNA molecules as key elements in genetic 
circuits to program cellular behavior, highlighting the relevance and advantages of RNA-
based control strategies.  
 
1.1 RNA as a natural regulatory molecule 
 The growing interest in using RNA to build synthetic controllers is due in large 
part to the steadily increasing examples of natural RNA regulators that control gene 
expression through diverse mechanisms in different organisms. One of the earliest 
examples is the regulation of gene expression through RNA secondary structure. The 
study of differential expression of genes in phage genomes led to the discovery that 
secondary structure of a mRNA transcript can restrict access to the ribosome binding site 
(RBS), thereby inhibiting translation (9). Similarly, bacteria utilize the formation of tight 
hairpins in mRNA transcripts to stall and attenuate translation in the regulation of amino 
acid biosynthesis (10). In addition, RNA structure is highly temperature sensitive, such 
that in certain cases hairpin structures that inhibit translation and can be modulated by 
temperature have been found to have functional roles in the heat and cold shock 
responses of several bacteria (9). Finally, it has been shown that strong secondary 
structures on the 5’ and 3’ ends of a mRNA strand can protect the transcript from 
degradation by exoribonucleases and endoribonucleases (11). The resulting extended 
half-lives of the transcripts can significantly increase protein production and have 
functional roles in processes such as photosynthesis and bacterial cell adhesion (11,12).   
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In addition to structural mechanisms, the discovery that RNA can exhibit catalytic 
activity opened the door to a wider array of regulatory functions (13). These catalytic 
RNAs, or ribozymes, typically catalyze cleavage or ligation of the RNA backbone 
through a reversible phosphodiester cleavage reaction (14). Ribozymes have functional 
roles in alternative splicing, RNA replication, translation, and transcript stability and 
function in both prokaryotes and eukaryotes (14). Furthermore, the discovery that 
ribozyme cleavage of the glmS transcript in bacteria is inhibited by binding of the 
metabolite GlcN6P has led to several discoveries of ribozymes acting as key components 
in riboswitches, a class of RNA regulators that respond to cellular metabolites and 
cofactors to modulate enzyme levels in related biosynthesis (15). Finally, RNase P is a 
catalytic RNA that functions in trans and can carry out multiple turnover cleavage events 
in the processing of 5’ leader sequences from tRNA (14). The discovery of ribozymes 
with natural gene regulatory activity in trans presents an intriguing proof of principle that 
a single catalytic RNA can be used to regulate several different genes in a biological 
system. 
 The last major mechanism that RNA uses to regulate protein synthesis is through 
antisense-mediated regulation of translation. Trans-acting small RNAs in bacteria are 
generally transcribed from their own independent transcripts and can range from 50-514 
nucleotides (nts) in length (16). These RNAs often act in concert with the RNA binding 
protein Hfq and can promote or inhibit translation of their target mRNAs by relieving 
secondary structural elements or inhibiting ribosome initiation or processivity (17). 
Similarly, in higher eukaryotes, RNA interference (RNAi) pathways use small RNAs, 
siRNA and microRNAs, to guide protein complexes to complementary mRNAs, leading 
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to silencing of those targets (18). MicroRNAs have diverse roles in almost every cellular 
process and they are currently thought to regulate up to a third of human genes (19). 
RNAi, particularly the siRNA pathway, is widely used as a tool in biological research for 
genetic loss of function studies and is currently being explored for therapeutic and 
biotechnological uses (20). 
 Finally, RNA is involved in gene regulation in several other less widespread or 
well-studied mechanisms. For example, noncoding RNAs have been characterized that 
have roles in quality control of translation (16), binding to and inhibiting proteins 
involved in protein synthesis, and epigenetic DNA modification (21). Furthermore, the 
recent discovery of the widespread regulatory activity and conservation of long 
noncoding RNAs represents an exciting area for further research in RNA-based gene 
regulation (22). 
 
1.2 RNA as a programmable and efficient substrate for engineering biological 
controllers 
In addition to the diversity of mechanisms by which RNA can act as a regulatory 
molecule in nature, RNA exhibits several properties that make it an attractive design 
substrate in synthetic systems. RNA is composed of four building blocks that interact 
through well-characterized hydrogen-bond, base-stacking, and electrostatic interactions. 
The folding of RNA is primarily dictated by its secondary structure, in contrast to the 
folding of proteins, which involves a large degree of tertiary interactions. Models that 
predict RNA secondary structure have been developed based on the optimization of 
energies contributed by the Watson-Crick AU and GC base pairs as well as the GU 
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wobble pair (23-25). Progress in RNA three-dimensional structural studies have revealed 
a set of non-canonical base pairing interactions, or Hoogsteen base pairs, that are key in 
the formation of the RNA tertiary structure. Early modeling frameworks that predict 
RNA tertiary structure based on a primary sequence have been developed and 
demonstrated to generate native-like structure predictions (26,27). In addition to structure 
prediction based on thermodynamics, RNA kinetic folding program has also been 
developed to capture the stochastic nature of the RNA folding process (28). These 
computational tools can be utilized to access structural information encoded in the 
primary RNA sequence, thereby aiding the rational design of genetic controllers based on 
hybridization schemes or structural elements.  
 RNA-based controllers exhibit additional advantages as functional elements in 
synthetic biological systems as the field moves toward more complex genetic systems 
design. RNA controllers generally exhibit more compact genetic footprints than their 
protein counterparts. In addition, RNA controllers generally place less of an energetic and 
resource load on the host cell as functional RNA molecules do not require the translation 
process to synthesize the functional elements. Another important consideration in genetic 
system design is timing of coupled control processes, where RNA-based 
posttranscriptional control strategies will generally act at faster time scales than 
transcription-based control strategies. The energetic, resource, and space efficiencies of 
RNA-based control strategies present important features supporting scaling to large-scale 
genetic system designs. 
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1.3 Approaches to generate functional RNA components 
Functional RNA components are the basic building blocks for constructing 
genetic devices that encode human-defined functions. A fundamental challenge in the 
field then is the efficient generation of new component functions, such as sensing, 
information transmission, and actuation functions, that can be assembled into more 
complex devices. Three general approaches are taken to engineer new functional RNA 
components: harvesting from nature, computational design, and molecular evolution 
(Figure 1.1). 
 
 
 
Figure 1.1 RNA components used to engineer synthetic control functions can be 
harvested from natural systems or generated using molecular evolution and 
computational approaches. These components, encoding sensing, actuation, and 
information transmission activities, can then be assembled into RNA devices using 
various molecular engineering strategies to link one or more inputs of interest, such as 
temperature, RNA, small molecules, or proteins, to desired regulatory activities. 
8 
 
1.3.1 Harvesting and refining RNA components from nature 
Many functional RNA components are derived from naturally-occurring 
elements, as advances in RNA biology have led to discoveries of natural RNA molecules 
that exhibit diverse functional activities. In certain instances the RNA component can be 
‘harvested’ from its native context and used in a synthetic genetic context where it will 
exhibit the desired activity. In one example, researchers isolated a ligand-binding RNA 
sequence to thiamine pyrophosphate (TPP) from a natural riboswitch and linked this 
natural RNA ligand-binding component to a hammerhead ribozyme to construct a 
synthetic RNA-based sensing-actuation element that responded to TPP in E. coli (29). 
The native function of a naturally-occurring RNA element can also be altered to generate 
new functions or ‘refined’ to make the element compatible with modular integration into 
broader genetic device or system platforms. Combined rational and evolutionary 
strategies have been applied to alter the native function of natural RNA elements. In one 
example, the native activity of an RNase III hairpin substrate was altered in yeast by 
modifying key sequences that are essential to protein-binding and cleavage activities 
within the regulatory element (30,31). The resulting hairpin libraries were inserted in the 
3’ UTR of the target transcript, and an in vivo screen was performed to identify a set of 
new hairpin sequences exhibiting a wide-range of regulatory activities. Similar 
approaches have been applied to alter the native activities of diverse RNA regulatory 
elements, including ribozymes (32), RNase cleavage sites (33), stabilizing elements (34), 
RBS sequences (35) , and riboswitches (36). 
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1.3.2 Computational tools for the design of RNA components 
Computational tools have been developed to aid researchers in designing 
functional RNA components. For example, a computational method for designing 
synthetic RBS sequences was recently described based on predicting the energies of 
secondary structures around and including the RBS and the energies associated with the 
RBS:rRNA interaction (37). A two state thermodynamic model was devised, the initial 
state being the free 30S ribosomal subunit and folded mRNA transcript and the final state 
being the 30S complex bound to the transcript. The difference in free energy between 
these two states was used to predict a translation initiation rate for a given mRNA 
sequence. The computational method was applied to generate RBS sequences in E. coli 
that resulted in fluorescent reporter levels that spanned several orders of magnitude. This 
tool was then applied to design and optimize the expression of an input to a genetic AND 
gate. As another example, design tools for microRNA and shRNA elements have been 
developed by companies such as Life Technologies and Thermo Scientific. Given the 
sequence of a target gene of interest, these RNAi design tools can predict targeting 
sequences that will allow for efficient RNAi-mediated knockdown of that gene. These 
programs will design a shRNA or miRNA that incorporate the predicted targeting 
sequences, including the structural elements necessary for correct biogenesis and 
silencing efficiency, and primer sequences for construction and cloning of the regulatory 
element.  
Forward engineering with current computational tools is not precise, and 
strategies for most effectively using these tools require some level of generating multiple 
functional RNA elements and then screening for those sequences that exhibit desired 
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activities. For example, the RBS design tool has a probability of 0.47 of achieving a 
target protein expression level within two-fold. Further development of design tools that 
more accurately predict the precise DNA sequence needed to achieve a quantitative 
functional activity for different RNA components will allow for the efficient design, 
construction, and implementation of functional components tailored for various networks 
and systems. 
 
1.3.3 Evolving new RNA component functions 
While many functional RNA components can be harvested from natural 
biological systems and then refined and enhanced through rational design and 
evolutionary methods, such strategies can be limited to generating functions that are 
closely-related to the native activities. To generate new RNA component functions de 
novo, researchers have turned to in vitro selection strategies. The ability to readily 
interconvert between genetic information (DNA) and functional molecule (RNA) through 
transcription and reverse transcription (RT) processes and the ability to readily amplify 
DNA through polymerase chain reaction (PCR) processes allows efficient sampling of 
large RNA sequence space in vitro. Thus, large RNA libraries can be searched for rare 
functional sequences, which can subsequently be recovered, amplified, and searched 
again.  
RNA presents a unique advantage over protein as a design substrate for control 
devices, as new sensing functions can be generated de novo through an in vitro selection 
strategy, systematic evolution of ligands by exponential enrichment (SELEX) (38,39). 
SELEX typically starts with an initial RNA library of ~10
14
-10
15
 molecules, each 
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composed of a randomized region spanning ~30-70 nts flanked by constant sequences. 
Ligand-binding sequences are isolated by partitioning the RNA library through any of a 
number of different strategies, although affinity chromatography-based methods are most 
commonly used. The recovered sequences are subsequently amplified through RT-PCR 
and used as the starting library for the next round of selection. Iterative rounds of 
selection are performed, and the selection stringency and counterselections can be 
tailored to enrich for RNA sequences with high affinities and specificities to the target 
ligand. As one example, by incorporating counterselections against caffeine in the later 
selection rounds, an aptamer was selected to theophylline that exhibits a 10,000-fold 
lower affinity for caffeine, which differs from theophylline by a single methyl group (40). 
In vitro selection strategies have also been applied to the generation of novel ribozymes 
capable of RNA ligation (41). 
When utilizing RNA components generated through in vitro selection strategies 
for cellular applications, the activities of the in vitro optimized components may not 
translate directly to the complex cellular environment. Cell-based selection and screening 
strategies have been used to perform a secondary screen on in vitro enriched RNA 
component libraries by the component function to a measurable gene expression output. 
In one example, an in vitro enriched aptamer pool to a small molecule ligand, atrazine, 
was screened in E. coli through a cell-based motility assay (2). The RNA aptamer library 
was coupled to an RBS through a randomized linker region, where the resulting device 
library was linked to a gene that controls cell motility, such that functional aptamer 
sequences could be recovered from cells exhibiting greatest mobility in the presence of 
atrazine on solid medium. A similar approach has also been taken by directly inserting an 
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in vitro enriched aptamer pool to neomycin in the 5’ UTR of a GFP reporter gene in E. 
coli and screening for in vivo functional neomycin aptamers (42). The combined in vitro 
and in vivo approaches provide a powerful strategy for generating and tailoring new 
component functions for the cellular environment. 
 
1.4 Design strategies for small molecule-responsive synthetic RNA devices 
 Construction of RNA control devices generally starts by functionally linking 
sensor and actuator components to support transmission of information detected by the 
sensor into regulated activity of the actuator. Two strategies are generally taken in the 
design of RNA control devices: (i) direct linkage of sensor and actuator components; (ii) 
linkage of sensor and actuator components through a distinct information transmission 
component. In the first strategy, the regulatory effect is imparted by the resulting 
conformational change in the sensor component in the presence of the input signal, which 
directly affects the activity of the actuator component. In the second strategy, the 
transmitter component guides secondary structure changes in the sensor and actuator 
components, which direct these components between active and inactive conformations. 
Both modular and non-modular design strategies have been adopted in the construction of 
RNA controllers. Modular device design strategies introduce standardized 
communication interfaces between the sensor and actuator components to insulate the 
specific sequences of these components from one another, resulting in design platforms 
that support the interchange of functional components (i.e., sensor, actuator) without 
significant device redesign. Utilizing these design approaches researchers have 
constructed small molecule-responsive RNA control devices by coupling RNA aptamers 
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(sensors) to various gene-regulatory (actuator) components, whose mechanism of action 
is generally specific to the gene expression machinery associated with the host cell. 
 
1.4.1 Prokaryotes 
Small molecule-responsive control devices have been engineered in bacteria by 
modifying or adding component functions in natural riboswitch or regulatory elements. In 
one example, researchers modified the information transmission function encoded in a 
natural TPP-responsive riboswitch, which exhibits TPP-dependent gene repression, by 
randomizing a sequence within the riboswitch and screening the resulting library for new 
synthetic devices that exhibit TPP-dependent gene activation (43). In another example, a 
theophylline aptamer was coupled to a natural riboswitch through a randomized linker 
sequence and the resulting library was screened for devices that exhibit logic operations 
(AND, NAND) by modulating ribosome access to the RBS (44). RNA control devices 
have also been built by direct integration of RNA sensors into natural regulatory 
elements. A theophylline aptamer was integrated into a stem in the group I self-splicing 
intron from the bacteriophage T4 thymidylate synthase gene to construct a theophylline-
dependent RNA splicing device that regulated E. coli growth (45).  
The majority of small molecule-responsive RNA control devices in bacteria have 
been designed to control translation initiation, due to the relative ease with which 
ribosome loading can be modulated through structural rearrangement of the RBS. For 
example, RBS-based devices were built in E. coli by coupling a theophylline aptamer to 
the RBS through a linker sequence capable of structural rearrangement through strand-
displacement (46) or helix-slipping (47) mechanisms. The accessibility of the RBS 
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(related to its single-stranded state) is altered by ligand-dependent changes in base pairing 
interactions between the sensor and linker (strand-displacement) or local nucleotide shifts 
within the linker (helix-slipping). In the device design strategy based on strand 
displacement, part of the aptamer sequence directly interacts with the RBS sequence, 
such that independent modification of either component may disrupt these interactions 
and thus require redesign of the linker sequence to maintain device function. Therefore, 
cell-based screening strategies have been developed to support the identification of new 
linker sequences through colorimetric (48), flow cytometry (49), and motility assays (50). 
Other examples of RBS-based devices were designed by coupling a theophylline aptamer 
to an indirect actuator, a hammerhead ribozyme, which in turn was coupled to a direct 
actuator, a RBS (51,52). In this device design, the RBS is sequestered within the 
ribozyme stem, such that ligand-induced ribozyme cleavage results in unwinding of the 
ribozyme stem, thereby increasing ribosomal access to the RBS and thus gene expression 
levels. 
 
1.4.2 Yeast 
Different design approaches have been taken to engineer small molecule-
responsive RNA control devices in eukaryotes, as fewer examples of natural riboswitch 
elements are available to build from and more sophisticated gene-regulatory mechanisms 
are available than in prokaryotes. RNA control devices have been built by integrating the 
RNA sensor directly into part of the actuator component, such that the conformational 
change associated with ligand binding to the aptamer affects the activity of the actuator. 
In one example, a tetramethylrosamine (TMR) aptamer and a synthetic RNA 
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transcriptional activator were joined through the stem of the transcription activator, where 
part of the stem was randomized to allow screening for TMR-responsive gene-regulatory 
activity in Saccharomyces cerevisiae (53). In another example, a theophylline aptamer 
was integrated into the core cleavage region of a synthetic RNase III hairpin, which when 
placed in the 3’ UTR of a target transcript, directed cleavage and subsequent inactivation 
of that transcript in yeast (31). However, the binding of theophylline to the integrated 
aptamer restricts cleavage activity of the RNase III enzyme, thereby activating gene 
expression. Other small molecule-responsive RNA control devices have been built by 
integrating an aptamer in proximity to a 5’ splice site (54) or a branch point (55). As an 
example, a tetracycline aptamer in close proximity to a 5’ splice site, where the consensus 
sequence of the splice site is integrated into the aptamer stem (54). The binding of 
tetracycline to the aptamer results in a conformation that potentially prevents access to 
the splice site, thereby achieving ligand-dependent regulation of splicing.  
As a second design approach, composition frameworks have been developed to 
support the modular assembly of RNA control devices from underlying functional 
components in yeast (56). In the proposed framework, ribozyme-based devices were 
constructed by linking an aptamer to a hammerhead ribozyme through a distinct 
transmitter sequence designed to both encode the information processing function of the 
device and insulate the sensor and actuator components. This design strategy was 
demonstrated to support independent swapping of the sensor and transmitter components 
and thus tailoring of the encoded sensing and information processing functions without 
significant device redesign. Rational design strategies have been developed that utilize 
RNA structure prediction programs to guide sequence changes in the transmitter 
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component to alter the energetic values associated with alternate device conformations, 
thereby changing the energetic partitioning between functional states of the device and 
the resulting device regulatory activities (56,57). The composition framework also 
supported extension to the modular assembly of multiple sensor, transmitter, and actuator 
domains to construct devices that exhibit higher-order information processing functions, 
including logic operations, signal and bandpass filters, and programmed cooperativity 
(57). The utilization of ribozymes as actuators in this RNA device platform also allows 
for transportability of the device across different organisms, because the ribozyme 
activity is independent of cell-specific gene-regulatory machinery (3).  
 
1.4.3 Mammalian cells 
 RNA control devices in mammalian cells have been designed through numerous 
strategies ranging from directly adapting regulatory mechanisms that were developed in 
simpler organisms to taking advantage of the rich complexity of RNA processing 
pathways unique to higher organisms. Several RNA control devices have been developed 
through design strategies that directly integrate an RNA aptamer to a gene-regulatory 
element. These approaches have been applied to the design of small molecule-responsive 
RNA control devices that conditionally silence target genes through RNAi-mediated 
silencing mechanisms (58,59). These devices have been designed by integrating an RNA 
aptamer directly within the basal segments of a miRNA or in the loop region of a shRNA, 
such that binding of the input molecule prevents correct biogenesis of the RNAi substrate 
and thus results in increased target gene expression levels. Conditional RNAi silencing in 
response to a wide range of ligands, including theophylline, tetracycline, and xanthine, 
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have been demonstrated with these RNAi-based devices. While direct integration 
strategies generally limit the tuning of device regulatory activity that one can achieve 
through molecular alteration strategies, researchers demonstrated a tuning strategy for the 
miRNA-based device based on rational design of device clusters (59). 
 Other mammalian RNA control devices have been developed through design 
strategies that couple the sensor and actuator components through a distinct transmitter 
component. In one example, a transmitter and RNA aptamer were integrated into the 
loop region of a shRNA (60). In the active ligand-unbound conformation, the aptamer 
was incorrectly formed and the RNAi machinery correctly processed the device, 
resulting in silencing of the target gene. The inactive conformation of the device 
coincided with correct formation of the aptamer, such that binding of the small molecule 
input to the aptamer stabilized this conformation. The RNAi machinery did not correctly 
process this inactive conformation, thus resulting in increased target protein levels in the 
presence of input. As another example, the previously-described ribozyme-based 
devices, originally demonstrated in yeast, were shown to retain small molecule-
responsive gene-regulatory activity in mammalian cell culture and in vivo (3). RNA 
devices that incorporate a distinct transmitter component can generally be tuned by 
altering the sequence of the transmitter component to optimize the thermodynamics of 
the competing hybridization reactions underlying the strand-displacement mechanism. 
For both the shRNA- and ribozyme-based devices, sequence alterations within the 
transmitter components were used to optimize the regulatory performance of the 
resulting devices in mammalian cells (3,60). 
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1.5 Broad applicability of the small molecule-responsive synthetic RNA devices 
 Synthetic RNA control devices hold much promise for leading to transformative 
advances in how we interact with and program biology, providing access to otherwise 
inaccessible information on cellular state, and allowing sophisticated exogenous and 
embedded control over cellular functions. Small molecule-responsive synthetic RNA 
devices have been integrated into engineered biological systems for applications spanning 
biosynthesis, bioremediation, to health and medicine (Figure 1.2). 
 
 
 
Figure 1.2 RNA-based controllers have been integrated into engineered biological 
systems for applications spanning biosynthesis, bioremediation, to health and medicine. 
(A) A metabolite-responsive ribozyme-based device linked to a fluorescent reporter 
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output was demonstrated in yeast as a noninvasive sensor of metabolite concentration. 
(B) A pollutant-responsive RBS-based device linked to a motility gene output was 
demonstrated in bacteria to program the cells to move along a gradient of the pollutant. 
(C) A small molecule-responsive ribozyme-based device linked to a proliferative 
cytokine gene output was demonstrated in T cells to control T-cell survival. 
 
1.5.1 Implementation in genetic networks directed to biomanufacturing/biosynthesis 
applications 
 Small molecule-responsive synthetic RNA devices have important applications in 
biosynthesis processes, where they can be implemented as noninvasive sensors of 
metabolite accumulation and controllers for optimizing flux and product yield. In one 
example, an RNA control device was utilized for noninvasive detection of metabolite 
accumulation in yeast (56) (Figure 1.2A). Cells were engineered to express a construct 
harboring a xanthine-responsive ribozyme-based device regulating a GFP reporter gene. 
Xanthosine was fed to the yeast cells, which converted this fed substrate to xanthine 
through an endogenous enzyme activity. The conversion of xanthosine to xanthine was 
monitored indirectly as an increase in GFP levels, where increases in fluorescence 
correlated with increased product accumulation as measured by LC-MS. 
 
1.5.2 Implementation in genetic networks directed to environmental/agricultural 
applications 
 Small molecule-responsive synthetic RNA devices also have important 
applications in agricultural biotechnology and environmental remediation. In the latter 
case, engineered organisms that may be released into the environment will need precise 
control over designed functions and safety mechanisms in place to prevent uncontrolled 
release. In one example, an RBS-based RNA control device was implemented to detect a 
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toxic environmental pollutant, atrazine (2) (Figure 1.2B). The atrazine-responsive device 
was coupled to the cheZ gene to control the motility of an E. coli strain engineered to 
express an atrazine-catabolizing enzyme activity. The presence of atrazine activates the 
expression the cheZ gene, which allows cells to move along the source of the pollutant 
and convert atrazine into less harmful product, hydroxyatrazine.  
 
1.5.3 Implementation in genetic networks directed to health and medicine 
application 
Finally, small molecule-responsive synthetic RNA devices can be applied to 
improve the safety or efficacy of cell-based therapeutics. Recent progress has been made 
in the application of RNA devices to adoptive T-cell therapy, an approach currently in 
clinical trials, in which a patient’s own T cells are harvested and trained against tumor-
specific antigens or engineered to express chimeric antigen receptors before being 
injected back into the body. A major challenge associated with this strategy is ensuring 
that the T cells can survive and proliferate sufficiently when engrafted into the host to 
eradicate the diseased cells. To overcome this problem, small molecule-responsive RNA 
devices were applied to control T-cell proliferation in response to the application of drug 
molecules (3) (Figure 1.2C). Researchers placed ribozyme-based devices in the 3’ UTR 
of transcripts encoding the proliferative cytokines, IL-15 and IL-2, such that in the 
absence of the small molecule input the transcript was destabilized through ribozyme 
cleavage, resulting in reduced T-cell survival. In the presence of the drug input, IL-2 or 
IL-15 was produced, resulting in increased T-cell proliferation and survival. As a proof of 
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concept, this platform was shown to be modular in that aptamers to different small 
molecules (theophylline, tetracycline) were used to control the expression of different 
proliferative cytokines and hence proliferation of the T cells. The regulatory performance 
of the RNA-based system was tailored rationally by integrating multiple devices in series 
to improve the regulatory stringency. Currently, RNA sensors to clinically relevant 
molecules are needed to advance this strategy forward for therapeutic applications.  
 
1.6 Challenges for the scalable construction and programming of RNA devices 
 The broad implementation of synthetic RNA control devices in genetic networks 
will require enabling technologies that support scalable generation of new functional 
RNA components for the construction of devices and quantitative tailoring of device 
regulatory performance. Currently, the scalable construction of RNA devices is limited 
by a small number of existing functional RNA components, in particular components that 
exhibit sensing functions to desired molecular inputs for cellular engineering 
applications. While advances have been made in the generation of protein aptamers by 
utilizing high-throughput, high-efficiency, solution-based partitioning methods, such as 
capillary electrophoresis (61), the generation of small molecule aptamers still relies on 
low-throughput, inefficient, matrix-based partitioning methods (38,39), thus limiting our 
ability to generate new aptamers to diverse molecular ligands. 
Another challenge in the field is the reliable construction of devices from 
components to achieve desired regulatory performance for specific cellular engineering 
applications. The in vitro-generated components need to be linked to other functional 
component in order to construct synthetic control devices. The regulatory performance of 
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the resultant devices depends both on the component linkage strategy and the activities of 
individual components within the host cell. Therefore, the component activities may 
require further optimization in the context of the device and cellular environment to 
achieve desired gene-regulatory activities for the targeted applications. Cell-based 
selection and screening strategies have been developed by linking the gene-regulatory 
activities of the control devices to a single measurable gene expression output (48-50,62). 
Although these strategies have been demonstrated for tailoring device regulatory 
performance, the efficiency of these single-output methods can be negatively impacted by 
the stochastic nature of gene expression, thereby making these methods less quantitative 
and efficient. 
 
1.7 Interrelationship among the thesis projects 
To allow scalable construction and programming of RNA control devices, this 
thesis focuses on developing a scalable framework for generating new RNA component 
functions and quantitative tailoring of the resultant device functions for broad 
applications within cellular environments. Chapter 1 provides an overview of strategies in 
generating and optimizing RNA functional components and diverse approaches to the 
construction of small molecule-responsive synthetic RNA control devices.  
We focus primarily on the construction and programming of ribozyme-based 
devices, as devices utilizing ribozymes as actuator component have the advantage of 
being portable across different environments (i.e., in vitro, in vivo). Chapter 2 describes 
the development of a high-throughput and quantitative two-color FACS-based screen for 
efficient tailoring of RNA device activity. This screening strategy enables direct 
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generation and optimization of RNA component functions within the device platform in 
the cellular environment, which aids in the broader integration of these devices within 
biological networks. Chapter 3 describes work on an efficient cis-blocking strategy for in 
vitro ribozyme characterization, as our work demonstrated that the in vitro cleavage rates 
associated with these ribozyme-based devices are closely correlated to the corresponding 
gene-regulatory activities. Chapter 4 describes progress towards the development of a 
high-throughput, solution-based in vitro aptamer selection strategy based on the ribozyme 
device platform. The successful development of this method will enable the generation of 
new RNA aptamers to diverse small molecule ligands without the need of conjugation to 
a solid matrix. Ultimately, this method can be coupled to the two-color FACS-based 
screen, such that an in vitro enriched library can be subjected to a secondary screen for in 
vivo functional activity. Chapter 5 describes the development of a label-free and 
quantitative method supporting rapid characterization of RNA aptamers to small 
molecules. Chapter 6 describes the immediate efforts that need to be directed to 
integrating these enabling technologies into a scalable framework for the engineering of 
new synthetic devices. Collectively, this thesis describes powerful strategies for tailoring 
RNA control devices to respond to application-specific small molecule inputs with 
tailored regulatory properties, thereby enabling their effective implementation within 
biological networks.  
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Chapter 2.  
A high-throughput, quantitative cell-based screen for 
efficient tailoring of RNA device activity 
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Abstract 
Recent advances have demonstrated the use of RNA-based control devices to 
program sophisticated cellular functions; however, the efficiency with which these 
devices can be quantitatively tailored has limited their broader implementation in cellular 
networks. Here, we developed a high-efficiency, high-throughput, and quantitative two-
color FACS-based screening strategy to support the rapid generation of ribozyme-based 
control devices with user-specified regulatory activities. The high-efficiency of this 
screening strategy enabled the isolation of a single functional sequence from a library of 
over 10
6
 variants within two sorting cycles. We demonstrated the versatility of our 
approach by screening large libraries generated from randomizing individual components 
within the ribozyme device platform to efficiently isolate new device sequences that 
exhibit increased catalytic activity up to 6.8-fold and increased activation ratios up to 
160%. We also established a correlation between in vitro cleavage rates and in vivo gene-
regulatory activities, supporting the importance of optimizing RNA device activity 
directly in the cellular environment. We further demonstrated the utility of the generated 
devices to regulate cell fate determination through a MAPK pathway associated with the 
mating response in yeast, highlighting our two-color FACS-based screen as an important 
strategy in quantitatively tailoring genetic control devices for broader integration within 
biological networks. 
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2.1 Introduction 
The engineering of biological systems that exhibit complex functions has 
significant potential to develop solutions addressing global challenges spanning health 
and medicine, sustainability, and the environment (1-4). Core to the engineering of 
biological systems is the ability to process information within cellular networks and link 
this information to new cellular behaviors. Synthetic biology is a rapidly growing 
interdisciplinary field that involves the application of engineering principles to support 
the scalable construction and design of complex biological systems. One key focus of 
synthetic biology is to develop engineering frameworks for the reliable construction of 
genetic control devices that process and transmit information within living systems. Such 
information processing capabilities will allow researchers to implement diverse cellular 
control strategies, thus laying a critical foundation for designing genetic systems that 
exhibit sophisticated biological functions. 
RNA control devices represent an important class of synthetic genetic control 
devices, whose development has been fueled by advances in RNA biology, engineering, 
and nucleic acid computing (5-9). We recently described a modular ligand-responsive 
ribozyme-based platform that supports efficient tailoring of RNA device function (10). 
The ribozyme device platform specifies physical linkages between three functional RNA 
components: a sensor encoded by an RNA aptamer, an actuator encoded by a 
hammerhead ribozyme, and a transmitter encoded by a sequence that undergoes a strand-
displacement event (Figure 2.1). The dynamic range of an RNA control device, defined 
as the difference between gene expression levels in the presence and absence of ligand, is 
commonly described by two key parameters: basal activity and activation ratio. The basal 
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activity is a measure of regulatory stringency, which is set by the gene expression level in 
the absence of the input ligand, whereas the activation ratio is a measure of input 
responsiveness, which is set by the ratio of expression level in the presence to that in the 
absence of input ligand. The dynamic range exhibited by an RNA control device is 
important for its effective integration within biological systems. We have previously 
demonstrated a rational device tuning strategy guided by secondary structure predictions 
from an RNA folding program to direct the partitioning between the two functional 
device conformations (10). While we demonstrated the generation of a series of devices 
that span wide regulatory ranges, this strategy relies on predictions made by RNA folding 
programs, which base their computations on parameters acquired in vitro, and thus do not 
fully capture the complex RNA folding process in vivo. Therefore, an alternative strategy 
that enables more direct engineering of device dynamic ranges in the cellular 
environment is desired to increase the efficiency with which RNA devices can be tailored 
to cellular networks. 
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Figure 2.1 Schematic representation of modular assembly and mechanism of an RNA 
control device based on a ribozyme actuator. Ribozyme-based devices are constructed by 
modular assembly of three functional RNA components. A sensor (RNA aptamer) is 
linked to an actuator (hammerhead ribozyme) through a distinct information transmitter 
sequence (which directs a strand-displacement event and insulates the sensor and actuator 
components). Ribozyme-based devices are integrated into the 3’ untranslated region 
(UTR) of the target gene and can adopt at least two functional device conformations, 
where each conformation is associated with different actuator and sensor activities. In the 
depicted example, a ribozyme ON device (up-regulation of gene expression in response 
to increased input ligand concentration) adopts a ribozyme-active conformation 
associated with an aptamer ligand-unbound state, where ribozyme cleavage results in an 
unprotected transcript that is subject to rapid degradation by ribonucleases, thereby 
leading to a decrease in gene expression. The ribozyme-inactive conformation is 
associated with an aptamer ligand-bound state, such that ligand binding to the aptamer 
stabilizes the ribozyme-inactive conformation, thereby leading to an increase in gene 
expression in response to ligand.    
 
Significant research efforts have been directed toward developing high-
throughput in vitro and in vivo selection and screening strategies to generate RNA control 
devices with user-specified regulatory activities. In vitro selection strategies were applied 
to allosteric ribozymes to select for variants that exhibit enhanced ligand-responsive 
components
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cleavage activities (11,12). However, in one case the selected variants did not retain their 
enhanced activities in vivo, suggesting that the observed activities were sensitive to the 
environment in which the selection was performed (11). To address potential loss of 
activities in transitioning between in vitro and in vivo environments, researchers have 
developed cell-based selection and screening strategies to support direct generation of 
RNA control devices and regulatory components in the relevant environment.  
A cell-based selection strategy was developed to select for more active ribozyme 
variants by directly recovering cleaved ribozyme fragments from cells (13). However, 
this in vivo method decoupled cleavage activity from gene-regulatory activity, resulting 
in a less quantitative selection strategy that did not support effective identification of 
sequence variants with varying gene-regulatory activities. Cell-based screening and 
selection strategies have been developed for RNA control devices by introducing a 
randomized region into the device and linking the regulatory function of the resulting 
device library to a single measurable gene expression output, such as colorimetric and 
fluorescence levels (14-16), motility (17), or viability (18). However, the majority of 
these methods are most effective at enriching devices from the population exhibiting 
extreme (either low or high) gene expression levels, limiting the recovery of devices with 
specific quantitative activities. In addition, the enrichment efficiencies (or, alternatively, 
the throughput) of screening methods based on a single output can be negatively 
impacted by the stochastic nature of gene expression. In particular, when utilizing high-
throughput methods that measure activities within single cells, such as fluorescence-
activated cell sorting (FACS), the inability to resolve changes in gene expression activity 
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as a result of the genetic control device from cellular noise make single-output strategies 
less efficient and quantitative. 
In this work, we developed a new screening strategy that utilizes two measurable 
outputs to resolve device regulatory activity from cellular noise. A high-efficiency, high-
throughput, and quantitative two-color FACS-based screening strategy was developed to 
support rapid generation of RNA control devices with user-specified regulatory activities. 
We validated the high-efficiency of our screening strategy by performing a control sort to 
isolate the original functional sequence from a library over 10
6
 variants within just two 
sorting cycles. We demonstrated the versatility of our two-color FACS-based approach 
by screening large libraries generated from randomizing individual components within 
the ribozyme device platform to efficiently isolate devices with improved regulatory 
properties. Using this screening strategy we effectively isolated new ribozyme actuator 
sequences that increase catalytic activity up to 6.8-fold within the device platform and 
new transmitter sequences that increase activation ratios up to 160%. By generating 
variants of RNA components with varying quantitative activities, the in vivo device 
screening approach was used to elucidate sequence-function relationships of RNA 
components and relationships between ribozyme cleavage rates and gene-regulatory 
activities. Last, we applied a newly generated device from our screens to control the 
expression of a key component in a MAPK pathway associated with the mating response 
in yeast. The new device with improved regulatory stringency allowed for robust 
rerouting of the mating phenotype in response to a small molecule input. These results 
highlight the utility of our two-color screen in tailoring the quantitative regulatory 
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properties of RNA devices to support more effective programming of complex cellular 
behaviors. 
 
2.2 Results 
2.2.1 A two-color reporter construct supports a high-efficiency, high-throughput, 
quantitative, cell-based screening strategy 
Genetic control devices with desired regulatory activities are often generated 
through cell-based screening strategies by coupling the regulatory function to a 
measurable output. However, the efficiencies of high-throughput cell-based screening 
strategies based on measuring activities in single cells are negatively impacted by gene 
expression noise that arises from both extrinsic (e.g., cell size and shape, cell cycle stage, 
plasmid copy number) and intrinsic (e.g., fluctuation in numbers of DNA, RNA, 
transcription factors, environmental stimuli) factors (19,20). To develop a more effective 
and quantitative in vivo screening strategy for gene-regulatory devices, we constructed a 
screening plasmid composed of two independent functional modules (Figure 2.2A). The 
first module, the device activity reporter, utilizes a GFP reporter to measure the gene 
expression activity associated with the regulatory device, whereas the second module, the 
noise reporter, utilizes a mCherry reporter to provide a measure of cellular gene 
expression activity that is independent of the regulatory device. We used the same 
constitutive promoter (TEF1) in each module, although other promoter pairs may be 
substituted into the construct as previous studies in yeast suggest that extrinsic noise, 
which is the predominant source of gene expression noise, is not promoter specific (20). 
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Different terminators for each module were used to decrease the frequency of 
homologous recombination between the two modules. 
We first used the two-color screening construct to examine the basal activities of 
three previously characterized theophylline-responsive ribozyme-based devices (10) 
based on the output from the device activity reporter (GFP): L2bulge1 (L2b1), 40%; 
L2bulge5 (L2b5), 70%; and L2bulge8 (L2b8), 11%. The reported basal activities refer to 
the GFP expression levels relative to that of the inactive ribozyme control in the absence 
of theophylline. While these three devices exhibit a wide range of regulatory activities, 
cellular noise results in a broad distribution of GFP fluorescence levels, making it 
challenging to cleanly isolate members with target activities from a library through a 
FACS-based sorting strategy based solely on one output (Figure 2.2B, C). To provide a 
filter for changes in gene expression activity due to cellular noise, we used the noise 
reporter in the two-color screening construct to assess activity that is independent of the 
regulatory device. By using the output from the noise reporter (mCherry), we were able 
to normalize the gene expression activities of individual cells by correlating the outputs 
between the two reporters and cleanly resolve the cell populations harboring three 
different devices (Figure 2.2D). For each device, the cell population exhibits a tight linear 
relationship between the two outputs, such that the device regulatory activity is 
associated with a distinct slope (Supplementary Figure S2.1). The increased resolution 
between cell populations harboring devices with different regulatory activities enables the 
development of a high-efficiency, quantitative, two-color FACS-based screening strategy 
based on the output correlation between the two reporter modules (Figure 2.2E).  
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Figure 2.2 A high-efficiency, quantitative cell-based screening strategy for genetic 
devices based on a two-color screening construct. (A) The two-color screening construct 
is composed of two independent activity reporters. The device activity reporter measures 
the gene expression activity associated with the regulatory device from GFP fluorescence, 
whereas the noise reporter measures the cellular gene expression activity that is 
independent of the regulatory device from mCherry fluorescence. (B) Single-color (GFP) 
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scatter plots of three ribozyme-based devices that span a wide range of activities, as 
measured by their mean values, and cellular autofluorescence from a construct containing 
no fluorescence reporter gene exhibit significant overlap due to noise associated with 
gene expression. (C) Single-color (GFP) histograms illustrate that isolation of a device 
with a specific regulatory activity based on a single reporter output is inefficient due to 
overlapping population distributions. (D) The gene expression activities of individual 
cells can be normalized by correlating the device and noise reporter outputs from the two-
color screening construct. Cell populations harboring the three ribozyme-based devices in 
(B) can be cleanly resolved on a two-color scatter plot, where each population exhibits a 
tight linear relationship between the two outputs. (E) The two-color screening strategy is 
based on the output correlation between the two reporter modules. A library of control 
devices can be integrated in the two-color screening construct and transformed into the 
target cell host. The sorting gate is set by the two-color correlation (slope) associated 
with a control device that exhibits desired activity and applied to the library to 
specifically isolate a cell population that exhibits similar activity (slope). 
 
We demonstrated the high enrichment efficiency of our FACS-based two-color 
screening strategy by performing a control screen on a sensor library (sN10). The sN10 
sensor library was generated by randomizing 10 nt positions in the theophylline aptamer 
binding core (sensor component) within the L2b8 device (~1x10
6 
variants) (Figure 2.3A). 
We first assessed the basal activity of the sN10 sensor library through two-color flow 
cytometry analysis and observed that the majority of the library exhibits higher activity 
(greater slope) than the parent device (Figure 2.3B). We set a sorting gate based on the 
basal activity of the parent device (negative gate) and performed a negative sort to enrich 
cells (~10% of the initial library) that exhibit similar basal activities (same slope). We 
calculated the fold enrichment based on the percentage of the cell population isolated 
from each sort. In the initial negative sort, we collected 9.53% of the cell population and 
therefore this population was enriched ~11 times (100/9.53, or ~11-fold) for the 
subsequent screen. We performed a positive sort on the recovered cells, in which the 
lower bound of the sorting gate was set by the activity of the L2b8 device in the presence 
of 5 mM theophylline. The positive sorting gate was expanded further to enrich members 
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of the library (~7% of the enriched library) that exhibit equal or increased activities in 
response to theophylline relative to the parent device by ~15-fold. After one sorting cycle, 
a distinct small sub-population of cells that exhibit comparable basal activity to the parent 
device was observed. We then performed another round of sorting to specifically enrich 
this sub-population (~1% of the enriched library) through a negative sort by ~143-fold, 
followed by a positive sort on the recovered cells to enrich a clearly distinct cell 
population that exhibits increased gene expression activity (~4% of the enriched library) 
in response to theophylline by ~25-fold. After two sorting cycles, ~80% of the enriched 
library exhibits a clear population shift in response to theophylline (Figure 2.3C). 
 
 
Figure 2.3 Screening of a sensor library within the device platform demonstrates the high 
enrichment efficiency of the two-color sorting strategy. (A) A sensor library, sN10, is 
generated by randomizing 10 nts at key positions within the aptamer component in a 
previously engineered theophylline-responsive ribozyme-based device, L2b8. (B) The 
sN10 library is subjected to two sorting rounds. Each round consists of one negative sort 
in the absence of theophylline (light green gate set by the activity of the parent L2b8 
device in the absence of theophylline), followed by one positive sort in the presence of 
theophylline (dark green gate set by the activity of the parent L2b8 device in the presence 
A
C
0 mM Theo
5 mM Theo
B
6.52%
collected
0.71%
collected
4.28%
collected
mCherry
G
F
P
9.53%
collected
grown with 
theophylline
grown with 
theophylline
grown without 
theophylline
mCherry
G
F
P
grown with 
and without 
theophylline
44 
 
 
 
of 5 mM theophylline). Percentage of cells collected in the sorting gate is indicated on 
each plot. (C) After two sorting rounds, ~80% of the enriched sensor library exhibits a 
clear population shift in response to theophylline (theo). 
 
Since the two rounds of sorting yield an overall ~6×10
5
-fold enrichment, given an 
initial library diversity of ~10
6 
variants we expected to recover the original parent device 
from the enriched library by screening a small number of individual clones. We 
characterized 48 individual colonies from the enriched library for increased theophylline-
responsive activities through flow cytometry. All 48 colonies exhibit similar increases in 
GFP expression levels in response to theophylline as the parent L2b8 device. We 
sequenced the recovered devices from 10 colonies, and all were verified to be the parent 
sequence. These results demonstrate the high efficiency of our two-color FACS-based 
screening strategy, which can enrich a single sequence from a large ~10
6
 library to close 
to pure isolation in as few as two sorting rounds. The efficiency of our screening strategy 
is a direct result of the high resolving power of our two-color screening construct. For 
example, when examining the enriched library after one round of sorting, we could 
observe a distinct cell population that exhibits comparable basal activity to the parent 
L2b8 device on a two-color scatter plot (Supplementary Figure S2.2). However, when 
examining the cell population on a single-color (GFP) histogram, noise associated with 
the gene expression activity results in poor resolution between the device regulatory 
activity and cellular noise, thereby significantly decreasing the enrichment efficiency of a 
screening strategy based on a single output. 
 
2.2.2 Screening of an actuator library results in RNA control devices with improved 
regulatory stringencies 
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The implementation of RNA control devices in biological systems requires 
flexible tailoring of regulatory functions, where regulatory stringency of a device can be 
an important property for crossing phenotypic thresholds (1). The basal activity of a 
single ribozyme-based device depends on both the actuator and transmitter components. 
The catalytic activity of the hammerhead ribozyme (actuator) within the context of the 
device platform sets a lower limit to the minimal gene expression level a device exhibits 
in the absence of ligand, whereas the transmitter directs the partitioning between the 
functional conformations, which in turn impacts the basal activity (10). The device 
platform specifies the integration of a sensor-transmitter element through loop II (or loop 
I) of the satellite tobacco ringspot virus (sTRSV) ribozyme actuator. Previous sTRSV 
ribozyme characterization studies have demonstrated that a tertiary interaction between 
loop I and loop II is essential for the catalytic activity of the ribozyme in cellular 
environments (21). The integration of additional structural elements through the 
ribozyme loops may negatively impact the required loop-loop interaction, thus resulting 
in a less active ribozyme within the device platform. The previously described 
theophylline-responsive ribozyme devices (L2b1, 40%; L2b5, 70%; L2b8, 11%) exhibit a 
basal expression activity higher than that exhibited by the ribozyme alone (1%) 
(Supplementary Figure S2.3), suggesting that the current natural ribozyme sequence in 
the device platform may limit our ability to generate RNA control devices that exhibit 
tighter regulatory stringencies. 
 We focused initially on optimizing the sTRSV ribozyme sequence in the L2b8 
device as it has the lowest basal activity among the series of previously engineered 
theophylline-responsive devices (10). As prior sTRSV ribozyme characterization studies 
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have demonstrated that mutations to either loop I or II sequences can enhance or hinder 
ribozyme cleavage activity (21), we designed a device library by randomizing loop 
sequences and applied our two-color FACS-based screening approach to search for 
improved loop-loop interactions that support lower basal activity. We generated an 
actuator library (aN7) by randomizing 7 nts in loop I within the L2b8 device (~2x10
4
 
variants) (Figure 2.4A). Loop I was targeted for randomization as it is isolated from the 
conformational change that is facilitated by the transmitter component, which is 
integrated via loop II. We analyzed the initial aN7 actuator library by two-color flow 
cytometry analysis and observed that ~99% of the library exhibits a higher basal activity 
(greater slope) than the parent L2b8 device, indicating that the majority of loop I library 
sequences have deleterious effects on ribozyme catalytic activity (Figure 2.4B). The two-
color approach also enables us to clearly distinguish cells with low gene expression 
activity from cells that have lost or mutated the plasmid, whereas the two cell populations 
are almost indistinguishable if GFP is used as the only measure of device regulatory 
activity (Supplementary Figure S2.3). We set a sorting gate based on cells harboring the 
parent L2b8 device and collected cells that exhibit a decreased slope relative to the parent 
device (~0.4% of the initial library) to enrich library members with enhanced loop-loop 
interactions that support lower device basal activity. 
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Figure 2.4 Screening of an actuator library within the device platform results in ribozyme 
variants that exhibit improved gene-regulatory stringencies and cleavage rates. (A) An 
actuator library, aN7, is generated by randomizing 7 nts at key positions within the loop I 
region of the ribozyme actuator in the L2b8 device. (B) The aN7 library is subjected to a 
single sort to enrich for devices that exhibit lower basal gene expression levels than the 
parent L2b8 device. The majority (~99%) of the aN7 library exhibits a greater slope than 
that of the parent L2b8 device, such that one sort is sufficient to isolate members that 
exhibit improved regulatory stringency. (C) Ribozyme variants isolated from the aN7 
library screen exhibit lower basal activities relative to the parent L2b8 device. Gene-
regulatory activities are reported as the geometric mean of the GFP fluorescence of the 
indicated sample normalized to that of a positive control (sTRSV Contl, a noncleaving 
sTRSV ribozyme with a scrambled core) that is grown under identical ligand conditions 
and is set to 100%. Reported values are the mean and standard deviation of at least three 
independent experiments. (D) The recovered ribozyme variants (L2b8-al, -a14) exhibit 
faster cleavage rates than the parent device (L2b8). Cleavage assays were performed at 
37˚C with 500 µM MgCl2, 100 mM NaCl, 50 mM Tris-HCl (pH 7.0). Cleavage rate 
constants (k) and errors are reported as the mean and standard deviation from at least 
three independent assays. (E) In vitro cleavage kinetics of the ribozyme variants (L2b8-al, 
-a14) and the parent device (L2b8). The projected cleavage kinetics are generated from 
the single-exponential equation Ft = F0 + (F∞ − F0 )×(1 – e
−kt
), setting the fraction cleaved 
before the start of the reaction (F0) and at reaction endpoint (F∞) to 0 and 1, respectively, 
and k to the experimentally determined value for each RNA device. 
 
Due to the relatively small sequence space of the library and high-efficiency of 
our screen, we directly plated the sorted cells to obtain single colonies for further 
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characterization. We recovered a total of 22 clones and identified 22 unique device 
sequences from the recovered clones. However, only eight of the recovered devices 
maintained low basal activities upon re-cloning (Figure 2.4C), while the remaining 
devices likely had mutations within the recovered plasmid backbone. The basal activities 
exhibited by the recovered devices are up to 3.5-fold lower than that of the parent device, 
while five of the devices retained functional switching (i.e., responsiveness to ligand) 
(Supplementary Figure S2.4). 
We performed a sequence analysis to identify the loop I sequence requirements 
that support high ribozyme catalytic activity within the device platform. A series of point 
mutations to the recovered loop I sequences were designed, and the activities of these 
loop I sequences were characterized through flow cytometry analysis (Supplementary 
Figure S2.5). Two distinct consensus sequences were identified that support lower basal 
activities than the parent L2b8 device. RNA devices with a loop I heptaloop adhering to 
the consensus sequence AUNNRRG, where N is any nucleotide base and R is a purine 
base, exhibit basal activities that are less than or equal to that of the parent (11%). A 
subset of these devices with the loop I consensus sequence AU(C/U/G)NARG exhibit 
basal activities less than 80% of that of the L2b8 parent device. Further restricting the 
loop I consensus sequence to AUCNARG results in additional improvements to the basal 
activity, to 40% of that of the parent. RNA devices with a second, distinct loop I 
consensus sequence predicted to form a triloop N1UN2GGGN1
|
, where N1 and N1
|
 are any 
Watson-Crick base pair, exhibit improved basal activities less than 70% of that of the 
L2b8 parent. 
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2.2.3 Engineered actuator components result in optimized ribozyme-based devices 
exhibiting faster cleavage rates 
In vitro kinetic analysis of select ribozyme-based devices harboring loop I 
sequence modifications was performed to assess whether the improved in vivo basal 
activities were a result of increased catalytic rate relative to the parent device. Cleavage 
rates (k) were determined at physiologically-relevant reaction conditions (500 μM MgCl2, 
100 mM NaCl, and 50 mM Tris-HCl (pH 7.0)) at 37°C, where the submillimolar 
magnesium concentration is within the range estimated for intracellular magnesium 
concentration (22). Cleavage rate constants were obtained for the L2b8 parent device and 
the L2b8-a1 and -a14 engineered devices (Figure 2.4D, E) by quantifying relative levels 
of full-length and cleaved radiolabeled transcripts through polyacrylamide gel 
electrophoresis analysis (Supplementary Figure S2.6). Compared to the cleavage rate 
constant of L2b8 (0.14 min
-1
), the cleavage rates associated with the engineered devices 
are increased 5- and 6.8-fold for L2b8-a1 (0.70 min
-1
) and -a14 (0.92 min
-1
), respectively. 
The cleavage rate of the sTRSV hammerhead ribozyme (4.3 min
-1
) was determined at 
these conditions to be 45-fold greater than L2b8 (Supplementary Figure S2.6), in 
agreement with prior analyses on this ribozyme (21) and other well characterized natural 
ribozymes under physiologically relevant conditions (23). The results indicate that the 
modified loop I sequences produce ribozyme-based devices exhibiting faster cleavage 
rates and thus lower basal expression levels. 
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2.2.4 Screening of transmitter libraries results in RNA devices exhibiting improved 
activation ratios 
The dynamic range of an RNA control device depends on many parameters, 
including irreversible rate (e.g., ribozyme cleavage activity), intracellular ligand 
concentration, and mechanism by which binding information at the sensor is transmitted 
to an activity change in the actuator (e.g., transmitter design). We applied our two-color 
FACS-based screening strategy to explore a greater functional space to search for new 
transmitter sequences that support improved activation ratios given the designated sensor 
and actuator component pairs. We generated two transmitter libraries, tN11 and a1-tN11, 
based on two theophylline-responsive ribozyme-based devices, L2b8 and L2b8-a1, 
respectively, with ribozyme components that exhibit varying catalytic activities. Both 
libraries were generated by randomizing 11 nts in the transmitter component within the 
corresponding parent device (~4x10
6
 variants) (Figure 2.5A). We limited the number of 
randomized nucleotides in the transmitter components to result in libraries that could be 
completely searched based on the efficiency of our yeast library transformation method 
(see Materials and Methods). Both libraries were screened to identify devices with 
comparable basal activities but with greater activation ratios relative to the corresponding 
parent devices (Figure 2.5B, D). We first performed a negative sort on both libraries by 
setting the sorting gates based on the basal activity of the respective parent device. The 
negative sort enriched members of the library (~3% of the initial tN11 library; ~5% of the 
initial a1-tN11 library) that exhibit lower or comparable basal activities as the parent 
device. A subsequent positive sort was performed on the recovered cell populations by 
setting sorting gates based on the gene expression activity of the respective parent device 
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in the presence of 5 mM theophylline. To enrich members of the library that exhibit 
improved activation ratios, cells that exhibit equal or higher gene expression activities 
(~0.3% of the enriched tN11 library; ~0.4% of the enriched a1-tN11 library) were 
isolated. One additional positive sort was performed on the enriched tN11 library to 
further enrich for cells that exhibit activation ratios greater than or equal to the parent 
device (~24% of the enriched library). 
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Figure 2.5 Screening of transmitter libraries within the device platform results in 
transmitter variants that exhibit improved activation ratios. (A) Two transmitter libraries, 
tN11 and a1-tN11, are generated by randomizing 11 nts within the transmitter 
components in the L2b8 (wild-type ribozyme actuator) and L2b8-a1 (enhanced ribozyme 
actuator) devices, respectively. (B) The tN11 library is subjected to one sorting round 
(negative and positive sort), followed by an additional positive sort to further enrich 
members of the library that exhibit equal or greater increases in gene-regulatory activities 
in response to theophylline. The negative (light green) and positive (dark green) sorting 
gates are set based on the activity of the parent L2b8 device in the absence and presence 
of 5 mM theophylline, respectively. (C) Transmitter variants isolated from the tN11 
library screen exhibit improved activation ratios. Gene-regulatory activities are reported 
as described in Figure 2.4C. Reported values are the mean and standard deviation of at 
least three independent experiments. The activation ratio (AR) is determined as the ratio 
of gene expression levels in the presence and absence of theophylline. (D) The a1-tN11 
library is subjected to one sorting round to enrich members of the library that exhibit 
equal or greater increased in gene-regulatory activities in response to theophylline. The 
negative (light green) and positive (dark green) sorting gates are set based on the activity 
of the parent L2b8-a1 device in the absence and presence of 5 mM theophylline, 
respectively. (E) Transmitter variants isolated from the a1-tN11 library screen exhibit 
improved activation ratios. Gene-regulatory activities are reported as described in Figure 
2.4C. Reported values are the mean and standard deviation of at least three independent 
experiments. 
 
We plated the recovered cells from both final enriched libraries and screened 287 
and 207 individual colonies from the tN11 and a1-tN11 libraries, respectively, through 
flow cytometry in the absence and presence of 5 mM theophylline and verified improved 
device activation ratios by re-cloning. We identified a total of five (t11, t24, t47, t197, 
t241) and three (a1-t41, a1-t55, a1-t64) transmitter variants from the tN11 and a1-tN11 
library screen, respectively, that exhibit moderately improved activation ratios up to 
160% relative to the parent devices (Figure 2.5C, E). We speculated that the intracellular 
theophylline concentration in yeast might limit the maximum activation ratio achievable 
by a device, as previous studies have estimated an 1000-fold drop in theophylline 
concentration across the Escherichia coli cell membrane (24). We tested this hypothesis 
by characterizing the activation ratios of the transmitter variants at a higher theophylline 
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concentration (40 mM) and observed devices with activation ratios up to 10.7-fold, 
corresponding to up to a 290% improvement in activation ratios relative to 5 mM 
theophylline (Supplementary Figure S2.7, S2.10). No difference in cell viability was 
observed under all theophylline conditions tested (Supplementary Figure S2.8A), 
although the higher theophylline concentration resulted in slower cell growth, possibly 
due to the ligand cytotoxicity, thus potentially rendering the implementation of these 
devices at higher ligand concentrations less effective for cellular applications. 
 
2.2.5 Modular assembly of optimized actuator components results in devices 
exhibiting improved regulatory stringencies 
The modular composition framework of our ribozyme device platform supports 
modular assembly of functional RNA components to generate new device functions 
without significant redesign (10,25). We examined the ability of the optimized ribozyme 
sequences to be used to build new device regulatory functions, by coupling two of the 
recovered ribozyme variants (a1, a14) with different sensor and transmitter components. 
We coupled the new actuator sequences with the transmitter and sensor components from 
two theophylline-responsive ribozyme ON devices (L2b1, L2b5), one theophylline-
responsive OFF device (L2bOFF1), and one tetracycline-responsive ON device (L2b8tc) 
to generate eight new devices. All newly generated devices exhibit lower basal activities 
relative to their respective parent, and the majority of them retain switching activity 
(Supplementary Figure S2.9A-D). The ribozyme variants were also coupled with selected 
transmitter variants to generate new functional devices with varying regulatory 
stringencies and activation ratios (Supplementary Figure S2.10). The results indicate that 
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the improved ribozyme variants are relatively insensitive to the sequence identities of the 
other device components (transmitter, sensor) and highlight that the modular device 
platform can be used in combination with improved components to program RNA 
devices exhibiting desired activities. Finally, we examined the activities of the loop 
sequences outside of the device context by replacing the wild-type loop I sequence of 
sTRSV to generate two ribozyme variants (Supplementary Figure S2.9E). The gene 
expression activities of the resulting ribozyme variants were substantially higher than that 
of wild-type sTRSV, indicating that the improvement in regulatory stringencies 
associated with these loop sequences were specific to the context of the device platform, 
thus supporting the importance of optimizing component functions directly within the 
device platform. 
 
2.2.6 In vitro cleavage kinetics reflect in vivo RNA device gene-regulatory activities 
The observation that loop I modified ribozyme-based devices exhibit improved in 
vivo basal activities and in vitro cleavage rates relative to the L2b8 parent device suggests 
a correlation between these two measures of activity. However, previous studies had 
shown that allosteric ribozymes exhibiting enhanced in vitro cleavage rates through in 
vitro selections failed to exhibit enhanced in vivo gene-regulatory activities (11). 
Therefore, we examined the relationship between in vitro cleavage rates and in vivo gene-
regulatory activities for a set of RNA devices generated through the two-color screening 
and rational tuning strategies. Cleavage assays were performed under the previously 
described physiologically-relevant reaction conditions in the absence and presence of 5 
mM theophylline (Supplementary Figure S2.6). The ribozyme-based devices exhibit 
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cleavage rates that span approximately two orders of magnitude from 0.01 min
-1
 (L2b5) 
to 1.0 min
-1
 (L2b8-a1, a14) (Figure 2.6A, B). Nearly all of the examined RNA devices 
exhibit reduced cleavage rates in the presence of theophylline, except for L2b8-a14, 
which did not exhibit changes in gene-regulatory activity in response to theophylline 
(Supplementary Figure S2.4). The rank ordering of the examined RNA devices and the 
sTRSV ribozyme control by in vitro-determined cleavage rates matches the inverse 
ranking by in vivo gene-regulatory activities (Figure 2.6C). A correlation analysis 
between these two measures of activity indicates a strong negative correlation (Pearson 
coefficient, r = -0.9018) between the cleavage rates 0.007 and 0.16 min
-1
, where at a 
cleavage rate of 0.16 min
-1
 near background levels of gene expression are reached such 
that further decreases in gene-regulatory activity are not observed with faster cleavage 
rates. 
 
Figure 2.6 In vitro cleavage kinetics of selected ribozyme-based devices and controls. 
Cleavage assays were performed at 37˚C with 500 µM MgCl2, 100 mM NaCl and 50 mM 
Tris-HCl (pH 7.0) and in the presence of 5 mM theophylline when indicated. (A) 
Ribozyme-based devices exhibit decreased cleavage rates in the presence of ligand. 
Cleavage assays were performed as described in Figure 2.4D in the absence or presence 
of 5 mM theophylline. (B) In vitro cleavage kinetics of ribozyme-based devices in the 
absence and presence of ligand. Projected cleavage kinetics are generated as described in 
Figure 2.4E. Solid lines: 0 mM theophylline; dashed lines: 5 mM theophylline. (C) 
Correlation analysis of normalized gene expression levels and cleavage rate constants 
indicates a strong correlation between the in vivo gene-regulatory activity and in vitro 
cleavage rate; Pearson correlation coefficient (r) of -0.9018. A semi-log line is well-fit 
(R
2
 = 0.94) for cleavage rates less than or equal to 0.16 min
-1
 (black data points). Devices 
excluded from this analysis are indicated in red. 
BA C
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2.2.7 RNA control devices with improved regulatory stringency allow for robust 
redirecting of yeast mating fates 
To achieve robust control of cell fate, the dynamic range of a genetic device must 
cross the threshold activity of the gene associated with the phenotypic change in the 
absence and presence of input molecule. RNA control devices have been integrated with 
biological systems to program complex cellular behaviors, such as proliferation and 
apoptosis (1,2). In these and other systems, devices with more stringent regulatory 
activities are necessary to sufficiently reduce background expression to achieve the 
desired control over the targeted phenotype. From our two-color FACS-based screens, we 
isolated new device variants that exhibit more than 3.5-fold lower basal activities relative 
to the parent device. To demonstrate the utility of devices with improved regulatory 
stringency, we applied these devices to control cell fate determination through a MAPK 
pathway associated with the mating response in yeast (Figure 2.7A). 
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Figure 2.7 Fate routing in the yeast mating pathway with RNA devices. (A) Signaling 
through the yeast mating pathway starts with pheromone (α-factor) binding to a 
transmembrane receptor. Receptor binding is transmitted to the scaffold-bound canonical 
three-tiered MAPK cascade via a phosphorylation relay. Msg5 antagonizes signaling by 
dephosphorylating Fus3. Translocation of the phosphorylated MAPK, Fus3, to the 
nucleus initiates transcription at mating genes. Pathway activation is indicated by 
increased GFP levels (from a transcriptional fusion to the mating-responsive promoter 
FUS1p) and cell cycle arrest (observed via halo assays). (B) Schematic representation of 
fate routing constructs, where ribozyme-based devices and controls are placed 
downstream of a TEF1m7p-Msg5 cassette. (C) Gene-regulatory activities of RNA 
devices and controls utilized to regulate the yeast mating pathway. Gene-regulatory 
activities are reported as described in Figure 2.4C. Reported values are the mean and 
standard deviation of at least three independent experiments. (D) Stringent control of a 
negative regulator component in the yeast mating pathway is necessary to regulate 
pathway activation. Normalized pathway activity is reported as the geometric mean of 
three biological replicates normalized to FUS1p-yEGFP3 expression in the absence of 
MSG5 expression, and error bars represent the standard deviation of the replicates. (E) 
Stringent control of a negative regulatory component in the yeast mating pathway is 
necessary to route cellular fate. Halo formation is a direct read-out of pheromone-induced 
cell cycle arrest, where reduced halo formation in the presence of pheromone indicates 
pathway inhibition. Notably, halo formation is inhibited for the systems implementing 
L2b8 and sTRSV Contl as controllers in the absence or presence of theophylline. In 
contrast, the system implementing L2b8-a1 exhibits normal halo formation in the absence 
of theophylline (comparable to sTRSV) and significantly reduces halo formation in the 
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presence of theophylline. Representative images from three biological replicates are 
shown. 
 
 We targeted a key negative regulator in the mating pathway, Msg5, which is a 
MAPK phosphatase that inactivates signaling through this pathway by dephosphorylating 
the MAPK Fus3 (26). We first examined the impact on cell fate by ectopically expressing 
Msg5 regulated by either the wild-type ribozyme (sTRSV) or the inactive ribozyme 
(sTRSV Contl) controls (Figure 2.7B, C). These two controls represent the minimal and 
maximal expression levels of Msg5 in our synthetic system, and the corresponding 
pathway activation was analyzed through a fluorescent reporter assay that measures 
transcriptional activation of the pathway and a phenotypic assay that measures cell cycle 
arrest in the presence of pheromone (Figure 2.7D, E). The low expression level of Msg5 
associated with the sTRSV construct allowed pathway activation in the presence of the 
pheromone, thereby leading to high GFP levels and wild-type halo formation. In contrast, 
the high expression level of Msg5 associated with the sTRSV Contl construct inhibited 
pheromone-induced pathway activation, thereby eliminating cell cycle arrest and 
resulting in low GFP levels. 
To redirect yeast mating behavior in response to an exogenously applied 
molecular input, we implemented two theophylline-responsive ribozyme ON devices, 
L2b8 and L2b8-a1, to conditionally regulate expression of Msg5 (Figure 2.7B, C). The 
L2b8 device exhibits the lowest basal expression activity (11%) among the devices 
previously engineered through a rational design strategy (10). However, the basal 
expression level of Msg5 associated with the L2b8 device inhibited pathway signaling 
sufficiently to eliminate cell cycle arrest in the presence of pheromone even in the 
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absence of theophylline (Figure 2.7D, E). In contrast, the newly selected L2b8-a1 device 
exhibits a more stringent control profile than that of the L2b8 device and when applied to 
the regulation of Msg5 achieved rerouting of cell fate in response to the small molecule 
input. In the absence of theophylline, the basal expression level of Msg5 associated with 
the L2b8-a1 device was sufficiently low to permit elevated pathway activity in response 
to pheromone and characteristic halo formation as is observed for the wild-type ribozyme 
control. In the presence of theophylline, the increased expression level of Msg5 inhibited 
pathway activation sufficiently to reduce pheromone-induced cell cycle arrest, 
diminishing the appearance of the halo as is observed for the inactive ribozyme control. 
These results highlight the importance of tunable controllers, including those exhibiting 
stringent profiles, in targeting thresholds of key pathway components to achieve desired 
phenotypic switching. Although the L2b8 device exhibits a greater activation ratio 
relative to that of the L2b8-a1 device (Supplementary Figure S2.4), the higher basal 
activity of the L2b8 device rendered it ineffective in redirecting cell fate in this system. 
 
2.3 Discussion 
We developed a two-color FACS-based screening approach that enables the 
efficient isolation of devices with targeted regulatory activities (enriching a single 
sequence from a large ~10
6
 library to close to pure isolation in two sorting rounds), 
providing a substantial improvement over the enrichment efficiencies of more commonly 
used single output screening strategies that can be negatively impacted by noise 
associated with gene expression. We applied our two-color screening approach to 
optimize the actuator and transmitter components directly within the context of the 
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ribozyme device platform in the relevant cellular environment, thereby addressing 
challenges previously encountered with optimizing component activities through in vitro 
strategies (11). The highly quantitative nature of our screening approach allowed us to 
efficiently isolate ribozyme and transmitter variants that exhibit specified regulatory 
activities. Our two-color screening approach is also fully complemented by the modular 
composition framework of the ribozyme-based platform. We demonstrated a plug-and-
play device construction strategy by linking components with varying activities to 
generate new RNA devices that span wide regulatory ranges. In comparison to the 
previously demonstrated computational-guided device tuning strategy, which is restricted 
to experimentally sampling a smaller sequence space, our two-color screening approach 
offers greater flexibility and higher-throughput in quantitatively tailoring device 
regulatory properties. 
We further characterized the isolated ribozyme and transmitter variants in 
addition to the devices generated previously by rational design through both in vivo and 
in vitro assays and found a strong negative correlation between gene-regulatory activities 
and cleavage rates, for cleavage rates within the range of 0.007 and 0.16 min
-1 
(measured 
at the specified reaction condition of 500 M MgCl2). Gene expression levels reach 
background values at ~0.16 min
-1
, such that that increases in cleavage rate above this 
value have minimal impact on expression levels. In addition, our analysis (Figure 2.6C) 
indicates that below cleavage rates of ~0.007 min
-1
 gene expression levels reach 
saturating (fully ON) levels, such that further decreases in cleavage rate below this value 
do not significantly impact gene expression. Our work demonstrates that there is a narrow 
window of in vitro cleavage rates (spanning less than two orders of magnitude) that 
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correspond to titratable in vivo gene-regulatory activities. This observation may explain 
previous work in the field that observed no changes in gene-regulatory activities between 
ribozyme variants exhibiting different cleavage rates, if the changes in cleavage rates 
were occurring outside of the titratable window (13). 
Our results also highlight the importance of optimizing individual components 
within the context of device platforms. The parent actuator component (sTRSV ribozyme) 
is a type-III hammerhead ribozyme, in which the 5’ and 3’ ends of viroid RNA extend 
from stem III. The tertiary interactions essential for cleavage activity at physiological 
conditions are formed by a Watson-Crick base triple between the 5’ U of loop I, next-to-
last U of loop I, and the 3’ A of loop II. Recent structural analyses have shown that these 
essential tertiary interactions are conserved across a significant fraction of natural 
hammerhead ribozymes (27). As the loop I sequence of the originally designed ribozyme-
based devices, including the parent device L2b8, is unchanged from the native sTRSV 
ribozyme (UGUGCUU), it was assumed that aptamer integration into loop II would 
maintain the same tertiary interactions required for cleavage activity (10). However, both 
the heptaloop (AUCNARG) and triloop (N1UN2GGGN1
|
) consensus sequences identified 
through the actuator library screen that result in devices exhibiting lower basal activities 
than the L2b8 parent device do not follow the common tertiary motif of the sTRSV 
ribozyme. The divergence of the improved loop I sequences from the L2b8 and sTRSV 
parents are not necessarily surprising, given recent work identifying thousands of new 
hammerhead ribozymes in all domains of life with unique tertiary motifs (27-29). In 
particular, the integration of the transmitter-aptamer element into loop II of the sTRSV 
hammerhead ribozyme in the device platform makes the overall structure of the 
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ribozyme-based devices more similar to other, less well-characterized hammerhead 
ribozymes (Supplementary Figure S2.11). Interestingly, the improved loop I consensus 
sequences identified in our screen share similarities to these other natural ribozymes and 
do not exhibit improved activities in the context of the sTRSV ribozyme alone. 
Finally, we demonstrated the utility of our newly selected device variants to 
control the expression level of a key negative regulator in the yeast mating pathway 
through an exogenously applied molecular input. In this particular system, the regulated 
pathway component exhibits a low threshold level, thus requiring a regulatory device 
with low background activity to permit pathway activation in the absence of the effector 
molecule. We applied one of the selected device variants with improved regulatory 
stringency to achieve phenotypic switching in response to the exogenous molecular input, 
whereas the original device was ineffective in redirecting cell fate. These results highlight 
the importance of fine-tuning regulatory properties of gene-regulatory elements for their 
successful integration within biological systems. Recent examples have relied on using 
low-throughput and inefficient single-color screening strategies on individual clones from 
libraries of control elements, including promoters and RNase cleavage sites, to identify 
new elements that exhibit varying activities in different organisms (30-32). In contrast, 
our two-color FACS-based screening approach is based on the correlation between the 
gene outputs from two independent functional modules. Similar dual-reporter screening 
plasmid systems can be constructed in other organisms, including bacteria and 
mammalian cells, to support the efficient generation of new gene control elements, 
including those acting through transcriptional and posttranscriptional mechanisms. Our 
strategy offers a high-throughput and high-efficiency alternative to rapidly screen through 
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diverse libraries of control elements for members exhibiting specified quantitative 
activities, thereby addressing a key challenge in quantitatively tailoring these control 
elements to specific genetic systems. 
 
2.4 Materials and Methods 
2.4.1 Plasmid and strain construction 
Standard molecular biology cloning techniques were used to construct all 
plasmids (33). DNA synthesis was performed by Integrated DNA Technologies 
(Coralville, IA) or the Protein and Nucleic Acid Facility (Stanford, CA). All enzymes, 
including restriction enzymes and ligases, were obtained through New England Biolabs 
(Ipswich, MA). Ligation products were electroporated with a GenePulser XCell (Bio-Rad, 
Hercules, CA) into an E. coli DH10B strain (Invitrogen, Carlsbad, CA), where cells 
harboring cloned plasmids were maintained in Luria-Bertani media containing 50 mg/mL 
ampicillin (EMD Chemicals, Philadelphia, PA). All cloned constructs were sequence 
verified by Elim Biopharmaceuticals (Hayward, CA). 
The two-color screening plasmid pCS1748 (Supplementary Figure S2.12) was 
constructed by inserting an open reading frame (ORF) encoding a yeast-optimized 
mCherry gene (ymCherry) flanked by a TEF1 promoter and a CYC1 terminator upstream 
of the existing ORF encoding a yeast-enhanced GFP gene (yEGFP3) flanked by a GAL1-
10 promoter and an ADH1 terminator in the pCS321 backbone (10). The TEF1 promoter 
was PCR amplified from pG2M (34) using forward and reverse primers SacI-TEF1-fwd 
(5’-GAGAGCTCAAGCTTCAAAATGTTTCTACTCC) and SacII-TEF1-rev (5’-
GGCCGCGGCAAAACTTAGATTAGATTGCTATGC), respectively, and inserted into 
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pCS321 via the unique restriction sites SacI and SacII. The ymCherry gene was PCR 
amplified from BBa_E2060 obtained from the iGEM parts registry (35) using forward 
and reverse primers SacII-mCherry-fwd (5’-
GACCGCGGGAAATAATGTCTATGGTTAGTAAAGGAGAAGAAAATAACATGG
C) and NotI-mCherry-rev (5’-
GGGCGGCCGCTTATTATTTGTATAGTTCATCCATGCCACCAG), respectively, and 
inserted downstream of the cloned TEF1 promoter via the unique restriction sites SacII 
and NotI. The CYC1 terminator was PCR amplified from pCM159 (36) using forward 
and reverse primers NotI-CYC1t-fwd (5’-GAGCGGCCGCGAGGGCC 
GCATCATGTAATTAG) and XbaI-CYC1t-rev (5’-
GGTCTAGAGGCCGCAAATTAAAGCCTTCG), respectively, and inserted 
downstream of the cloned ymCherry gene via the unique restriction sites NotI and XbaI. 
A spacer sequence was amplified from pCS745 (gift from M. Jensen, Seattle Children’s 
Research Institute) using forward and reverse primers XbaI-Spacer-fwd (5’-
GGTCTAGACGCCTTGAGCCTGGCGAACAGTTC) and Spacer-rev (5’-AGTAAAA 
AAGGAGTAGAAACATTTTGAAGCTATCGATGACAGGATGAGGATCGTTTCGC
ATG), respectively. A TEF1 promoter fragment was amplified from pG2M using 
forward and reverse primers Spacer-TEF1-fwd (5’-
CATGCGAAACGATCCTCATCCTGTCATCGATAGCTTCAAAATGTTTCTACTCC
TTTTTTACT) and BamHI-TEF1-rev (5’-GGGGATCCCAAAACTTAG 
ATTAGATTGCTATGCTTTCTTTC), respectively, and PCR assembled with the spacer 
fragment. The assembled spacer-TEF1 promoter fragment was inserted into the modified 
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pCS321 backbone to replace the GAL1-10 promoter via the unique restriction sites XbaI 
and BamHI. 
Two single-color plasmids harboring GFP (pCS1585) and mCherry (pCS1749) 
were constructed as compensation controls for FACS analysis. A fragment harboring the 
TEF1 promoter was PCR amplified from pGM2 using forward and reverse primers SacI-
TEF1-fwd (5’-GAGAGCTCATAGCTTCAAAATGTTTCTACTCC) and EcoRI-TEF1-
rev (5’-GGGAATTCT TTGTAATTAAAACTTAGATTAGA), respectively. The GFP-
only plasmid pCS1585 was constructed by inserting the TEF1 promoter fragment into 
pCS321 to replace the GAL1-10 promoter via the unique cloning sites SacI and EcoRI. 
The mCherry-only plasmid pCS1749 was constructed by inserting the TEF1p-ymCherry–
CYC1t cassette from pCS1748 into a modified version of pRS316 (37) via the unique 
restriction sites SacI and XbaI. The modified version of pRS316 (pCS4), containing no 
fluorescence reporter gene, was used as the negative-control construct. 
Ribozyme-based devices and appropriate controls were inserted into the 3’ 
untranslated region (UTR) of yEGFP3 in pCS1748 through appropriate restriction 
endonuclease and ligation-mediated cloning. DNA fragments encoding the ribozyme-
based devices and controls were PCR amplified using forward and reverse primers L1-2-
fwd (5’-GACCTAGGAAACAAACAAAGCTGTCACC) and L1-2-rev (5’-
GGCTCGAGTTTTTATTTTTCTTTTTGCTGTTTCG), respectively, and inserted into 
pCS1748 via the unique restriction sites AvrII and XhoI, which are located 3 nts 
downstream of the yEGFP3 stop codon. Cloned plasmids were transformed into the 
budding yeast Saccharomyces cerevisiae strain W303a (MATa his3-11, 15 trp1-1 leu2-
3 ura3-1 ade2-1) through a standard lithium acetate method (38). All yeast strains 
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harboring cloned plasmids were maintained on synthetic complete media with a uracil 
dropout solution containing 2% dextrose (SC-URA) and grown at 30ºC. 
The mating fate routing plasmid pCS2293 was constructed by cloning a TEF1 
mutant 7 (TEF1m7) promoter (31), and the coding region for Msg5 into the pCS321 
backbone (10). The TEF1m7 promoter was PCR amplified from pCS1142 using forward 
and reverse primers pTEF7-fwd (5’-AAGAGCTCATAGCTTCAAAATGTCTCT 
ACTCCTTTTT) and pTEF7-rev (5’-
AAAGGATCCAACTTAGATTAGATTGCTATGCTTTCTTTCC), respectively, and 
inserted into pCS321 via the unique restriction sites SacI and BamHI. The MSG5 gene 
was PCR amplified from genomic DNA using forward and reverse primers Msg5.K2-fwd 
(5’-AAAGGATCCAATTAATAGTGCACATGCAATTTCAC) and Msg5-rev (5’-
AAAACCTAGGTTAAGGAAGAAACATCATCTG), respectively, and inserted via the 
unique restriction sites BamHI and AvrII. Ribozyme-based devices and appropriate 
controls were inserted into the 3’ UTR via the unique restriction sites AvrII and XhoI, 
located immediately downstream of the MSG5 stop codon as described previously. 
The mating reporter construct (pCS1124) was built by cloning FUS1p, a mating-
responsive promoter, into the pCS321 backbone (10). The FUS1 promoter was PCR 
amplified from pDS71 (39) using forward and reverse primers pDS71.Fus1-fwd (5’-
TTTGCGGCCGCCCAATCTCAGAGGCTGAGTCT) and pDS71.Fus1-rev (5’-
TTTGGATCCTTTGATTTTCAGAAACTTGATGGC), respectively, and inserted 
upstream of yEGFP3 in pCS321 via the unique restriction sites NotI and BamHI. The 
FUS1p-yEGFP3-ADH1t cassette from pCS1124 was cloned into pCS1391, a loxP 
integrating vector (40), via the unique restriction sites SacI and KpnI to make pCS2292. 
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FUS1p-yEGFP3-ADH1t was chromosomally integrated into yeast strain EY1119 
(W303a ∆sst1 ∆kss1::HIS3) (41) via homologous recombination using the gene cassette 
from pCS2292 to construct yeast strain CSY840 (W303a ∆sst1 ∆kss1::HIS3 
trp1::FUS1p-yEGFP3-ADH1t-loxP-KanR). Briefly, the FUS1p-yEGFP3-loxP-KanR 
cassette was PCR amplified using Expand High Fidelity PCR system (Roche, 
Indianapolis, IN) from pCS2292 using forward and reverse primers TRP1.INT.all.fwd 
(5’-
GTATACGTGATTAAGCACACAAAGGCAGCTTGGAGTATGTCTGTTATTAATTT
CACAGGAAGATTGTACTGAGAGTGCAC) and TRP1.INT.all.rev (5’-
TTGCTTTTCAAAAGGCCTGCAGGCAAGTGCACAAACAATACTTAAATAAATA
CTACTCAGCGACTCACTATAGGGAGACC), respectively, each carrying 60 nts of 
homologous sequence to the TRP1 locus. Yeast strain EY1119 was transformed with 12 
g of gel purified PCR product and plated on G418 plates to build yeast strain CSY840. 
All plasmids and yeast strains constructed in this study are summarized in Supplementary 
Table S2.1. 
 
2.4.2 Library-scale yeast transformation 
Device libraries (Supplementary Figure S2.13) were amplified using forward and 
reverse primers GAP-L1-2-fwd (5’-
TCCATGGTATGGATGAATTGTACAAATAAAGCCTAGGAAACAAACAAAGCTG
TCACC) and GAP-L1-2-rev (5’-AAGAAATTCGCTTATTTAGAAGTGGCGCGC 
CCTCTCGAGTTTTTATTTTTCTTTTTGCTGTTTCG), respectively. The library was 
inserted into pCS1748 through homologous recombination-mediated gap-repair during 
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transformation into yeast strain W303 (42). Briefly, an 800 L library PCR reaction was 
performed with 160 pmol of each primer and 16 pmol of the library template. 8 g of the 
plasmid pCS1748 was digested with AvrII and XhoI. The digested vector was combined 
with the library PCR product, extracted with phenol chloroform, and precipitated into a 
dry pellet with ethanol. A Tris-DTT buffer (2.5 M DTT, 1 M Tris, pH 8.0) was added to a 
50 mL yeast culture (OD600 1.3-1.5) and incubated at 30ºC for 10-15 min. The yeast were 
pelleted, washed with chilled Buffer E (10 mM Tris, pH 7.5, 2 mM MgCl2, 270 mM 
sucrose), and resuspended in Buffer E to a final volume of 300L. The yeast mixture 
was directly added to the precipitated DNA pellet and 50 L of the mixture was 
transferred to a chilled 2 mm gap cuvette for electroporation (540 V, 25 F, 1000 Ω). 
Following transformation, the cells were resuspended in 1 mL warmed YPD media and 
incubated at 30ºC for 1 hr. Multiple transformations (~5) were performed to cover the 
desired library diversity (~10
6
-10
7
). Transformation efficiencies were determined by 
plating serial dilutions of the transformants, and transformed cells were propagated in 
SC-URA media for FACS. 
 
2.4.3 Two-color FACS-based screen 
Cells harboring the RNA device libraries and control constructs were washed, 
resuspended in FACS buffer (1% BSA in PBS), and stained with a DAPI viability dye 
(Invitrogen). The cell suspension was filtered through a 40 M cell strainer (BD Systems, 
San Jose, CA) prior to analysis on a FACSAria II cell sorter (BD Systems). GFP was 
excited at 488 nm and measured with a splitter of 505 nm and bandpass filter of 525/50 
nm. mCherry was excited at 532 nm and measured with a splitter of 600 nm and a 
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bandpass filter of 610/20 nm. DAPI was excited at 355 nm and measured with a bandpass 
filter of 450/50 nm. A scatter gate was set based on the forward and side-scatter area of 
cells harboring the negative-control plasmid (pCS4) to exclude debris, followed by a 
DAPI-(-) viability gate to exclude dead cells in the DAPI-(+) gate from the analysis. 
Cells harboring the single-color control plasmids (pCS1585, pCS1749) were analyzed to 
compensate spillover from GFP to the mCherry detector. A general sorting strategy was 
followed in which cells harboring devices with targeted activities were analyzed to set a 
sorting gate on a two-dimensional scatter plot that correlates GFP and mCherry 
fluorescence. Cells within this gate were collected into SC-URA media and propagated to 
sufficient density for further screening or analysis. 
 
2.4.4 Ribozyme-based device characterization through flow cytometry analysis 
Enriched device libraries from FACS were directly plated onto SC-URA solid 
medium. Individual colonies were screened and characterized for gene-regulatory activity 
of the devices based on flow cytometry analysis. The GFP fluorescence was measured on 
a Quanta flow cytometer (Beckman Coulter, Fullerton, CA). GFP was excited at 488 nm 
and measured with a splitter of 488 nm and a bandpass filter of 525/40 nm. Cells 
harboring the negative-control plasmid (pCS4) were analyzed to set the GFP-(-) and 
GFP-(+) gate. Activities were determined as the geometric mean of the GFP fluorescence 
based on the GFP-(+) population using FlowJo (Tree Star), and normalized to the 
geometric mean of the GFP fluorescence of a positive control (sTRSV Contl, a 
noncleaving sTRSV ribozyme with a scrambled core) that is grown under identical ligand 
conditions, run in the same experiment, and set to 100%. 
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Devices that exhibited desired activities were amplified by colony PCR using 
forward and reverse primers CS653 (5’-
GGTCACAAATTGGAATACAACTATAACTCT) and CS654 (5’-
CGGAATTAACCCTCACTAAAGGG), respectively, and sequenced. The recovered 
devices were resynthesized and recloned into the vector backbone to confirm the 
observed activity. DNA oligos were synthesized and amplified for insertion into 
pCS1748 using forward and reverse primers L1-2-fwd (5’-
GACCTAGGAAACAAACAAAGCTGTCACC) and L1-2-rev (5’- GGCT 
CGAGTTTTTATTTTTCTTTTTGCTGTTTCG), respectively. The resynthesized devices 
were inserted into pCS1748 via the unique restriction sites AvrII and XhoI. The 
reconstructed device plasmids were transformed into the W303 yeast strain through a 
standard lithium acetate method (38). Cells harboring the selected devices and 
appropriate controls were prepared as described above for the sorting experiments and 
analyzed on an LSRII flow cytometer (BD Systems) to characterize the gene-regulatory 
activity of each device. GFP was excited at 488 nm and measured with a splitter of 505 
nm and a bandpass filter of 525/50. mCherry was excited at 532 nm and measured with a 
splitter of 600 nm LP and a bandpass filter of 610/20 nm. DAPI was excited at 405 nm 
and measured with a bandpass filter of 450/50 nm. FlowJo was used to process all flow 
cytometry data. Cells harboring pCS4 and pCS1749 were analyzed to set the mCherry-(-) 
and mCherry-(+) gates. Activities in the absence or presence of ligand were determined 
as the geometric mean of the GFP fluorescence based on the mCherry-(+) population, and 
normalized to the geometric mean of the GFP fluorescence of a positive control (sTRSV 
Contl, a noncleaving sTRSV ribozyme with a scrambled core) in the absence or presence 
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of ligand, respectively, to correct for any non-specific effects of ligand on the measured 
fluorescence (Supplementary Figure S2.8). Reported device activities are the mean and 
standard deviation of at least three independent experiments. 
 
2.4.5 In vitro transcription and purification of ribozyme-based devices 
Selected ribozyme-based devices and ribozyme and noncleaving controls were 
PCR amplified to include an upstream T7 promoter site and spacer sequence and 
downstream spacer sequence using forward and reverse primers T7-L1-2-fwd (5’-
TTCTAATACGACTCACTATAGGGACCTAGGAAACAAACAAAGCTGTCACC) 
and L1-2-rev (5’-GGCTCGAGTTTTTATTTTTCTTTTTGCTGTTTCG), respectively. A 
total of 1-2 g of PCR product was transcribed in a 25 l reaction, consisting of the 
following components: 1×RNA Pol Reaction Buffer (New England Biolabs), 2.5 mM 
rATP, 2.5 mM rCTP, 2.5 mM rUTP, 0.25 mM rGTP, 1 l RNaseOUT (Invitrogen), 10 
mM MgCl2, 1 l T7 Polymerase (New England Biolabs), and 0.5 Ci α-
32
P-GTP (MP 
Biomedicals, Solon, OH). 400 pmol of antisense DNA oligonucleotide, device-blocking 
(5’-GGTGACAGCTTTGTTTGTTTCCTAGGTCCCCC) and sTRSV-blocking (5’-
GCTGTTTCGTCCTCACG), was added to each reaction to inhibit cleavage of the RNA 
devices and sTRSV hammerhead ribozyme, respectively, during transcription. After 
incubation at 37°C for 2 hr, NucAway Spin Columns (Ambion, Austin, TX) were used to 
remove unincorporated nucleotides from the transcription reactions according to 
manufacturer’s instructions. 10 l aliquots of the recovered RNA were mixed with 3 
volumes of RNA stop/load buffer (95% formamide, 30 mM EDTA, 0.25% bromophenol 
blue, 0.25% xylene cyanol), heated at 95°C for 5 min, snap cooled on ice for 5 min, and 
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size-fractionated on a denaturing (8.3 M urea) 10% polyacrylamide gel at 25 W for 45 
min. Gels were imaged by phosphorimaging analysis on a FX Molecular Imager (Bio-
Rad). Uncleaved transcripts were gel extracted and recovered with the ZR Small-RNA™ 
PAGE Recovery Kit (Zymo Research, Irvine, CA) according to manufacturer’s 
instructions. Samples were stored in sterile, nuclease-free, deionized water at -80°C to 
limit the extent of RNA self-cleavage prior to performing the cleavage assays. 
 
2.4.6 In vitro ribozyme cleavage assays  
The purified uncleaved transcripts were incubated in 100 mM NaCl, 50 mM Tris-
HCl (pH 7.5) at 95°C for 5 min, cooled at a rate of -1.3°C to 37°C, and held there for 10 
min to allow equilibration of secondary structure. A zero time-point aliquot was taken 
prior to initiating the self-cleavage reaction at 37°C with the addition of MgCl2 to a final 
concentration of 500 M. Reactions were quenched at specified time points with addition 
of 3 volumes of RNA stop/load buffer on ice. Samples were heated 95°C for 5 min, snap 
cooled on ice for 5 min, and size-fractionated on a denaturing (8.3 M urea) 10% 
polyacrylamide gel at 25 W for 45 to 60 min. Gels were exposed overnight on a phosphor 
screen and analyzed for relative levels of the full-length transcript and cleaved products 
by phosphorimaging analysis. The cleaved product fraction at each time point (Ft) was fit 
to the single exponential equation Ft = F0 + (F∞ − F0 )×(1 – e
−kt
) using Prism 5 (GraphPad), 
where F0 and F∞ are the fractions cleaved before the start of the reaction and at the 
reaction endpoint, respectively, and k is the first-order rate constant of self-cleavage. 
Reported values are the mean of at least three independent experiments. 
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2.4.7 Measuring mating pathway activity via a transcriptional reporter and halo 
assays 
The mating fate routing plasmids with ribozyme-based devices and appropriate 
controls were transformed into yeast strain CSY840. Cells were inoculated into the 
appropriate drop-out media, grown overnight at 30°C, and back diluted into fresh media 
in the presence or absence of 5 mM theophylline to an OD600 of <0.1. After growing for 3 
hr at 30°C, cells were stimulated with saturating pheromone levels, to a final 
concentration of 100 nM α mating factor acetate salt (Sigma-Aldrich, St. Louis, MO), to 
activate the mating pathway. After 3 hr of stimulation, GFP fluorescence levels from the 
pFus1-yEGFP3 reporter were evaluated via flow cytometry using a Cell Lab Quanta SC 
flow cytometer (Beckman Coulter, Fullerton, CA). Normalized pathway activity is 
calculated as the geometric mean of three biological replicates of each sample normalized 
to the blank plasmid control (no MSG5) in the absence of theophylline. Mating associated 
cell-cycle arrest was evaluated via halo assays (43). Halo assays were performed on 
cultures grown overnight, back diluted into fresh media in the absence of theophylline, 
and grown another 6 hr. 200 l of each replicate was plated on the appropriate drop-out 
plates in the absence or presence of 5 mM theophylline. A gradient of α mating factor 
was established by saturating a filter disk (2 mm diameter) of Whatman paper with 9 l 
of 0.1 mg/mL α mating factor and placing the disk on the center of the plate. Cells were 
grown for 18 hr at 30°C and imaged via epi-white illumination with a GelDoc XR+ 
System (Bio-Rad). To control for any possible differences in growth rate between 
replicates, plates are compared within one biological replicate ensuring differences in 
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growth rate arise from divergence following plating in the absence or presence of 
theophylline.  
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2.5 Supplementary Information 
  
Supplementary Figure S2.1 Linear correlation between mCherry and GFP fluorescence 
for L2b1 (A), L2b5 (B), and L2b8 (C) devices within the two-color construct. For each 
device, 2,000 cells are plotted from a single representative experiment at 0 and 5 mM 
theophylline (theo). Linear regression and R
2
 values are reported and support a distinct 
slope for different device regulatory activities. 
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Supplementary Figure S2.2 Comparison of resolution between single-color and two-
color screens. Enriched sN10 library after one sorting cycle and an additional negative 
sort was analyzed through flow cytometry in the presence and absence of 5 mM 
theophylline. The positive sorting gate is set by the activity of the parent device in the 
presence of 5 mM theophylline. In the absence of theophylline, the gate contains cells 
that are false positives; in the presence of theophylline, the gate contains both true and 
false positives. (A) The left GFP histogram represents the enriched library in the absence 
of theophylline, while the right GFP histogram represents the enriched library in the 
presence of theophylline. For the single-color screen, a hypothetical sorting gate was set 
based on the percentage of cells isolated from the corresponding two-color screen 
(4.32%). If a single-color screen were performed, ~64% (2.77/4.35) of the isolated cells 
would be false positives. (B) The left two-color scatter plot represents the enriched 
library in the absence of theophylline, while the right two-color scatter plot represents the 
enriched library in the presence of theophylline. The two-color screen exhibits high 
resolving power, such that only ~6% (0.27/4.32) of the isolated cells were false positives, 
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resulting in a significant improvement in enrichment efficiency over the single-color 
screen. 
 
 
Supplementary Figure S2.3 The two-color sorting strategy supports separation of 
autofluorescent and low expression cell populations. sTRSV (the active ribozyme control) 
exhibits ~1.2% normalized GFP fluorescence, relative to a noncleaving ribozyme positive 
control (sTRSV Contl) with a scrambled core. (A) A cell population harboring the 
sTRSV construct exhibits low fluorescence levels that overlap significantly with a cell 
population harboring no fluorescence reporter gene in the single-color histogram. (B) The 
sTRSV and autofluorescent populations separate based on mCherry expression in the 
two-color plot, allowing cells exhibiting low GFP expression due to stringent device 
gene-regulatory activity to be effectively enriched through two-color sorting. 
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Supplementary Figure S2.4 An actuator sort preserves switching activity in 6 out of 8 
characterized devices. Basal activity of the parent device, L2b8, is indicated by a dashed 
line. Gene-regulatory activities are reported as the geometric mean of the GFP 
fluorescence of the indicated sample normalized to that of a positive control (sTRSV 
Contl, a noncleaving sTRSV ribozyme with a scrambled core) that is grown under 
identical ligand conditions and is set to 100%. Reported values are the mean and standard 
deviation of at least three independent experiments. The activation ratio (AR), 
determined as the ratio of gene expression levels in the presence and absence of 
theophylline (theo), is indicated for each device. 
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Supplementary Figure S2.5 Point mutation analyses of variant loop I sequences identify 
consensus sequences of ribozyme variants supporting improved gene-regulatory activities. 
The impact of point mutations to the recovered loop I sequences on basal activity was 
measured by flow cytometry. Relative expression levels are reported as the geometric 
mean of the GFP fluorescence of the indicated sample normalized to that of the L2b8 
parent device. Reported values are the mean and standard deviation of at least three 
independent experiments. Two putative loop I consensus sequences were supported from 
the sequences recovered from the actuator library screen: a heptaloop (AUYNRRG) and a 
triloop (NUYGGGN
|
).  
Analysis of the point mutants made to interrogate nucleotide base constraints at each 
position of the heptaloop sequence found that any base (N) is tolerable at the third and 
fourth positions, but specific identities at the third position result in improved basal 
activity (C > A/U > G). The fifth and sixth positions accept both purine bases (A, G) and 
retain activity similar to that of the L2b8 parent; however, an adenine base (A) in the fifth 
position results in improved basal activity. Point mutants verified the requirement of a 
guanine base (G) in the seventh position.  
For the triloop sequence, point mutants indicate that any combination of bases in the first 
and seventh positions resulting in canonical Watson-Crick base pairing (AU, GC; order 
independent) results in improved basal activity. The bases in the second and sixth 
positions must result in a Watson-Crick GU wobble pair, where this requirement is 
sensitive to identity and order (i.e., standard Watson-Crick pairing abolishes improved 
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activity). The point mutants indicate that the third position is able to accept any 
nucleotide base (N), whereas a guanine base (G) is required at the fourth and fifth 
positions to retain improved activity relative to the L2b8 parent device. 
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D L2b8-a1: 
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G sTRSV ribozyme:  
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H 
RNA Device Cleavage Rate (k, min
-1
) 
0 mM theophylline 5 mM theophylline 
L2b1 0.033 ± 0.008 0.011 ± 0.003 
L2b5 0.013 ± 0.002 0.007 ± 0.001 
L2b8 0.14 ± 0.02 0.025 ± 0.009 
L2b8-a1 0.7 ± 0.3 0.1 ± 0.03 
L2b8-a14 0.9 ± 0.4 1.0 ± 0.2 
L2b8-a1-t41 0.16 ± 0.05 0.096 ± 0.02 
sTRSV ribozyme 4.3 ± 0.8 4.3 ± 1.4 
 
 
Supplementary Figure S2.6 Representative cleavage assays for measuring cleavage rate 
constants (k) for ribozyme-based devices and controls. A representative assay is shown 
for each device in the absence and presence (0 and 5 mM, respectively) of theophylline: 
L2b1 (A), L2b5 (B), L2b8 (C), L2b8-a1 (D), L2b8-a14 (E), L2b8-a1-t41 (F), and sTRSV 
ribozyme (G). Bands for both the cleaved products (5’C, 3’C) and the full-length 
uncleaved substrate (UC) are shown for L2b1. For subsequent devices, the shorter 5’C 
product is omitted from the inset image for clarity. Methods used to prepare full-length, 
uncleaved RNA transcripts and conditions of the cleavage assays are detailed in the 
Materials and Methods section of the main text. Briefly, RNA was heated to 95°C for 5 
min and cooled to 37°C in a secondary structure refolding buffer (100 mM NaCl, 50 mM 
Tris-HCl (pH 7.5)). A zero time point aliquot was removed prior to initiating the reaction 
with addition of MgCl2 to a final concentration of 500 μM. Reactions were quenched at 
the indicated time points. At least seven time points were taken in each cleavage assay to 
capture the cleavage dynamics of RNA devices exhibiting different cleavage kinetics. 
Phosphorimaging analysis of relative levels of the UC, 5’C, and 3’C bands was used to 
determine the fraction cleaved at each time point (Ft). The fraction cleaved at the 
beginning (F0) and end of reaction (F∞) varied between assays, but all assays were well-
fit to the single exponential equation (R
2
 > 0.95): 
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Ft = F0 + (F∞ − F0 )×(1 – e
−kt
) 
 
The black and red fit lines represent assays performed at 0 and 5 mM theophylline, 
respectively. The cleavage rate constant value (k) was determined for each assay. The 
reported k for each device and theophylline assay condition is the mean and standard 
deviation of at least three independent experiments (H). 
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Supplementary Figure S2.7 Increased input ligand concentration results in higher 
device ON states. Increasing ligand concentration to 40 mM theophylline (theo) increases 
device activation ratio (AR) compared to 5 mM theophylline. Gene-regulatory activities 
are reported as the geometric mean of the GFP fluorescence of the indicated sample 
normalized to that of a positive control (sTRSV Contl, a noncleaving sTRSV ribozyme 
with a scrambled core) that is grown under identical ligand conditions and is set to 100%. 
Reported values are the mean and standard deviation of at least three independent 
experiments. The activation ratio (AR), determined as the ratio of gene expression levels 
in the presence and absence of theophylline (theo), is indicated for each device. 
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A 
 GFP (A.U.) mCherry (A.U.) Viability (%) 
 0mM Theo 5mM Theo Ratio 0mM Theo 5mM Theo Ratio 0mM Theo 5mM Theo Ratio 
Replicate 1 3969.31 4532.12 1.14 2097.92 2339.26 1.12 98.24 97.16 0.99 
Replicate 2 6282.93 6868.85 1.09 2699.57 2589.77 0.96 97.51 96.60 0.99 
Replicate 3 2960.27 3129.06 1.06 2505.69 2496.95 1.00 96.47 96.73 1.00 
Mean ± S.D.   1.10 ± 0.04   1.02 ± 0.08 97.41 ± 0.89 96.83 ± 0.29 0.99 ± 0.01 
 0mM Theo 40mM Theo Ratio 0mM Theo 40mM Theo Ratio 0mM Theo 40mM Theo Ratio 
Replicate 1 4687.84 6380.01 1.36 5653.65 5504.26 0.97 97.63 96.62 0.99 
Replicate 2 4777.71 6249.37 1.31 5137.39 5502.14 1.07 98.39 96.59 0.98 
Replicate 3 4878.88 5977.69 1.23 4722.92 4921.71 1.04 97.99 94.83 0.97 
Mean ± S.D.   1.30 ± 0.07   1.03 ± 0.05 98.00 ± 0.38 96.01 ± 1.02 0.98 ± 0.01 
 0mM Tc 1mM Tc Ratio 0mM Tc 1mM Tc Ratio 0mM Tc 1mM Tc Ratio 
Replicate 1 2585.21 2382.28 0.92 2791.13 2278.18 0.82 98.05 98.72 1.01 
Replicate 2 2310.21 2036.61 0.88 2896.15 2628.35 0.91 97.73 98.74 1.01 
Replicate 3 2326.70 2203.89 0.95 3694.26 3691.82 1.00 97.75 98.22 1.00 
Mean ± S.D.   0.92 ± 0.03   0.91 ± 0.09 97.84 ± 0.18 98.56 ± 0.29 1.01 ± 0.00 
B    
 
 
 
Supplementary Figure S2.8 Quantification of nonspecific ligand effect on fluorescence 
intensity and cell viability. (A) Unnormalized data for GFP fluorescence, mCherry 
fluorescence, and cell viability for the positive control construct (sTRSV Contl, a 
noncleaving sTRSV ribozyme with a scrambled core) in all ligand conditions tested. 
Fluorescence values are reported as the geometric mean of the GFP or mCherry 
fluorescence of sTRSV Contl. Cell viability is reported as the percentage of cells 
included in the DAPI-(-) gate. Mean and standard deviation of three independent 
experiments are indicated. The ratio of fluorescence levels or cell viability percentages in 
the presence and absence of theophylline (theo) or tetracycline (tc) is indicated for each 
ligand condition. Variability in absolute GFP or mCherry signal among replicates for an 
individual ligand condition is due to differences in instrument calibration between 
experiments. Values for each replicate pair in the absence and presence of ligand were 
obtained in the same experiment with identical instrument calibration. (B) Scatter plots 
for sTRSV Contl under each ligand condition from a single representative experiment. 
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Supplementary Figure S2.9 Component swapping demonstrates modularity of the 
optimized actuator components. Replacement of the loop I sequence with the a1 or a14 
sequence decreases basal activity in all devices tested, including theophylline (theo)-
responsive ON (A, B) and OFF (C) switches and a tetracycline-responsive ON switch (D). 
Switching activity is maintained in most devices. Notably, replacement of the loop I 
sequence in the sTRSV ribozyme (E) significantly increases basal activity. Gene-
regulatory activities are reported as the geometric mean of the GFP fluorescence of the 
indicated sample normalized to that of a positive control (sTRSV Contl, a noncleaving 
sTRSV ribozyme with a scrambled core) that is grown under identical ligand conditions 
and is set to 100%. Reported values are the mean and standard deviation of at least three 
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independent experiments. The activation ratio (AR), determined as the ratio of gene 
expression levels in the presence and absence of theophylline (theo) (A, B, C) or of 
tetracycline (D), is indicated for each device. 
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Supplementary Figure S2.10 The activities of the optimized actuator components are 
maintained in the context of the newly selected transmitter components. For devices 
isolated from the tN11 sort (L2b8-t11 and L2b8-t47), replacement of the actuator loop I 
sequence with the a1 sequence results in lower basal activity. For L2b8-a1-t41, which 
was isolated from the a1-tN11 sort, replacement of the a1 sequence with the loop I 
sequence of L2b8 results in higher basal activity. Gene-regulatory activities are reported 
as the geometric mean of the GFP fluorescence of the indicated sample normalized to that 
of a positive control (sTRSV Contl, a noncleaving sTRSV ribozyme with a scrambled 
core) that is grown under identical ligand conditions and is set to 100%. Reported values 
are the mean and standard deviation of at least three independent experiments. The 
activation ratio (AR), determined as the ratio of gene expression levels in the presence 
and absence of theophylline (theo), is indicated for each device. 
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A L2b8 parent (Loop I: UGUGCUU) 
 
  
 
B aN7 heptaloop consensus (AUCNARG) 
 
  
 
C Newt hammerhead ribozyme 
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D aN7 triloop consensus (N1UN2GGGN1
|
) 
 
  
 
E CarSVRNA(-) hammerhead ribozyme 
 
  
 
 
Supplementary Figure S2.11 Secondary structure analysis indicates similarities between 
engineered RNA devices and natural hammerhead ribozymes (HHRzs). The HHRz 
invariant nucleotide bases are boxed in black, and the cleavage site is denoted by an 
arrow in all structures. In RNA device structures (A, B, D), nucleotide bases of the 
transmitter and aptamer domains are boxed in grey and olive green respectively. Using 
the common numbering system for HHRz with apical loops (44), nucleotide bases 
highlighted in cyan (L1.1 U) and red (L1.6 U) are those conforming to the common 
HHRz loop I motif, UNmYN, where m is typically 3 or 4 bases. Common loop II motif 
nucleotide bases, (RNnA), are highlighted in yellow (L2.1 G) and orange (L2.1 A), where 
n is usually 2 or 4 bases (27). R and Y denote purine and pyrimidine bases respectively. 
(A) The HHRz core of the L2b8 parent device forms a predicted GU base pair at L2.2-
L2.3 due to transmitter-sensor integration into loop II when analyzed by RNAstructure 
folding software (45). HHRz loop sequence similarities exist between a device containing 
the variant heptaloop consensus sequence selected in this study (B) and the newt HHRz 
(C). In loop I, both HHRz structures have AU in the first two positions 5’ from the 
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catalytic core (boxed in green) and RG in last two positions (boxed in brown). In loop II, 
both structures have a G nucleotide not constrained in a Watson-Crick base pair (circled 
in cyan). Loop sequence similarities also exist between a device containing the variant 
triloop consensus sequence (D) and the CarSVRNA(-) HHRz (E). Both loop I sequences 
in these HHRzs contain a triloop with a GU base pair closing the loop (circled in purple) 
and accommodate GG in the first two positions 5’ from the catalytic core (boxed in 
green). In loop II, both HHRz structures have L2.1 G and L2.4 A nucleotides not 
constrained in Watson-Crick base pairs, available for loop I-loop II interaction, circled in 
cyan (27). Secondary structures rendered using VARNA software (46). 
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Supplementary Figure S2.12 Plasmid map of pCS1748. RNA devices are inserted in the 
3’ UTR of yEGFP3. 
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Supplementary Figure S2.13 Library design for sN10 sensor, aN7 actuator, and tN11 
and a1-tN11 transmitter libraries. Predicted secondary structures of the active ribozyme 
conformation with unbound theophylline aptamer (left) and the inactive ribozyme 
conformation with bound theophylline aptamer (right) are shown. The sequence for the 
L2b8 parent device is shown. Nucleotides that comprise the sensor, actuator, and 
transmitter components are colored blue, black, and yellow, respectively. Theophylline is 
represented by the red polygon. Filled circles within each component indicate nucleotides 
randomized to generate respective device libraries. Secondary structures were predicted 
by RNAstructure folding software (45) and rendered using VARNA software (46). 
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Supplementary Table S2.1 Summary of plasmids and yeast strains constructed. 
 
Plasmid   Color Controls 
pCS1748  
two-color screening plasmid: TEF1p-GFP-ADH1t and TEF1p-mCherry-
CYC1t 
pCS1585  single-color plasmid: TEF1p-GFP-ADH1t 
pCS1749   single-color plasmid: TEF1p-mCherry-CYC1t 
    Ribozyme-based Devices and Controls 
pCS1750  pCS1748+sTRSV 
pCS1751  pCS1748+sTRSV Contl 
pCS1752  pCS1748+L2b1 
pCS1753  pCS1748+L2b8 
pCS2260  pCS1748+L2b5 
pCS2261  pCS1748+L2b8-a1 
pCS2262  pCS1748+L2b8-a6 
pCS2263  pCS1748+L2b8-a9 
pCS2264  pCS1748+L2b8-a10 
pCS2265  pCS1748+L2b8-a11 
pCS2266  pCS1748+L2b8-a12 
pCS2267  pCS1748+L2b8-a14 
pCS2268  pCS1748+L2b8-a27 
pCS2269  pCS1748+L2b8-t11 
pCS2270  pCS1748+L2b8-t24 
pCS2271  pCS1748+L2b8-t47 
pCS2272  pCS1748+L2b8-t197 
pCS2273  pCS1748+L2b8-t241 
pCS2274  pCS1748+L2b8-a1-t41 
pCS2275  pCS1748+L2b8-a1-t55 
pCS2276  pCS1748+L2b8-a1-t64 
pCS2277  pCS1748+L2b1-a1 
pCS2278  pCS1748+L2b1-a14 
pCS2279  pCS1748+L2b5-a1 
pCS2280  pCS1748+L2b5-a14 
pCS2281  pCS1748+L2bOFF1 
pCS2282  pCS1748+L2bOFF1-a1 
pCS2283  pCS1748+L2bOFF1-a14 
pCS2284  pCS1748+L2b8tc 
pCS2285  pCS1748+L2b8tc-a1 
pCS2286  pCS1748+L2b8tc-a14 
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pCS2287  pCS1748+sTRSV-a1 
pCS2288  pCS1748+sTRSV-a14 
pCS2289  pCS1748+L2b8-a1-t11 
pCS2290  pCS1748+L2b8-a1-t47 
pCS2291   pCS1748+L2b8-t41 
    Yeast Mating Pathway 
pCS1124  FUS1p-GFP-ADH1t 
pCS2292  FUS1p-GFP-ADH1t in LoxP integrating vector 
pCS2293  TEF1m7p-Msg5-ADH1t 
pCS2294  pCS2293+sTRSV 
pCS2295  pCS2293+L2b8-a1 
pCS2297  pCS2293+L2b8 
pCS2299  pCS2293+sTRSV Contl 
Strain   
CSY840  W303a ∆sst1 ∆kss1::HIS3 trp1::FUS1p-yEGFP3-ADH1t-loxP-KanR 
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wrote the paper. 
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Chapter 3. 
A versatile cis-blocking strategy for ribozyme 
characterization 
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Abstract 
Synthetic RNA control devices that utilize ribozyme-based actuator components 
have been demonstrated in diverse organisms to regulate cellular behaviors in response to 
environmental signals. The quantitative measurements of the in vitro cleavage rates 
associated with these synthetic devices are essential for advancing our understanding of 
the corresponding in vivo gene-regulatory activities. One of the key challenges in the 
ribozyme characterization is the efficient generation of full-length RNA through 
transcription reactions. Current methods of full-length RNA generation require a 
laborious gel purification step. We developed a cis-blocking strategy that supports 
efficient generation of full-length RNA by a simple gel-free process. We demonstrated 
that our cis-blocking strategy is applicable to both natural ribozymes and synthetic 
ribozyme devices. The cleavage rates obtained on the full-length RNA generated from 
the cis-blocking strategy were characterized and closely correlated to those from the 
trans-blocking strategy. We further developed a rapid, label-free cleavage assay based on 
surface plasmon resonance (SPR). The SPR-based assay allows rapid monitoring of 
ribozyme cleavage under varying reaction conditions. With further optimization and 
development, our cis-blocking and SPR-based characterization strategies will provide a 
powerful method for ribozyme characterization. 
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3.1 INTRODUCTION 
Synthetic biology is advancing the design of genetic circuits encoding desired 
functions (1). As the proper functioning of synthetic genetic circuits often relies on the 
precise control and tuning of key protein component levels, much effort in the field has 
focused on developing programmable gene-regulatory devices. One class of gene-
regulatory devices, so called RNA control devices, utilize RNA molecules to link 
changes in molecular signals to gene expression events. Progress in the fields of RNA 
biology and engineering have allowed construction of RNA control devices through the 
assembly of natural or synthetic components that encode more basic functions, such as 
sensing, information transmission, and actuation (2). Because hammerhead ribozymes 
can exhibit activity independent of cell-specific machinery, RNA control devices that 
utilize ribozyme-based actuator components have been demonstrated in diverse 
organisms spanning from bacterial, yeast, and mammalian systems to regulate cellular 
behaviors in response to one or more environmental signals (3-6).  
We recently described a modular ribozyme device platform based on the 
functional coupling of three distinct components: an actuator encoded by a hammerhead 
ribozyme from satellite RNA of tobacco ringspot virus (sTRSV), a sensor encoded by an 
RNA aptamer, and an information transmitter encoded by a sequence capable of a 
programmed strand-displacement event (3) (Figure 3.1). The transmitter component 
directs the device to partition between two primary functional conformations, where the 
aptamer-folded conformation can be associated with the disruption or restoration of the 
ribozyme catalytic core to construct ON (increased gene expression) or OFF (decreased 
gene expression) devices, respectively, in response to ligand binding to the aptamer. The 
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quantitative tuning of device regulatory dynamic range, which is set by the gene 
expression activity in the absence and presence of input ligand, has been demonstrated to 
be important for achieving effective control over phenotypic behaviors (see Chapter 2). 
Computational models of ribozyme devices have predicted that the values of the 
ribozyme cleavage rate can have substantial impact on the device gene-regulatory 
activities (7). Therefore, quantitative measurements of the ribozyme cleavage rates are 
essential to advance our understanding of the relationship between the in vitro cleavage 
rates and the corresponding in vivo gene-regulatory activities. 
 
Figure 3.1 Modular composition of a synthetic ribozyme device. The ribozyme device is 
constructed by linking a RNA aptamer (indicated in grey) to a hammerhead ribozyme 
(indicated in white) through a programmed sequence (indicated in black) that directs a 
strand-displacement event. The device can adopt two primary functional conformations, 
in which the ribozyme-active conformation is associated with either aptamer-unformed or 
aptamer–formed conformation to construct a ribozyme ON or OFF device, respectively. 
In the case of a ribozyme ON device (depicted here), the device adopts a ribozyme-active 
conformation in the absence of the input ligand, thereby leading to self-cleavage. In the 
presence of the input ligand, binding of the ligand to the aptamer stabilizes a device 
conformation in which the ribozyme catalytic core is disrupted, thus resulting in no 
cleavage. Secondary structures were rendered using VARNA software (8). 
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A key challenge in characterizing ribozyme cleavage rates is in the efficient 
generation of full-length RNA for ribozyme constructs, including natural ribozymes and 
synthetic ribozyme devices, by in vitro T7 transcription reactions. Typical transcription 
reactions require high MgCl2 (~mM) to achieve sufficient yield, conditions at which most 
ribozyme constructs exhibit high cleavage activity, thereby resulting in low yield of full-
length RNA for the downstream kinetic analysis. In early characterization studies of 
natural ribozymes, researchers split the whole ribozyme sequence into an enzyme and a 
substrate strand (9,10). The two strands were transcribed separately and annealed to 
generate the functional two-stranded ribozyme complex. One disadvantage of this 
strategy is that experimental conditions need to be optimized to ensure that the measured 
cleavage rate is not affected by the association step between the two strands (11). Later, 
researchers developed a trans-blocking strategy to generate full-length single-stranded 
ribozyme transcripts by transcription reactions in the presence of an antisense DNA 
strand complementary to the ribozyme catalytic core. Full-length trans-blocked RNA was 
purified through polyacrylamide gel electrophoresis (PAGE) under denaturing conditions 
and renatured prior to cleavage assays (9,12). Although this strategy allows 
characterization of a ribozyme in its native conformation, previous studies have shown 
that the gel-purified full-length RNA was still capable of cleaving during sample 
handling, resulting in an ~30% loss prior to cleavage assays, and ~50% of the remaining 
full-length RNA does not exhibit cleavage activity (9). Therefore, a more efficient 
ribozyme-blocking strategy is desired. 
As the kinetics of ribozyme cleavage are slow relative to many protein enzymes, 
ribozyme cleavage rates are typically measured through a gel electrophoretic separation 
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method (11,12). The cleavage reaction is initiated by the addition of MgCl2 to the 
radiolabelled full-length RNA and quenched at different time points. The quenched 
samples are resolved by denaturing PAGE to determine the fraction RNA cleaved as a 
function of time, which are fit to a first-order exponential equation to obtain the cleavage 
rate. Because the gel-based ribozyme cleavage assay is discontinuous, several time points 
are required in the initial as well as the final phase of the reaction for proper analysis, 
thereby making the gel-based assay a time-consuming process. A continuous ribozyme 
cleavage assay based on the intramolecular fluorescence resonance energy transfer 
(FRET) has been developed and applied to characterize ribozyme cleavage rates (13,14). 
However, the FRET-based cleavage assay requires labeling of RNA molecules with 
appropriate fluorophores and is currently limited to the characterization of two-stranded 
ribozyme complexes only.  
Advances in biosensor technologies have led to the development of the Biacore 
platform based on surface plasmon resonance (SPR) for real-time detection of 
biomolecular interactions (15). The Biacore platform utilizes a sensor surface modified 
with one molecule and measures the refractive index change, which is associated with the 
local mass density change, due to the association or dissociation of another molecule in 
solution. The refractive index change is converted into an SPR signal, which is expressed 
in resonance units (RU), and fitted to a mathematical model to acquire thermodynamic 
and kinetic parameters. The Biacore platform requires no labeling of molecules, 
consumes little sample, and is highly-automated, thus making it an attractive tool for 
developing novel ribozyme characterization strategies. 
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In this work, we developed a simple two-step gel-free process that allows efficient 
generation of full-length transcription products for diverse ribozyme constructs. We 
designed an RNA sequence that was directly incorporated into the target transcript to co-
transcriptionally inhibit the formation of the ribozyme-active conformations. The 
catalytic activity of the RNA was restored by the use of a DNA competing strand to 
activate the blocked RNA through a fast toehold-mediated strand-displacement reaction. 
We demonstrated our cis-blocking strategy to generate full-length RNA transcripts for 
various natural ribozymes and synthetic ribozyme devices, with a blocking efficiency of 
up to ~90%. We performed gel-based cleavage assays to measure the cleavage rates of 
RNA generated from the cis-blocking strategy and compared these rates to those obtained 
from the more traditional trans-blocking strategy. The two rates were closely correlated, 
but further optimization of gel-based assays on RNA generated from the cis-blocking 
strategy is needed. Lastly, we described a label-free and real-time SPR-based ribozyme 
cleavage assay. Initial results suggested that the SPR-based cleavage assay can provide a 
rapid and quantitative alternative to the traditional gel-based assay.  
 
3.2 RESULTS 
3.2.1 A cis-acting RNA blocking sequence supports inhibition of ribozyme cleavage 
during transcription 
To prevent ribozyme constructs from cleaving during transcription, we developed 
a new strategy to inhibit the formation of ribozyme-active conformation co-
transcriptionally. We illustrated our strategy using a hammerhead ribozyme from satellite 
RNA of tobacco ringspot virus (sTRSV) as an example (Figure 3.2A). We rationally 
designed a 12 nt RNA blocking sequence that is complementary to part of the sTRSV 
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ribozyme transcript (Figure 3.2A). The RNA blocking sequence was inserted in the 5’ 
end of the sTRSV ribozyme transcript to generate a cis-blocked sTRSV construct. As the 
RNA is being synthesized, the blocking sequence is capable of competitively hybridizing 
to the targeted ribozyme sequence, thus preventing the transcribed RNA from adopting a 
ribozyme-active conformation (Figure 3.2A).  
 
A
B
Targeted Ribozyme 
Sequence
Stabilizing
Sequence
Activation
Sequence
Blocking
Sequence
Blocked Conformation
sTRSV Ribozyme
Activated Conformation
DNA Activator
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Figure 3.2 Development of the cis-blocking strategy to generate full-length RNA through 
transcription reactions. The cis-blocking strategy is demonstrated on a sTRSV ribozyme 
construct. The arrow indicates the cleavage site. (A) RNA blocking (indicated in red) and 
activation sequences (indicated in yellow) complementary to part of the ribozyme 
(indicated in grey) are directly incorporated in the 5’ end of the ribozyme transcript and 
can inhibit the ribozyme construct from folding into the active conformation during the 
transcription reaction. (B) The cis-blocked ribozyme construct can be relieved by the 
addition of a DNA activator strand (indicated in brown), which competes with the 
blocking sequence to bind to the ribozyme sequence through a toehold-mediated strand-
displacement reaction. As shown here, the fully hybridized ribozyme construct with the 
activator results in the ribozyme-active conformation. Secondary structures were 
predicted by RNAstructure folding software (16) and rendered using VARNA software 
(8). 
 
3.2.2 A trans-acting DNA activator allows release of blocked RNA through a strand-
displacement reaction 
To activate the blocked sTRSV RNA for subsequent cleavage assays, we 
rationally designed a 10 nt RNA activation sequence as a single-stranded domain directly 
attached to the 5’ end of the RNA blocking sequence (Figure 3.2A). The RNA activation 
sequence serves as a toehold to allow for the design of a DNA activator complementary 
to the RNA blocking sequence (Figure 3.2B). A toehold length between 5-10 nt has been 
demonstrated to enhance the rate of strand-displacement reaction by ~10
6
 fold (17). The 
DNA activator can sequester the RNA blocking sequence through a fast toehold-
mediated strand-displacement reaction, thus activating the blocked RNA for subsequent 
cleavage assays. 
 
3.2.3 A RNA stabilizing sequence allows tuning of blocking efficiency 
We tuned the strength of the competitive hybridization between the RNA 
blocking and targeted ribozyme sequences by introducing a stabilizing sequence at the 3’ 
end of the sTRSV construct (Figure 3.2A). The stabilizing sequence is designed to 
112 
 
hybridize to the RNA activation sequence, such that the thermal stability of the blocked 
conformation can be tuned by varying the length of the stabilizing sequence. We 
increased the length of the stabilizing sequence from 4 to 14 nt to generate a variety of 
cis-blocked sTRSV constructs (Supplementary Figure S3.1). The blocking efficiency of 
the resultant sTRSV construct variants were determined by analyzing the transcription 
products by PAGE analysis (Figure 3.3A). By adding 4 nt to the originally designed 
stabilizing sequence (sTRSV-4 construct), we increased the uncleaved RNA percentage 
to ~90% from the transcription reaction. These results support that the cis-blocking 
strategy is efficient in inhibiting ribozyme cleavage during transcription. 
We examined the efficacy of the toehold-mediated activation strategy by 
incubating the cis-blocked sTRSV construct variants at 5 mM MgCl2 in the absence and 
presence of the activator strand for 30 minutes at 25ºC (Figure 3.3A). In the absence of 
the activator strand, no cleavage was observed even at high MgCl2, indicating that the 
RNA was incapable of spontaneously releasing itself from the blocked conformation. In 
the presence of the activator strand, however, up to ~80% of the constructs with a toehold 
length between 4–6 nt cleaved. Little cleavage was observed for constructs with a toehold 
length between 0-2 nt, suggesting that the rate of strand-displacement reaction is too slow 
to allow effective activation of the blocked RNA (17). These results highlight that our 
cis-blocking strategy is efficient in generating full-length functional RNA through two 
simple steps: transcription and activation.     
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Figure 3.3 Quantification of the blocking efficiencies of the cis-blocking strategy on cis-
blocked ribozyme constructs. (A) The cis-blocked sTRSV construct variants 
(Supplementary Figure S1) were incubated in: (i) HBS-EP buffer (10 mM HEPES, 150 
mM NaCl, 3 mM EDTA, 0.05% P20, pH 7.4) (first lane); (ii) HBS-N buffer (10 mM 
HEPES and 150 mM NaCl, pH 7.4) in the presence of 5 mM MgCl2 for 30 minutes at 
25ºC (second lane); (iii) HBS-N buffer in the presence of 5 mM MgCl2 and 6 M 
activator for 30 minutes at 25ºC (third lane). The fraction of uncleaved fragment is 
determined through phosphorimaging analysis. A black vertical bar is used to denote 
samples run on different gels. (B) The blocking and activation sequences designed for the 
sTRSV ribozyme were directly incorporated into different synthetic ribozyme devices 
(L2b1, L2b5, L2b8, L2bOFF1, and L2b8tc) (Supplementary Figure S3.2). The 
transcription products of these constructs were analyzed as described for the cis-blocked 
sTRSV constructs. For clarity, only the full-length and 3’ cleaved products are shown. 
 
3.2.4 The sTRSV-blocking sequence provides a modular strategy for inhibiting 
cleavage of sTRSV ribozyme-based devices  
Because the designed RNA blocking sequence targets only the sTRSV ribozyme, 
it is expected that the cis-blocking strategy can be applied to generate full-length RNA 
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activator
MgCl2 - +     +
- - +
- +     +
- - +
- +     +
- - +
- +     +
- - +
L2bOFF1 L2b8tc
- +     +
- - +
- +     +
- - +
full length
3’ cleaved
B
115 
 
for the sTRSV-based ribozyme devices. We inserted the RNA blocking and activation 
sequences in several previously characterized ribozyme devices composed of different 
sensors, transmitters, and actuators to generate the corresponding cis-blocked L2b1, L2b5, 
L2b8, L2b8-a1, L2bOFF1, and L2b8tc constructs (see Chapter 2) (Supplementary Figure 
S3.2). The transcription products of these constructs were diluted in HBS-EP buffer and 
analyzed on the gel to determine the blocking efficiencies (Figure 3.3B). Up to 90% of 
the total transcribed RNA was uncleaved, supporting that the RNA blocking sequence is 
modular to constructs based on the same ribozyme. In contrast, performing transcription 
reactions on a ribozyme construct without the blocking sequence resulted in significant 
cleavage (Supplementary Figure S3.3). The cis-blocked constructs were further incubated 
at 5 mM MgCl2 in the absence and presence of the activator strand for 30 minutes at 25ºC 
(Figure 3.3B). Similarly, the blocked constructs required both the presence of MgCl2 and 
activator to cleave. Up to ~80% of the full-length blocked RNA was released by the 
activator and cleaved, supporting that the activation sequence optimized for the sTRSV 
ribozyme is modular to the corresponding ribozyme devices as well.  
 
3.2.5 Full-length RNA generated through cis- and trans-blocking strategies exhibits 
comparable cleavage rates  
We next examined the cleavage rates (k) measured for the full-length RNA 
generated from the cis-blocking strategies. The gel-based cleavage assays were 
performed at physiologically-relevant reaction conditions (500 μM MgCl2, 100 mM NaCl, 
and 50 mM Tris-HCl (pH 7.0)) at 37°C (Supplementary Figure S3.4). The blocked RNA 
was activated by incubating with the DNA activator strands prior to addition of MgCl2. 
The cleavage rate constants were obtained for the L2b8 (0.063, 0.008 min
-1
) and L2b8-a1 
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(0.351, 0.043 min
-1
) constructs in the absence and presence of 5 mM theophylline, 
respectively (Figure 3.4A). These rates were compared to those previously obtained on 
the full-length RNA generated from standard trans-blocking strategies requiring PAGE 
purification of the blocked RNA strands (see Chapter 2) (Figure 3.4B). A correlation 
analysis between the cleavage rates determined through these two methods indicates a 
strong positive correlation (Pearson coefficient, r = 0.9999). However, the cleavage rates 
associated with the cis-blocking strategy are slower than those associated with the trans-
blocking strategy. We postulate that the hybridizing reaction between the cis-blocked 
RNA and the activator strand may result in a slower apparent cleavage rate, thus 
requiring a longer incubation prior to the initiation of the cleavage reaction to allow 
complete activation of the RNA.    
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Figure 3.4 Comparison of the ribozyme cleavage rates on full-length RNA generated 
from different blocking strategies. (A) Gel-based cleavage assays were performed on the 
cis-blocked L2b8 and L2b8-a1 constructs at 37˚C with 500 µM MgCl2, 100 mM NaCl, 
50 mM Tris-HCl (pH 7.0). Cleavage rate constants (k) and errors are reported as the 
mean and standard deviation from at least three independent assays. The cleavage rate 
constants for the trans-blocked L2b8 (0.14, 0.025 min
-1
) and L2b8-a1 (0.7, 0.1 min
-1
) 
constructs were characterized previously at the same reaction conditions in the absence 
and presence of 5 mM theophylline, respectively (see Chapter 2). (B) Correlation analysis 
of cleavage rates of full-length RNA generated from the cis- and trans-blocking strategies 
indicates a strong correlation between these two rates; Pearson correlation coefficient (r) 
of 0.9999. 
 
A
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3.2.6 A label-free SPR-based assay to support rapid monitoring of ribozyme 
cleavage 
Our cis-blocking and trans-activating strategies allow the development of a label-
free and continuous cleavage assay based on the Biacore sensor platform (Figure 3.5). 
We generated a reaction sensor surface by covalently linking the DNA activator strand to 
the sensor surface (Figure 3.5A). The reaction sensor surface then allows both the capture 
and activation of the cis-blocked RNA through programmed hybridization interactions 
(Figure 3.5B). The capture of RNA is monitored in real time and represented as an 
increase in the SPR signal due to increased mass density near the sensor surface. The 
cleavage reaction is initiated by the injection of a buffer containing MgCl2 (Figure 3.5C). 
Cleavage of the RNA results in a 3’ cleaved fragment that is weakly hybridized to the 
immobilized DNA activator strand through five bases (14). Therefore, the 3’ cleavage 
fragment rapidly dissociates, resulting in a decrease in the SPR signal due to decreased 
mass density near the sensor surface. The observed RNA dissociation rate, which reflects 
how fast the ribozyme construct cleaves, is obtained by fitting the sensorgram to a first-
order exponential decay equation. Because the DNA-based reaction sensor surface is 
highly stable, the surface can be regenerated by an injection of nuclei acid denaturants 
(i.e., NaOH) to remove residual RNA and reused for the next cleavage assay (Figure 
3.5D). 
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Figure 3.5 Schematic of the SPR-based ribozyme cleavage assay. (A) A sensor surface 
for ribozyme cleavage characterization is generated by conjugating the DNA activator 
strand directly to the chip surface. (B) The blocked ribozyme construct is injected over 
the activator-coated surface, and the hybridization interaction between the ribozyme 
construct and the activator, resulting in an increase in SPR signal, represented by 
resonance units (RU). The hybridization of the ribozyme constructs allows the activated 
of the blocked RNA. (C) The cleavage reaction is initiated by the injection of buffers 
containing MgCl2 over the sensor surface. Ribozyme cleavage results in a quick 
dissociation of the 3’ cleaved fragment, resulting in a decrease in SPR signal. The 
observed RNA dissociation rate is obtained by fitting the injection portion of the 
sensorgram to a first-order exponential decay equation (see Materials and Methods). (D) 
Finally, the surface is regenerated by an injection of 25 mM NaOH to remove residual 
RNA for the next assay. 
 
3.2.7 The observed RNA dissociation rates are closely correlated to the cleavage 
rates obtained through the gel-based assay  
We applied the SPR-based cleavage assays to monitor the cleavage of cis-blocked 
sTRSV, L2b8, and L2b8-a1 constructs under similar reaction conditions used for the gel-
based cleavage assays (Supplementary Figure S3.5). The reactions were initiated by 
injecting buffers (500 μM MgCl2, 100 mM NaCl, and 50 mM Tris-HCl (pH 7.0)) 
containing: (i) no MgCl2; (ii) 500 M MgCl2; and (iii) 500 M MgCl2 and 5 mM 
Blocked RNA
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RU
t
Mg2+
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Activated RNA Cleaved RNA
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t
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t
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theophylline (Figure 3.6A). Previous ribozyme kinetic studies have demonstrated that 
much higher NaCl concentrations (>4 M) are required for ribozymes to exhibit cleavage 
activities (18). Thus, the ribozyme constructs are expected to exhibit little cleavage 
activity in the absence of MgCl2 (reaction condition (i)), and the decrease in SPR signal 
over the course of injection is solely contributed by spontaneous RNA dissociation (full-
length and 5’ cleavage fragments) from the activator strands.  
The RNA dissociations rates were obtained through model fitting for each 
construct under different reaction condition (Figure 3.6B). The measured spontaneous 
RNA dissociation rates (reaction condition (i)) ranged from 0.05 to 0.18 min
-1
. The 
presence of theophylline has little nonspecific effect on the observed dissociation rates by 
examining the rates obtained for the sTRSV construct in the absence (1.66 min
-1
) and 
presence (1.54 min
-1
) of 5 mM theophylline. The observed RNA dissociation rates 
obtained for L2b8 (0.13, 0.09 min
-1
) and L2b8-a1 (0.55, 0.17 min
-1
) in the absence and 
presence of 5 mM theophylline, respectively, were generally in close agreement with 
those obtained through the trans-blocking gel-based assays (Figure 3.4B). However, the 
measured RNA dissociation rate (0.09 min
-1
) for the L2b8 construct in the presence of 
theophylline was significantly greater than the corresponding gel-based cleavage rate 
(0.025 min
-1
) obtained from the trans-blocking strategy, and was comparable to the 
spontaneous RNA dissociation rate (0.05 min
-1
) measured in the absence of MgCl2. This 
result suggests that our current SPR-based assay is limited by the spontaneous 
dissociation of RNA from the sensor surface, and thus may not be applicable to 
characterize ribozyme constructs that exhibit slow cleavage rates. 
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Figure 3.6 The observed RNA dissociation rate are closely correlated to the 
corresponding cleavage rates. (A) The SPR-based assays were performed on the cis-
blocked sTRSV, L2b8, and L2b8-a1 constructs. The reactions were initiated by injecting 
buffers (500 μM MgCl2, 100 mM NaCl, and 50 mM Tris-HCl (pH 7.0)) containing: (i) no 
MgCl2; (ii) 500 M MgCl2; and (iii) 500 M MgCl2 and 5 mM theophylline. A 
representative sensorgram for the characterization of the L2b8-a1 construct at three 
different assay conditions is shown here. The detailed assay steps are indicated. (B) The 
injection portions of the sensorgrams were fit to a first-order decay equation to obtain the 
RNA dissociation rate constants (kd) (Supplementary Figure S3.5). RNA dissociation rate 
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constants and errors are reported as the mean and standard deviation from at least three 
independent assays.  
 
3.3 DISCUSSION 
We described a ribozyme-blocking strategy to support efficient generation of full-
length RNA transcripts containing ribozyme constructs through in vitro transcription 
reactions. In contrast to the traditional trans-blocking strategy that requires laborious 
PAGE purification process for the recovery of full-length transcription products, our cis-
blocking strategy offers a rapid two-step process (transcription and activation) to yield 
large quantities of full-length RNA. We demonstrated the cis-blocking strategy on a 
variety of different ribozyme elements, including natural ribozymes and synthetic 
ribozyme devices. The cleavage rate constants associated with the full-length RNA 
generated from the cis- and trans- blocking strategies were shown to be in close 
agreement and correlate with one another, thus supporting our cis-blocking strategy as an 
efficient method for ribozyme characterization. 
We employed a robust toehold-mediated strand-displacement reaction to facilitate 
the activation of RNA. A similar toehold-mediated activation mechanism has been 
applied to the kinetic study of the hepatitis delta virus (HDV) ribozyme through the use 
of antisense oligomers that target the upstream natural cis-blocking sequence (19). We 
rationally designed the blocking, activation, and stabilizing sequences to achieve an 
optimal blocking efficiency up to ~90% for the sTRSV ribozyme. Previous kinetic 
studies on the sTRSV ribozyme have shown that ~50% of the full-length RNA generated 
by the trans-blocking strategy remained uncleaved at the end of reaction (9). In contrast, 
the full-length RNA generated by our cis-blocking strategy resulted in only ~16% 
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uncleaved products at the end of reaction, suggesting that full-length RNA prepared by 
our method is less prone to misfolding.  
Our cis-blocking strategy utilizes a trans-acting DNA strand to activate the 
blocked RNA, allowing the development of an ‘on-chip’ activation strategy by generating 
a reaction surface immobilized with DNA activator strands. We developed a rapid, label-
free cleavage assay based on SPR, which allows real-time monitoring of ribozyme 
cleavage. Our SPR-based assay offers several unique advantages over the more 
traditional gel-based assay in that: (i) it requires no radioactivity; (ii) it requires little 
material (microfluidics-based flow system); and (iii) it is highly automatable. However, 
to broaden the utility of our SPR-based strategy for the quantification of ribozyme 
cleavage rates, efforts need to be made to address several immediate challenges. Our 
strategy is currently based on a capture-based sensor surface. Although such strategy 
allows the reuse of the surface by regeneration, the measured observed RNA dissociation 
rate is contributed to both cleavage-dependent (3’ cleaved fragments) and spontaneous 
(full-length and 5’ cleaved fragments) dissociation rates. Thus, the spontaneous RNA 
dissociation rate prevents the quantitative measurement of cleavage rates solely based on 
the SPR-based assays. In addition, our current SPR-based assay is limited by the 
maximum injection volume allowed for the given instrument, which presents a challenge 
for the characterization of ribozyme constructs exhibiting low cleavage activities (thus 
requiring a longer injection).  
To allow direct measurement of cleavage rates through the SPR-based assays, 
efforts can be directed toward enhancing the stability of the hybridization reaction 
between the RNA and the DNA activator strand by extending the length of the RNA 
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activation sequence through its 5’ end. Further optimization of the blocking and 
stabilizing sequences may be necessary to ensure that a longer activation sequence does 
not interact nonspecifically with neighboring sequences, thus impacting the blocking 
efficiency. Alternative activator backbone, such as peptide nucleic acid (PNA), may also 
be considered to enhance the stability of the RNA-captured sensor surface, as the PNA-
RNA duplex has been shown to exhibit greater thermal stability than the corresponding 
PNA-DNA and DNA-DNA duplexes (20). To expand the range of cleavage activities that 
can be analyzed by the SPR-based assays, strategies that allow a longer reaction have 
been described by either directly using the characterization buffer as the instrument 
running buffer (thus requiring no injection of the characterization buffer) or modifying 
the SPR instrument with an external peristaltic pump (21). With further development and 
optimization, the SPR-based cleavage assay will offer a powerful strategy for rapidly 
quantifying cleavage rates for a wide variety of ribozyme constructs, thereby supporting 
the functional design of RNA for diverse applications. 
 
3.4 MATERIALS AND METHODS 
3.4.1 Preparation of DNA templates for T7 transcription reaction 
DNA synthesis was performed by Integrated DNA Technologies (Coralville, IA) 
or the Protein and Nucleic Acid Facility (Stanford, CA). PCR products were used as 
DNA templates for in vitro T7 transcription reaction. For the cis-blocking strategy, PCR 
products were amplified from templates using forward primer T7-fwd (5’-
TTCTAATACGACTCACTATAGG) and corresponding reverse primers that are specific 
to each construct (Supplementary Table S3.1), respectively.  
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3.4.2 Generation of full-length RNA through cis-blocking strategy  
A total of 1-2 g of PCR product was transcribed in a 25 l reaction, consisting of 
the following components: 1×RNA Pol Reaction Buffer (New England Biolabs, Ipswich, 
MA), 2.5 mM of each rNTP, 1 l RNaseOUT (Invitrogen, Carlsbad, CA), 10 mM MgCl2, 
1 l T7 Polymerase (New England Biolabs), and 0.5 Ci α-32P-GTP (MP Biomedicals, 
Solon, OH). After incubation at 37°C for 2 hr, NucAway Spin Columns (Ambion, Austin, 
TX) were used to remove unincorporated nucleotides from the transcription reactions 
according to manufacturer’s instructions. The transcription products were purified with 
the RNA Clean & Concentrator
TM
-5 (Zymo Research, Irvine, CA) kit according to 
manufacturer’s instructions.  
 
3.4.3 Gel-based ribozyme cleavage assays  
All gel-based ribozyme cleavage assays were performed in a physiologically-
relevant reaction buffer composed of 500 μM MgCl2, 100 mM NaCl, and 50 mM Tris-
HCl (pH 7.0) at 37°C. Full-length RNA generated from the cis-blocking strategy were 
first incubated with 60 pmol DNA activator strand (5’- AAACAACTTTGTTTGTTTCC 
CCC) for 2 min to activate the blocked RNA. Full-length RNA generated from the trans-
blocking strategy were incubated at 95°C for 5 min, cooled at a rate of -1.3°C to 37°C, 
and held there for 10 min to allow equilibration of secondary structure. A zero time-point 
aliquot was taken prior to initiating the self-cleavage reaction with the addition of MgCl2. 
Reactions were quenched at specified time points with addition of 3 volumes of RNA 
stop/load buffer (95% formamide, 30 mM EDTA, 0.25% bromophenol blue, 0.25% 
xylene cyanol) on ice. Samples were heated to 95°C for 5 min, snap cooled on ice for 5 
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min, and size-fractionated on a denaturing (8.3 M Urea) 10% polyacrylamide gel at 25 W 
for 45 to 60 min. Gels were exposed overnight on a phosphor screen and imaged on a FX 
Molecular Imager (Bio-Rad, Hercules, CA). The relative levels of the full-length 
transcript and cleaved products were determined by phosphorimaging analysis. The 
cleaved product fraction at each time point (Ft) was fit to the single exponential equation 
Ft = F0 + (F∞ − F0)×(1 – e
−kt
) using Prism 5 (GraphPad), where F0 and F∞ are the fractions 
cleaved before the start of the reaction and at the reaction endpoint, respectively, and k is 
the first-order rate constant of self-cleavage. All reported cleavage rates are the mean of 
at least three independent experiments. 
 
3.4.4 Biacore sensor chip surface generation 
Biosensor experiments were performed on a Biacore X100 instrument (Biacore, 
Uppsala, Sweden). A CM5 sensor chip (Biacore) was docked in the Biacore X100 and 
equilibrated with HBS-N buffer at 25ºC. The DNA activator strand (5’-
AAACAACTTTGTTTGTTTCCCCC-/AmMO/), with an amino modification on its 3’ 
end, was immobilized to the chip surface via standard amine-coupling chemistry. Briefly, 
the carboxymethyl surface of the CM5 chip was activated for 7 min at a flow rate of 5 
l/min using a 1:1 volume ratio of 0.4 M 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (Biacore) and 0.1 M N-hydroxysuccinimide (Biacore). A molar ratio of 
1:60 of DNA activator to cetyl trimethylammonium bromide (Amresco, Solon, OH) was 
diluted in 10 mM HEPES buffer (Sigma, St. Louis, MO) to a final concentration of 10 
M and 0.6 mM, respectively, and injected over the activated surface for 10 min at a flow 
rate of 5 l/min. Excess activated groups were blocked by an injection of 1 M 
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ethanolamine (Biacore), pH 8.5, for 7 min at a flow rate of 5 l/min. The immobilization 
reaction was performed on both flow cells (FC1, FC2), where FC1 was used as a 
reference cell to correct for bulk refractive index changes, matrix effects, nonspecific 
binding, injection noise and baseline drift (22). Approximately 1600 RU of the activator 
strand was immobilized using this protocol. 
   
3.4.5 Label-free SPR-based ribozyme cleavage assays  
Full-length RNA was prepared by the cis-blocking strategy without the 
radiolabelled nucleotides. The Biacore X100 instrument was equilibrated with the 
physiologically-relevant reaction buffer at 37ºC prior to all ribozyme cleavage assays. 
The SPR baseline was stabilized by performing 2-5 startup cycles, each cycle includes a 
capture and a regeneration step. The capture step was performed by an injection of a total 
of 10-25 ng transcribed RNA diluted in the reaction buffer over the reaction flow cell 
(FC2) for 1 min at a flow rate of 10 l/min. The capture step typically yielded ~50-300 
RU of the SPR signal for the described constructs. The regeneration step was performed 
by an injection of 25 mM NaOH over both flow cells for 30 sec at a flow rate of 30 
l/min.  
Following the startup cycles, assay cycles were performed. Each assay cycle 
includes a capture, a reaction, and a regeneration step. The capture and regeneration steps 
were performed the same as those in the startup cycle. The reaction step was performed 
by an injection of the running buffer or running buffers containing 500 M MgCl2 with or 
without 5 mM theophylline over both FCs for 5 min at a flow rate of 10 l/min. Biacore 
sensorgram processing and analysis were performed using Biacore X100 Evaluation 
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Software v2.0 (Biacore). Due to the slight time delay at which injected analyte reaches 
the respective flow cells, the resultant sharp spikes at the beginning and the end of 
injection were excluded from the analysis (23). The processed sensorgram (R) was fit to a 
simple exponential equation R = R0×(e
-kdt 
- 1) + offset, where R0 (fit globally for a given 
replicate) is the initial SPR signal before the cleavage reaction, offset (fit locally for a 
given replicate) is the residual response at the end of the cleavage reaction, and kd is the 
first-order RNA dissociation rate constant. Reported values are the mean of at least three 
independent experiments.  
 
  
129 
 
3.5 Supplementary Information 
 
 
Supplementary Figure S3.1 Cis-blocked sTRSV constructs with varying stabilizing 
sequence length. The stabilizing sequence in the cis-blocked sTRSV construct (Figure 3.2) 
is increased in 2 nt increment to generate sTRSV-2, -4, -6, -8, and -10 constructs 
(Supplementary Table S3.1). The targeted ribozyme sequence, and the RNA blocking, 
activation, and stabilizing sequences are indicated in grey, red, yellow, and black, 
respectively. The additional 2, 4, 6, 8, and 10 nt to the stabilizing sequence in the original 
cis-blocked sTRSV construct results in a toehold length of 8, 6, 4, 2, and 0 nt, 
respectively.  
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B L2b1 
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C L2b5 
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D L2b8-a1 
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E L2bOFF1 
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F L2b8tc 
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Supplementary Figure S3.2 Cis-blocked constructs for synthetic ribozyme devices 
composed of different functional RNA components. The same blocking (targeting the 
same sTRSV ribozyme sequence), activation, and stabilizing sequences shown in Figure 
2 were directly incorporated into the synthetic ribozyme devices to generate the 
corresponding cis-blocked ribozyme constructs (Supplementary Table S3.1). The targeted 
ribozyme sequence, RNA blocking, activation, stabilizing sequences, and DNA activator 
are indicated in grey, red, yellow, black, and brown, respectively, for the (A) L2b8 
construct. The sensor (RNA aptamer), transmitter, and actuator (sTRSV ribozyme) in the 
L2b8 construct are indicated in green, blue, and white, respectively. For the subsequent 
constructs, only components that are different from those in the L2b8 device are indicated 
in brown. The blocked (top) and activated (bottom) conformations are shown for each 
construct. The (A) L2b8, (B) L2b1, and (C) L2b5 devices are theophylline-responsive 
ribozyme ON devices that differ slightly in the transmitter sequences. The (D) L2b8-a1 
device was modified from the L2b8 device by incorporating a ribozyme variant that 
exhibits improved cleavage activity (see Chapter 2). The (E) L2bOFF1 device is a 
theophylline-responsive ribozyme OFF device that is composed of a transmitter sequence 
that is different from those in the ribozyme ON devices. The (F) L2b8tc device is a 
tetracycline-responsive ribozyme ON device that was generated by directly replacing the 
theophylline aptamer in the L2b8 device with the tetracycline aptamer (see Chapter 2). 
Secondary structures were predicted by RNAstructure folding software (16) and rendered 
using VARNA software (8). 
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Supplementary Figure S3.3 Gel analysis of the transcription products for the L2b8 
construct without the cis-blocking sequence. PCR products, which were used as DNA 
templates for in vitro T7 transcription reactions, were amplified using forward and 
reverse primers T7-L1-2-fwd (5’- TTCTAATACGACTCACTATAGGGACCTAGGAA 
ACAAACAAAGCTGTCACC) and L1-2-rev (5’-GGCTCGAGTTTTTATTTTTCTTTT 
TGCTGTTTCG), respectively. The transcription reactions were performed in the absence 
and presence of 5 mM theophylline at the same reaction conditions as described for the 
generation of cis-blocked RNA (see Materials and Methods). A previously described 
non-switch control, L2Theo (3), which lacks the transmitter sequence in the L2b8 device 
(thus only adopting the ribozyme-inactive conformation and cleaves) was transcribed, 
resulting in 5’ (25 nt) and 3’ (109 nt) cleaved fragments. In addition, a ribozyme-inactive 
control, L2Theo Contl, generated by randomizing the ribozyme catalytic core in the 
L2Theo construct (thus abolishing the ribozyme cleavage activity) was transcribed, 
resulting in a full-length fragment (134 nt). The transcription products were size-
fractionated on a denaturing (7 M urea) 10% polyacrylamide gel at 25 W for 45 min and 
imaged by phosphorimaging analysis. The transcription of the L2b8 construct without the 
cis-blocking sequence resulted in 5’ (25 nt) and 3’ (116 nt) cleavage fragments, and little 
full-length (141 nt) fragment was observed. 
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A L2b8: 
 
 
B L2b8-a1: 
 
 
C 
RNA Device Cleavage Rate (k, min
-1
) 
0 mM theophylline 5 mM theophylline 
L2b8 0.063 ± 0.001 0.008 ± 0.002 
L2b8-a1 0.351 ± 0.007 0.043 ± 0.007 
 
 
Supplementary Figure S3.4 Representative gel-based cleavage assays for measuring 
cleavage rate constants (k) for RNA generated from the cis-blocking strategy. A 
representative assay is shown for each cis-blocked construct in the absence and presence 
(0 and 5 mM, respectively) of theophylline: (A) L2b8 and (B) L2b8-a1. Bands for the 
full-length uncleaved substrate (UC) and longer cleaved product (3’C) are shown, the 
shorter 5’C product is omitted from the inset image for clarity. Methods used to prepare 
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full-length, uncleaved RNA transcripts and conditions of the cleavage assays are detailed 
in the Materials and Methods section of the main text. Briefly, cis-blocked RNA was 
incubated with the DNA activator in a buffer (100 mM NaCl, 50 mM Tris-HCl (pH 7.0)) 
for 2 min to activate the blocked RNA. A zero time point aliquot was removed prior to 
initiating the reaction with addition of MgCl2 to a final concentration of 500 μM. 
Reactions were quenched at the indicated time points. Phosphorimaging analysis of 
relative levels of the UC, 5’C, and 3’C bands was used to determine the fraction cleaved 
at each time point (Ft). The fraction cleaved at the beginning (F0) and end of reaction (F∞) 
varied between assays, but all assays were well-fit to the single exponential equation (R
2
 
> 0.95): 
 
Ft = F0 + (F∞ − F0 )×(1 – e
−kt
) 
 
The black and red fit lines represent assays performed at 0 and 5 mM theophylline, 
respectively. (C) The cleavage rate constant value (k) was determined for each assay. The 
reported k for each device and theophylline assay condition is the mean and standard 
deviation of at least three independent experiments. 
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A L2b8 (Chi
2
: 0.0255): 
 
 
 
B L2b8-a1(Chi
2
: 0.0395): 
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C sTRSV(Chi
2
: 0.33): 
 
 
 
 
 
D 
RNA Device Dissociation Rate (k, min
-1
) 
No MgCl2 MgCl2  MgCl2  + theo 
L2b8 0.047± 0.003 0.133 ± 0.011 0.087 ± 0.008 
L2b8-a1 0.052 ± 0.001 0.552 ± 0.006 0.166 ± 0.001 
sTRSV ribozyme 0.18 ± 0.01 1.66 ± 0.04 1.54 ± 0.10 
 
 
 
Supplementary Figure S3.5 Representative SPR-based cleavage assays for measuring 
RNA dissociation rate constants (kd) for RNA generated from the cis-blocking strategy. 
A representative Biacore sensorgram is shown for each cis-blocked construct: (A) L2b8, 
(B) L2b8-a1, (C) sTRSV. The assays were performed in reactions buffers (100 mM NaCl, 
50 mM Tris-HCl (pH 7.0)) containing: (i) no MgCl2; (ii) 500 M MgCl2; and (iii) 500 
M MgCl2 and 5 mM theophylline at 37ºC. The capture, reaction, and regeneration steps 
in the assay cycle are indicated for the L2b8 sensorgrams. Methods used to prepare full-
length RNA transcripts and conditions of the cleavage assays are detailed in the Materials 
and Methods section of the main text. The reaction step of the sensorgram was well-fit to 
the single exponential equation (Chi
2
 < 0.34): 
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Rt = R0 × (e
−kdt 
- 1) + offset 
 
(D) The RNA dissociation rate (kd) was determined for each assay. The reported kd for 
each construct are the mean and standard deviation of at least three independent 
experiments. 
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Supplementary Table S3.1 Sequences of primers and templates for all described cis-
blocked constructs in this work. The T7 promoter region in the template sequence is 
indicated in bold. 
 
Primer   Sequence 
T7-fwd  TTCTAATACGACTCACTATAGG 
sTRSV-rev  CAAAGCTGTTTCGTCCTCAC 
sTRSV-2-rev  AACAAAGCTGTTTCGTCCTCAC 
sTRSV-4-rev  CAAACAAAGCTGTTTCGTCCTCAC 
sTRSV-6-rev  AACAAACAAAGCTGTTTCGTCCTCAC 
sTRSV-8-rev  GAAACAAACAAAGCTGTTTCGTCCTCAC 
sTRSV-10-rev  GGGAAACAAACAAAGCTGTTTCGTCCTCAC 
L2b1-rev  CAAAGCTGTTTCGTCCTCGTCCCGTCC 
L2b5-rev  Same as b-L2b1-rev 
L2b8-rev  CAAAGCTGTTTCGTCCTCCGT 
L2b8-a1-rev  Same as b-L2b8-rev 
L2bOFF1-rev  CAAAGCTGTTTCGTCCTCGTCCACTGC 
L2b8tc-rev  Same as b-L2b8-rev 
Template   Sequence 
sTRSV  TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTT
TTGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCCGTGA
GGACGAAACAGCTTTG 
sTRSV-2  TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTT
TTGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCCGTGA
GGACGAAACAGCTTTGTT 
sTRSV-4  TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTT
TTGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCCGTGA
GGACGAAACAGCTTTGTTTG 
sTRSV-6  TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTT
TTGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCCGTGA
GGACGAAACAGCTTTGTTTGTT 
sTRSV-8  TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTT
TTGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCCGTGA
GGACGAAACAGCTTTGTTTGTTTC 
sTRSV-10  TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTT
TTGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCCGTGA
GGACGAAACAGCTTTGTTTGTTTCCC 
L2b1  TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTT
TTGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCCGTGT
CCATACCAGCATCGTCTTGATGCCCTTGGCAGGGACGGGAC
GAGGACGAAACAGCTTTG 
L2b5  TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTT
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TTGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCCGTGT
CCAATACCAGCATCGTCTTGATGCCCTTGGCAGTGGACGGG
ACGAGGACGAAACAGCTTTG 
L2b8  TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTT
TTGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCCGTTG
TCCATACCAGCATCGTCTTGATGCCCTTGGCAGGGACGGGA
CGGAGGACGAAACAGCTTTG 
L2b8-a1  TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTT
TTGCTGTCACCGGAATCAAGGTCCGGTCTGATGAGTCCGTT
GTCCATACCAGCATCGTCTTGATGCCCTTGGCAGGGACGGG
ACGGAGGACGAAACAGCTTTG 
L2bOFF1  TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTT
TTGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCCGTGT
TGCTGATACCAGCATCGTCTTGATGCCCTTGGCAGCAGTGG
ACGAGGACGAAACAGCTTTG 
L2b8tc  TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTT
TTGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCCGTTG
TCCAAAACATACCAGATTTCGATCTGGAGAGGTGAAGAATT
CGACCACCTGGACGGGACGGAGGACGAAACAGCTTTG 
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Chapter 4. 
A high-throughput in vitro ribozyme-based selection 
strategy for generating new RNA sensing functions* 
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Abstract 
In vitro selection strategies have been developed to support de novo generation of 
RNA aptamers, allowing the potential to generate sensors to diverse ligands of interest. 
The scalability of these strategies to small molecule ligands is primarily limited by the 
partitioning method, which utilizes column-based affinity chromatography and therefore 
requires chemical modification of the target ligands. We propose a solution-based 
selection strategy that enables generation of new RNA sensing functions directly within a 
modular ribozyme device platform. In the proposed strategy, a large device library is 
generated by randomizing the sensor component within the device platform, and the 
resulting library is partitioned through ligand-dependent cleavage activities. We 
addressed challenges associated with the efficient generation of full-length ribozyme 
device libraries through in vitro transcription reactions by employing a cis-blocking 
strategy. We further developed a dual selection process based on magnetic bead-based 
partitioning, which supports rapid gel-free recovery of the desired library members. The 
dual selection process was optimized by modeling the effects of incubation times on the 
fold enrichment of an active device. Under optimal incubation times for positive and 
negative selections, our model predicted a ~13-fold enrichment per selection round. With 
further optimization and development, our ribozyme-based selection strategy may 
address current challenges in scaling the generation of synthetic RNA control devices 
exhibiting new sensing functions to small molecule ligands for broad cellular engineering 
applications. 
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4.1 Introduction  
Recent discovery of the widespread regulatory activity and conservation of 
noncoding RNAs represents an exciting area in RNA-based gene regulation (1). 
Significant research efforts have focused on the design of RNA-based sensing-actuation 
systems that link molecular binding information to programmed gene regulation (2). A 
unique advantage of RNA-based sensing systems is the potential to tailor the sensing 
function to detect a diverse array of small molecules through the de novo generation of 
RNA aptamers (3,4). In vitro selection strategies have been applied to generate RNA 
aptamers to many small molecule ligands, including alkaloids (5), amino acids (6), and 
oligosaccharides (7,8). Partitioning methods based on column affinity chromatography 
are generally used in selecting aptamers to small molecule ligands, where the target small 
molecule is conjugated to a solid support through an appropriate functional group.  
Small molecule aptamers are generated by applying iterative rounds of screening 
for sequences exhibiting desired binding affinities from very large libraries in vitro. The 
aptamer selection process begins with incubation of an initial RNA library (~10
14
-10
15
 
molecules) in a column modified with the target small molecule. Unbound or weak-
binding sequences are removed from the column by washing with the selection buffer. 
The washing step can be repeated to increase the selection stringency and therefore 
isolate rare sequences that exhibit high affinities to the target ligand. The bound 
sequences are recovered by a competitive elution process in which high concentration of 
free ligand is applied to the column to compete with the immobilized ligand for the 
binding of RNA. The recovered RNA is amplified through reverse transcription (RT) and 
polymerase chain reaction (PCR), and used as the input library for the next selection 
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round. In general, the selection process is performed iteratively 10-15 times to reduce 
library diversity sufficiently for characterization. Aptamers with affinities ranging from 
10 nM to 100 M have been generated through the described selection process (9). By 
incorporating appropriate counterselection cycles in the later rounds of the selection 
process, aptamers can be selected to discriminate between structurally similar metabolites. 
In one example, an aptamer selected to theophylline exhibits a 10,000 fold lower affinity 
for caffeine, which differs from theophylline by a single methyl group (5). 
 One key challenge to the broad generation of RNA aptamers capable of detecting 
diverse small molecule ligands is the limited scalability of current in vitro selection 
methods. In particular, current strategies require that the small molecule ligands have 
functional groups exhibiting chemistries that are appropriate for conjugation to solid 
supports. In many cases such functional groups are not readily available, necessitating the 
development of chemical modification strategies to append appropriate functional groups 
to the desired ligands. The need for coupling strategies have added disadvantages 
associated with (i) longer, more cumbersome, less efficient partitioning processes based 
on column chromatography; (ii) presentation of the ligand in an environment that does 
not closely mimic that of the cellular environment (i.e., ligand in solution versus ligand 
coupled to solid support); and (iii) removal of functional groups through chemical 
coupling that could play important roles in interacting with the RNA sequence to increase 
binding affinities. Improved solution-based partitioning methods, such as capillary 
electrophoresis, have been developed for the selection of aptamers to protein ligands (10). 
However, these methods are often based on the large size of the protein ligand and are 
not applicable to small molecule ligands. Therefore, the development of rapid, solution-
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based partitioning methods for small molecule ligands is critical to scaling aptamer 
selection to diverse molecular targets. 
 An in vitro solution-based selection strategy to facilitate the isolation of allosteric 
ribozymes that exhibit new ligand-activated ribozyme cleavage activities from large 
nucleic acid libraries was previously described (11) (Figure 4.1). The selection strategy 
utilized an allosteric ribozyme comprised of a minimal hammerhead ribozyme (HHRz) 
and a randomized sensor domain, coupled through a previously selected communication 
module (12). An initial DNA library was generated by coupling a randomized 25-mer 
sensor domain (N25) to the 5’ end of the minimal HHRz through the communication 
module. The DNA library was transcribed and purified by denaturing polyacrylamide gel 
electrophoresis (PAGE). The full-length allosteric ribozyme library was recovered from 
the gel and subjected to two sequential selections through which library members were 
partitioned based on ligand-activated ribozyme cleavage activity. An initial negative 
selection round was performed by incubating the library in the absence of ligand. Library 
members that resisted cleavage in the absence of ligand were recovered by PAGE 
purification. A subsequent positive selection round was performed by incubating the 
recovered full-length library with the ligand of interest. Library members that cleaved in 
the presence of ligand, or the 5’ cleaved library fragments, were recovered by PAGE 
purification and amplified through RT-PCR to generate the library pool for the next 
selection cycle.  
 
 
 
153 
 
 
 
Figure 4.1 Schematic of an in vitro allosteric ribozyme selection strategy (11). The RNA 
library is generated from the DNA library by transcription reactions (I). The full-length 
RNA is recovered by PAGE and is (II) subject to a negative selection in the absence of 
ligand. The red arrow indicates the cleavage site. Uncleaved library members are 
recovered by PAGE and subject to a positive selection in the presence of ligand (III). The 
5’ cleaved library members are recovered by PAGE and (IV) amplified through RT/PCR 
to generate the double-stranded DNA templates for the next selection cycle. Each round 
of selection requires three PAGE purifications, thus making the allosteric selection 
strategy laborious and time-consuming. 
 
 
The described allosteric selection strategy was applied to generate allosteric 
ribozymes that respond to secondary messengers cGMP and cAMP through a total of 22 
selection rounds, resulting in allosteric ribozymes with binding affinities ranging from 
~200 M to 4 mM (11,13). However, these ribozymes are based on a truncated form of 
HHRz, which requires high MgCl2 concentration (>10 mM) to exhibit activity and thus 
do not exhibit activity in cellular environments, where MgCl2 is in the submillimolar 
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range (14).  
We recently described a modular ligand-responsive ribozyme device platform that 
specifies physical linkage of three RNA components (15) (Figure 4.2). A sensor encoded 
by an RNA aptamer is linked to a HHRz from the satellite RNA of tobacco ringspot virus 
(sTRSV) through a transmitter sequence capable of facilitating a strand-displacement 
event. The device platform specifies the integration of the sensor-transmitter element 
through the ribozyme loops, which have been shown to provide a stabilizing tertiary 
interaction essential for activity under physiological concentrations of MgCl2 (14). We 
have demonstrated the gene-regulatory function of the ribozyme devices in yeast (15) and 
mammalian cells (16) and verified their ligand-dependent cleavage activities through in 
vitro characterization (see Chapter 2). Therefore, the potential exists to adapt the 
described allosteric selection strategy to our platform to generate new ligand-responsive 
ribozyme devices that are amenable to cellular engineering applications.  
The efficiency and throughput of the described selection strategy based on 
differential ribozyme cleavage activities are currently limited by the inefficient 
generation of uncleaved RNA through in vitro transcription reactions and the low-
throughput gel separation method to recover desired RNA fragments. Large RNA 
libraries are generated by in vitro T7 transcription, which requires high MgCl2 
concentrations (~mM) to achieve sufficient yields. Because the described allosteric 
ribozyme selection process is based on the truncated form of the HHRz, which only 
exhibits activity at high MgCl2 concentrations (>10 mM), sufficient yields of uncleaved 
RNA can be generated by transcription reactions to cover the desired sequence space. 
However, libraries based on our ribozyme device platform, which maintains the 
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stabilizing loop-loop interactions, can exhibit cleavage activity at submillimolar 
concentrations of MgCl2, such that library members that can adopt a ribozyme-active 
conformation will cleave during transcription, resulting in low yields of uncleaved RNA. 
Further, the cleavage-based partitioning strategy requires isolation of desired RNA 
fragments of different lengths. PAGE purification, a low-throughput and cumbersome 
process, is typically performed to recover the desired RNA fragments, which increases 
both the time and labor required for each selection round. Therefore, more efficient 
ribozyme generation and high-throughput separation strategies are desired. 
 
 
 
Figure 4.2 A modular ribozyme device platform allowing construction of devices that are 
amenable to cellular engineering applications. A ribozyme device is comprised of three 
RNA components: sensor (aptamer), actuator (ribozyme), and transmitter (sequence 
capable of a strand-displacement event). The device platform specifies the integration of 
the sensor-transmitter element through the ribozyme loops, which have been shown to 
provide a stabilizing tertiary interaction essential for activity under physiological 
concentrations of MgCl2. A ribozyme ON device is depicted here. In the absence of input 
ligand, the device adopts a ribozyme-active conformation, thereby leading to cleavage or 
decreased gene expression. In the presence of input ligand, the device adopts a ribozyme-
inactive conformation, which is stabilized by the ligand binding to the aptamer, thereby 
leading to no cleavage or increased gene expression.  
 
We aim to develop a scalable in vitro selection strategy based on the ribozyme 
sensor transmitter actuator
ribozyme ON device
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device platform to generate new sensing functions. The selection strategy will be applied 
to large device libraries (10
14
-10
15
 molecules) generated by randomizing the sensor 
component (Nx, where x indicates the number of randomized nucleotides) within the 
ribozyme device platform. A high-throughput and high-efficiency cleavage-based 
partitioning strategy will be developed to facilitate isolation of new ligand-responsive 
ribozyme devices. We focused initially on addressing limitations associated with the 
generation of uncleaved RNA device libraries through in vitro transcription reactions by 
employing an efficient cis-blocking strategy (see Chapter 3). A dual selection strategy 
based on magnetic beads was proposed to facilitate cleavage-based library partitioning 
and rapid isolation of desired RNA fragments. We optimized the fold enrichment of the 
dual selection process by developing a mathematical model based on a simple control 
device library composed of three populations that exhibit distinct cleavage activities. We 
examined the effects of incubation times on the fold enrichment of the desired population 
during the negative and positive selection steps. Our model predicted a ~13-fold 
enrichment for each round of selection under optimal incubation conditions. Future work 
will focus on the validation of our strategy on a control library (~10
6
 variants) that 
contains one known functional sequence.  
 
4.2 Results 
4.2.1 The cis-blocking strategy allows efficient generation of a full-length ribozyme 
device library by in vitro transcription 
 One key challenge in developing a scalable ribozyme-based selection strategy is 
the efficient generation of the full-length RNA library due to significant ribozyme 
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cleavage activity at the transcription reaction conditions. Our previous work 
demonstrated a cis-blocking strategy for the efficient generation of full-length RNA 
containing a ribozyme, including natural ribozymes and ribozyme devices (see Chapter 3). 
Specifically, an RNA blocking sequence was designed to inhibit the cleavage of a variety 
of ribozyme devices composed of different components during in vitro transcription, 
resulting in a blocking efficiency of up to ~90%. In addition, a RNA activation sequence 
was designed to allow triggered release of the blocked RNA in the presence of a DNA 
activator strand. We examined whether a similar strategy could be applied to the 
generation of full-length ribozyme device libraries. 
We applied the blocking, activation, and stabilizing sequences previously 
developed for the ribozyme-based devices to a small control device library (~10
6
 
variants), L2b8-N10. The L2b8-N10 library was generated by randomizing 10 nt 
positions in the aptamer binding core (sensor component) of a theophylline-responsive 
ribozyme device, L2b8 (Figure 4.3A and B). A radiolabeled library was transcribed 
through a standard T7 in vitro reaction with the cis-blocking strategy and the 
transcription products were analyzed by PAGE to quantify the blocking efficiency 
(Figure 4.3C). More than 50% of the transcription products were uncleaved, indicating 
that the cis-blocking sequence inhibited a majority of the library members from adopting 
a ribozyme-active conformation during transcription. We subsequently incubated the 
transcribed cis-blocked L2b8-N10 RNA with the DNA activator strand and 5 mM MgCl2 
for 15 minutes and verified that the activator was capable of restoring the ribozyme 
activity such that more than 60% of the full-length blocked RNA cleaved (Figure 4.3C). 
These results support that the cis-blocking strategy provides a gel-free strategy for 
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generating large yields of full-length RNA from a ribozyme device library. 
 
A Functional conformation 
 
B Blocked conformation 
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Figure 4.3 The cis-blocking strategy enables efficient generation of full-length ribozyme 
device library. The predicted secondary structures of the L2b8 device are shown here. (A) 
The L2b8 ribozyme-active device functional conformation is shown here. The 
randomized positions in the theophylline aptamer of the L2b8 device (to generate the 
L2b8-N10 device library) are indicated in blue. The cleavage site is indicated in yellow. 
(B) The blocked conformation is shown here, where the blocking, activation, and 
stabilizing sequences are indicated in orange, brown, and magenta, respectively. 
Secondary structures were predicted by RNAstructure folding software (17) and rendered 
using VARNA software (18). (B) The transcribed L2b8 and L2b8-N10 products with the 
cis-acting blocking sequence incorporated in the 5’ end of the transcript were 
characterized by PAGE analysis. More than 50% of the transcribed L2b8-N10 products, 
compared to ~90% of the transcribed L2b8 products, were uncleaved. When incubating 
with 5 mM MgCl2 and 10 M DNA activator, ~60% of the full-length L2b8-N10 
products, compared to ~90% of the full-length L2b8 products, were capable of self-
cleavage. 
 
4.2.2 Design of a dual selection strategy based on magnetic bead separation 
We designed a dual selection strategy that allows partitioning of library members 
through sequential cleavage reactions (Figure 4.4). A reaction surface is generated by 
immobilizing biotinylated DNA activator strands to the streptavidin-coated magnetic 
beads. The transcribed cis-blocked RNA libraries are incubated with the beads to allow 
activation of the full-length RNA through hybridization interactions between the RNA 
and the activator strand. The binding capacity of commercially available magnetic beads 
(Promega) is ~1 nmol/ml, making them scalable for library selection. For example, 
generation of new sensing functions typically requires searching within a large library of 
L2b8 L2b8-N10
activator
MgCl2 - +
- +
full length
3’ cleaved
- +
- +
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~10
14
-10
15
 sequences, corresponding to ~0.2-2 nmol of molecules. Therefore, at least 2 
ml of the magnetic beads need to be used to immobilize a sufficient amount of the DNA 
activator strands (and thus allow sufficient hybridization with RNA device libraries).  
The streptavidin-coated beads respond to a magnetic field, allowing the beads to 
be rapidly partitioned to the surface of a microfuge tube. Thus, RNA bound to the beads 
can be rapidly separated from unbound species in the supernatant, such as 3’ cleaved 
fragments, which can be removed by aspiration or pipetting. The bound full-length 
library is partitioned through sequential cleavage reactions. A positive selection is 
performed first by incubating the library in the presence of ligand and MgCl2. Active 
library members that resist cleavage in the presence of ligand will remain bound to the 
DNA activator strand, whereas cleaved library members are weakly bound to the 
activator strand and thus rapidly dissociate from the bead surface. The beads are collected 
to the tube surface by the magnetic field, allowing the cleaved library members in the 
supernatant to be removed by aspiration or pipetting. The remaining bound full-length 
library is next subjected to a negative selection by incubating in the absence of ligand and 
MgCl2. The dissociated cleaved library members are recovered from the supernatant and 
subsequently amplified through RT-PCR to generate the input library for the next 
selection round. In the proposed scheme, no gel purification step is required to facilitate 
the separation of RNA fragments. 
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Figure 4.4 Schematic of the dual selection strategy facilitated by magnetic bead-based 
separation. The cis-blocked RNA device library is transcribed from DNA template (I). 
The blocked RNA is activated by incubating with the DNA activator strands immobilized 
to magnetic beads (II). The red arrow indicates the cleavage site. The activated library is 
first subject to a positive selection (III) by incubating with the target ligand and MgCl2. 
The library members that resist cleavage in the presence of ligand (boxed) will remain 
bound to the DNA activator strand, whereas cleaved library members are discarded. The 
remaining library is subject to a negative selection (IV) by incubating with MgCl2. The 
cleaved library members (boxed) are recovered to be amplified through RT-PCR (V) to 
generate the DNA template for the next round of selection. 
 
4.2.3 Optimization of reaction parameters to achieve greater enrichment efficiency 
Our ribozyme device platform utilizes a linker sequence capable of a strand-
displacement event to facilitate information transmission between the sensor and actuator 
components. The interaction between the linker sequence and neighboring components 
dictates the partitioning between functional conformations of a device and thus the 
associated cleavage rate. When generating a device library by randomizing the sensor 
component, it is expected that each new sensor sequence will interact with the existing 
positive selection
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linker sequence differently, such that the library will exhibit a distribution of cleavage 
activities.  
 We have previously characterized three theophylline-responsive ribozyme devices, 
L2b1, L2b5, and L2b8, that span a wide range of in vitro cleavage rates in the absence 
(0.033, 0.013, and 0.14 min
-1
) and presence of 5 mM theophylline (0.011, 0.007, and 
0.025 min
-1
) at physiologically-relevant reaction conditions (500 μM MgCl2, 100 mM 
NaCl, and 50 mM Tris-HCl (pH 7.0) at 37°C) (see Chapter 2). The L2b5 and L2b8 
devices were characterized to be the slowest and fastest cleaving devices among the 
series based on the same ribozyme component, and thus these three devices were selected 
to represent the broad activities exhibited by a device library.  
To model the enrichment patterns of a typical device library, we assumed an 
initial library composed of three equally represented slow, medium, and fast-cleaving 
populations that exhibit similar cleavage activities as the L2b5, L2b1, and L2b8 devices, 
respectively, and do not respond to the ligand. We also assumed that a ligand-responsive 
target sequence (i.e., theophylline-responsive device) exists in the library and exhibits 
similar cleavage activities in the absence (0.14 min
-1
) and presence (0.025 min
-1
) of 5 
mM theophylline as the L2b8 device. The fraction of the cleaved population as a function 
of time can be modeled by a first-order exponential decay equation: e
-kt
, where k is the 
cleavage rate constant. For example, the fast-cleaving population, which exhibits the 
same cleavage rate (0.14 min
-1
) as the L2b8 device, will require 15 minutes to achieve 
~90% cleavage under the specified conditions, whereas the slow-cleaving population, 
which exhibits the same cleavage rate (0.013 min
-1
) as the L2b5 device, will require 180 
minutes to achieve the same extent of cleavage. Incubation times that are either too short 
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or too long will present practical limitations on the selection process, such as ease of 
liquid sample handling (e.g., short incubation time) and stability of the RNA-DNA 
activator hybrid and magnetic bead surface (e.g., long incubation time). Therefore, 
careful optimization of the cleavage reaction conditions is needed for both negative and 
positive selections. 
 
Optimization of the negative selection conditions 
 The negative selection step in the dual selection process enriches sequences that 
are capable of cleaving in the absence of ligand, and the cleaved sequences are recovered 
to be amplified through RT-PCR. We performed calculations based on a device library of 
10
15
 diversity (one functional sequence in 10
15
 variants), where the transcription reaction 
was set up to generate 10 copies of each sequence in the library (a total of 10
16
 members). 
As such, the initial library is composed of 3.3×10
15
 members in each population. We 
examined fractions of cleaved sequences within the three populations as a function of 
incubation time using our computational model (Figure 4.5A). Predicted fractions of 
cleaved sequences from each population were calculated based on rates obtained at the 
physiologically-relevant reaction conditions in the absence of theophylline 
(Supplementary Table S4.1).  
As the target device is part of the fast-cleaving population, we determined the 
respective fold enrichment of the fast-cleaving population relative to the medium and 
slow-cleaving populations for the negative selection step (Figure 4.5B). The fold 
enrichment is determined by calculating the ratios of the number of cleaved fast-cleaving 
members to that of the medium and slow-cleaving members, respectively. For example, 
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the fractions of cleaved slow, medium, and fast-cleaving populations after incubating the 
library for 1 minute are 0.01, 0.03, and 0.13, respectively (Supplementary Table S4.1). 
These fractions correspond to 4.31×10
13
, 1.08×10
14
, and 4.35×10
14
 cleaved members at 
the end of incubation, resulting in 10 and 4-fold enrichment of the fast-cleaving 
population relative to the slow and medium-cleaving populations, respectively. 
We further determined the percent of input library members recovered for the 
subsequent RT-PCR step (Figure 4.5C). The total number of recovered library members 
is calculated by summing up the numbers of cleaved members for each population. The 
percent recovery can then be determined by dividing the number of recovered library 
members to that of the input library (Supplementary Table S4.1). For example, after 1-
minute incubation the sum of the numbers of all cleaved members is 5.87×10
14
, 
corresponding to only ~6% of the input initial library (10
16 
members). This modeling 
result suggested that when there is a large diversity in the library (i.e., in the earlier 
selection rounds), the functional sequences are rare and therefore require proper scaling 
of the transcription reactions to ensure that library diversity is not lost in the process. 
Therefore, a longer incubation time (e.g., 5-10 minutes) is desired for the earlier selection 
rounds. For the later selection rounds when the functional sequences have been enriched, 
a shorter incubation time (<1 minute) can be employed to achieve greater fold enrichment 
for the fast-cleaving population. 
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Figure 4.5 Optimization of the negative selection conditions. The model is based on an 
initial device library composed of 3.3×10
15
 members in each slow, medium, and fast-
cleaving population (a total of 10
16
 variants) (Supplementary Table S4.1). (A) Fraction of 
cleaved members within each population as a function of incubation time. The fraction of 
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the cleaved population is determined by the first-order exponential decay equation: e
-kt
, 
where k is the cleavage rate constant. The fractions of the cleaved populations increase at 
different rates as a function of time. (B) Fold enrichment of the fast-cleaving population 
relative to the medium and slow-cleaving populations as a function of time. The fold 
enrichment is determined by calculating the ratios of the number of cleaved fast-cleaving 
members to that of the medium and slow-cleaving members, respectively. (C) Percent 
recovered library as a function of incubation time. The percent of the recovered cleaved 
library members is determined by summing up the numbers of cleaved members from the 
three populations and dividing the sum by the number of the input library members.  
 
 
Optimization of the positive selection conditions 
The positive selection step in the dual selection process enriches sequences that 
resist cleaving in the presence of ligand, and the cleaved sequences are discarded. 
Fractions of uncleaved sequences within the three populations during the positive 
selection were determined by the first-order exponential decay equation (1-e
-kt
) based on 
the same rates used for the modeling of negative selection, as these populations do not 
response to the ligand (theophylline). The fraction of cleaved target sequence was 
calculated based on the rate for the L2b8 device in the presence of 5 mM theophylline 
(Figure 4.6A and Supplementary Table S4.2). 
The fold enrichment of the target sequence is determined by the ratio of fraction 
compositions of the uncleaved target sequence in the library before and after the 
incubation (Figure 4.6B and Supplementary Table S4.2). As an example, the number of 
the uncleaved target sequence in the initial library of 10
16
 members is 10, corresponding 
to a fraction composition of 10
-15
. An incubation of 15 minutes results in the cleavage of 
~30% of the target sequences, thus decreasing the number of target sequence from 10 to 7. 
The fraction composition of the target sequence after the selection becomes 1.33×10
-15
, 
corresponding to a 1.3-fold enrichment. The modeling results predicted optimal fold 
enrichment of 1.3-fold for an incubation time ranged from 15 to 30 minutes, and a longer 
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incubation time (>30 minutes) has a negative impact on the fold enrichment. Although 
fold enrichment of the positive selection is modest, when coupled with the negative 
selection the overall fold enrichment of the target sequence is increased to ~5-fold after 
one round of dual selection on the initial device library (Supplementary Table S4.3).  
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Figure 4.6 Optimization of the positive selection conditions. The model is based on the 
same initial device library as described in Figure 4.5 (Supplementary Table S4.2). (A) 
Fraction of uncleaved members within each population as a function of incubation time. 
The fraction of the cleaved population is determined by the first-order exponential decay 
equation: 1-e
-kt
, where k is the cleavage rate constant. The fractions of the uncleaved 
populations decrease at different rates as a function of time. (B) Fold enrichment of the 
target sequence relative to the medium and slow-cleaving populations as a function of 
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time. The fold enrichment of the target sequence is determined by the ratio of fraction 
compositions of the uncleaved target sequence in the library before and after the 
incubation. The modeling results predicted optimal fold enrichment of 1.3-fold for an 
incubation time ranged from 15 to 30 minutes. 
 
4.3 Discussion 
  We proposed a solution-based ribozyme-based selection strategy to facilitate 
generation of new sensing functions. The solution-based selection strategy allows scaling 
of the selection process to diverse molecular targets. In contrast to a previously described 
selection with allosteric ribozymes, our proposed strategy offers several unique 
advantages by utilizing: (i) a device platform that has been demonstrated for gene-
regulatory activities in vivo; (ii) an efficient cis-blocking strategy for gel-free, full-length 
RNA library generation by in vitro transcription reactions; and (iii) an efficient gel-free 
strategy for partitioning RNA fragments. Thus, our proposed strategy may provide a 
more rapid and efficient method for generating RNA sensing functions. 
We demonstrated our cis-blocking strategy on a control L2b8-N10 library (~10
6
 
variants), which is much smaller than the library diversity (~10
14
-10
15
 variants) necessary 
for generating new sensing functions. Because the blocking sequence was optimized 
based on the L2b8 device, the blocking efficiency decreased by ~40% when being 
applied to the L2b8-N10 library and may further decrease when applied to a library with 
even more random sequences introduced. The reduced efficiency of blocking ribozyme 
cleavage associated with larger device libraries during transcription reactions will require 
proper scaling of the transcription reactions to cover the desired sequence space or 
appending additional stabilizing nucleotides to improve the stability of the blocked 
conformations (see Chapter 3). 
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We described a dual selection strategy based on separation of cleaved and 
uncleaved fragments with magnetic beads. Selection strategies based on magnetic bead 
partitioning have been employed for the generation of both DNA and RNA aptamers to 
protein targets (19-21). These examples highlight the advantages of utilizing magnetic 
beads to facilitate the rapid isolation of bound sequences from unbound sequences. 
However, the removal and recovery of the unbound and bound sequences in the proposed 
dual selection scheme are performed by techniques (aspiration, pipetting) subject to 
researcher-dependent variations. Therefore, automatable technologies, such as liquid-
handling robots and microfluidics, may be incorporated into our proposed selection 
strategy to develop a more reliable and consistent process.  
A microfluidics-based process offers many advantages over the magnetic bead-
based process by allowing: (i) lower fluid volumes (microfluidic channel vs. microfuge 
tube); (ii) quicker response upon change of fluids (continuous vs. batch process); (iii) 
better control of reaction conditions (i.e., constant temperature throughout the cleavage 
reaction); and (iv) higher throughputs by automating and parallelizing the selection 
processes across multiple microfluidic channels. To adapt our current magnetic bead-
based process to microfluidics-based process, we need to develop microfluidic devices 
that are amenable for library selection. Specifically, efficient strategies need to be 
developed for modifying the device surface with the DNA activator strands to cover large 
sequence space. Challenges associated with RNA dissociation from the activator strand in 
a flow-based system will also need to be addressed to improve the overall fold 
enrichment of the microfluidics-based selection process (see Chapter 3).  
Initial efforts will focus on the validation of our bead-based selection process on a 
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small control library, such as the described L2b8-N10 device library (~10
6
 variants).  
Control selections will be performed on the library to recover the parent L2b8 device. 
Furthermore, the fold enrichment of the proposed selection process can be improved by 
the re-design and optimization of the transmitter sequence. Currently, the fold enrichment 
per selection round (~13-fold) is limited by the small differences in ribozyme device 
cleavage rates. Previous efforts on screening new transmitter sequences that support 
greater ligand-dependent fold change of gene-regulatory activities (and thus cleavage 
activities) only showed modest improvement (see Chapter 2). Because the regulatory 
activities of the ribozyme devices depend on the partitioning between two functional 
device conformations, we postulate that the relatively slow rates of conformational 
switching may limit the regulatory dynamic range. Thus, different component linkage 
strategies or alternative transmitter architectures may be considered to engineer an 
improved device platform that supports greater fold change. Ultimately, the in vitro 
selection will be integrated with the in vivo two-color FACS-based screen (see Chapter 2). 
In vitro selections will be performed on large device libraries (~10
14
-10
15
 variants) to 
enrich library members that exhibit ligand-dependent cleavage activities. The enriched 
libraries (~10
6
-10
7
 variants) will be directly transformed into Saccharomyces cerevisiae 
to isolate library members that exhibit ligand-dependent gene-regulatory activities within 
the cellular environment. With further optimization and development, our ribozyme-
based selection strategy may address current challenges in scaling the generation of small 
molecule-responsive ribozyme devices for broad cellular engineering applications. 
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4.4 Materials and Methods 
4.4.1 In vitro transcription of cis-blocked ribozyme constructs 
Sequences of the described L2b8 and L2b8-N10 constructs are provided in 
Supplementary Table S4.4. DNA synthesis was performed by Integrated DNA 
Technologies (Coralville, IA) or the Protein and Nucleic Acid Facility (Stanford, CA). 
The cis-blocked L2b8 construct was prepared through a T7 transcription reaction using 
PCR products amplified from templates using forward and reverse primers T7-fwd (5’-
TTCTAATACGACTCACTATAGG) and b-L2b8-rev (5’- CAAAGCTGTTTCGTCCTC 
CGT), respectively. The cis-blocked L2b8-N10 construct was prepared through a T7 
transcription reaction using PCR products amplified from templates using forward and 
reverse primers b-library-fwd (5’-TTCTAATACGACTCACTATAGGGAAACAAACA 
AAGTTGTTTTGCTGTCACCGGATGTGCTTTCCGG) and b-library-rev (5’-CAAAG 
CTGTTTCGTCCTCCGTCCCG), respectively. A total of 1-2 g of PCR product was 
transcribed in a 25 l reaction, consisting of the following components: 1×RNA Pol 
Reaction Buffer (New England Biolabs, Ipswich, MA), 2.5 mM of each rNTP, 1 l 
RNaseOUT (Invitrogen, Carlsbad, CA), 10 mM MgCl2, and 1 l T7 Polymerase (New 
England Biolabs). For radiolabeled transcription reactions, 0.5 Ci α-32P-GTP (MP 
Biomedicals, Solon, OH) was added to the reaction. After incubation at 37°C for 2 hr, 
NucAway Spin Columns (Ambion, Austin, TX) were used to remove unincorporated 
nucleotides from the transcription reactions according to manufacturer’s instructions. The 
transcription products were cleaned up with the RNA Clean & Concentrator-5 (Zymo 
Research, Irvine, CA) kit according to manufacturer’s instructions.  
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4.4.2 Gel analysis of cis-blocked ribozyme constructs  
Radiolabeled cis-blocked transcription products were incubated for 5 min at 25ºC 
in the HBS-N buffer (Biacore, Uppsala, Sweden), comprising 10 mM HEPES and 150 
mM NaCl, pH 7.4, in the absence and presence of 5 mM MgCl2 and 60 pmol DNA 
initiator strand (5’- AAACAACTTTGTTTGTTTCCCCC). Reactions were quenched 
after 5 min with addition of 3 volumes of RNA stop/load buffer (95% formamide, 30 mM 
EDTA, 0.25% bromophenol blue, 0.25% xylene cyanol) on ice. Samples were heated at 
95°C for 5 min, snap cooled on ice for 5 min, and size-fractionated on a denaturing (8.3 
M Urea) 10% polyacrylamide gel at 25 W for 45 to 60 min. Gels were exposed for 10 
min on a phosphor screen and analyzed for relative levels of the full-length transcript and 
cleaved products by phosphorimaging analysis on a FX Molecular Imager (Bio-Rad, 
Hercules, CA).  
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4.5 Supplementary Information 
Supplementary Table S4.1 Fraction of each cleaved population, fold enrichment of the 
fast-cleaving population, and % input library recovered as a function of time during the 
negative selection.  
 
Population Slow Medium Fast 
k (min
-1
) 0.013 0.033 0.14 
Time (min) Fraction cleaved = exp(-kt) 
0 0 0 0 
1 0.01 0.03 0.13 
5 0.06 0.15 0.50 
10 0.12 0.28 0.75 
15 0.18 0.39 0.88 
30 0.32 0.63 0.99 
60 0.54 0.86 1.00 
 
 Number of members before selection   
 Slow Medium Fast   
 3.33E+15 3.33E+15 3.33E+15   
 Number of members before selection   
Time (min) Slow Medium Fast Sum % recovered 
0 0.00 0.00 0.00 0.00 0.00% 
1 4.31E+13 1.08E+14 4.35E+14 5.87E+14 5.87% 
5 2.10E+14 5.07E+14 1.68E+15 2.39E+15 23.95% 
10 4.06E+14 9.37E+14 2.51E+15 3.85E+15 38.55% 
15 5.91E+14 1.30E+15 2.93E+15 4.82E+15 48.17% 
30 1.08E+15 2.09E+15 3.28E+15 6.45E+15 64.55% 
60 1.81E+15 2.87E+15 3.33E+15 8.01E+15 80.11% 
 
  Fold Enrichment 
Time (min) Fast/Slow Fast/Medium 
0   
1 10.11 4.02 
5 8.00 3.31 
10 6.18 2.68 
15 4.95 2.25 
30 3.05 1.57 
60 1.85 1.16 
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Supplementary Table S4.2 Fraction of each uncleaved population and fold enrichment 
of the target sequence as a function of time during the negative selection.  
 
Population Slow Medium Fast Target 
k (min
-1
) 0.013 0.033 0.14 0.025 
Time (min) Fraction uncleaved = 1-exp(-kt) 
0 1 1 1 1 
1 0.99 0.97 0.87 0.98 
5 0.94 0.85 0.50 0.88 
10 0.88 0.72 0.25 0.78 
15 0.82 0.61 0.12 0.69 
30 0.68 0.37 0.01 0.47 
60 0.46 0.14 0.0002 0.22 
90 0.31 0.05 0.00 0.11 
120 0.21 0.02 0.00 0.05 
 
 
 Number of members before selection  
 Slow Medium Fast Target  
 3.33E+15 3.33E+15 3.33E+15 10  
 Number of members after selection  
Time (min) Slow Medium Fast Target Sum 
0 3.33E+15 3.33E+15 3.33E+15 10.0 1.00E+16 
1 3.29E+15 3.23E+15 2.90E+15 9.8 9.41E+15 
5 3.12E+15 2.83E+15 1.66E+15 8.8 7.61E+15 
10 2.93E+15 2.40E+15 8.22E+14 7.8 6.15E+15 
15 2.74E+15 2.03E+15 4.08E+14 6.9 5.18E+15 
30 2.26E+15 1.24E+15 5.00E+13 4.7 3.55E+15 
60 1.53E+15 4.60E+14 7.50E+11 2.2 1.99E+15 
90 1.03E+15 1.71E+14 1.12E+10 1.1 1.21E+15 
120 7.00E+14 6.35E+13 1.69E+08 0.5 7.64E+14 
  
175 
 
 Fraction composition before selection  
 Slow Medium Fast Target  
 0.33 0.33 0.33 1.00E-15  
 Fraction composition after selection  
Time (min) Slow Medium Fast Target Fold 
0 0.33 0.33 0.33 1.00E-15 1.00 
1 0.35 0.34 0.31 1.04E-15 1.04 
5 0.41 0.37 0.22 1.16E-15 1.16 
10 0.48 0.39 0.13 1.27E-15 1.27 
15 0.53 0.39 0.08 1.33E-15 1.33 
30 0.64 0.35 0.01 1.33E-15 1.33 
60 0.77 0.23 0.00 1.12E-15 1.12 
90 0.86 0.14 0.00 8.74E-16 0.87 
120 0.92 0.08 0.00 6.52E-16 0.65 
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Supplementary Table S4.3 Fold enrichment of the target sequence after one round of 
dual selection on the initial device library. The calculations are based on the fractions 
cleaved and uncleaved populations as described in Supplementary Table S4.1 and S4.2. 
An incubation time of 15 min and 1 min were used for the positive and negative selection, 
respectively, to determine the fold enrichment of the target sequence after one round of 
dual selection process (~5-fold). 
 
 
Number of members 
  Slow Medium Fast Target Sum 
Initial library 3.33E+15 3.33E+15 3.33E+15 10 1.00E+16 
Positive selection 2.93E+15 2.40E+15 8.22E+14 7.79 6.15E+15 
Negative selection 3.78E+13 7.78E+13 1.07E+14 1.02 2.23E+14 
      
 
Fraction composition 
   Slow Medium Fast Target Fold 
Initial library 0.33 0.33 0.33 1.00E-15 
 Positive selection 0.48 0.39 0.13 1.27E-15 
 Negative selection 0.17 0.35 0.48 4.56E-15 4.56 
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Supplementary Table S4.4 Summary of the cis-blocked ribozyme device sequences 
used in this work. The T7 promoter region is indicated in bold.  
 
Construct Sequence 
L2b8 TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTTT
TGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCCGTTGTC
CATACCAGCATCGTCTTGATGCCCTTGGCAGGGACGGGACGG
AGGACGAAACAGCTTTG 
L2b8-N10 TTCTAATACGACTCACTATAGGGAAACAAACAAAGTTGTTT
TGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCCGTTGTC
CANNNCNGCATCGTCTTGATGCCNNNGNNNGGGACGGGACG
GAGGACGAAACAGCTTTG 
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Chapter 5. 
A rapid, label-free, and quantitative method for 
characterizing binding properties of RNA aptamers 
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Abstract 
Aptamers are nucleic acid sequences that are capable of binding molecular 
ligands with high affinities and provide important functional components for construction 
of synthetic genetic devices. RNA aptamers are typically generated de novo through 
iterative in vitro selection strategies to isolate sequences that bind small molecule ligands 
with high affinities and specificities from large nucleic acid libraries. Small molecule 
RNA aptamers have traditionally been characterized through isocratic elution and 
equilibrium filtration methods. However, these methods require labeling of molecules, 
thereby limiting their general applicability to characterize many RNA-small molecule 
pairs. Newer methods based on isothermal titration calorimetry (ITC) offer the potential 
of providing a label-free aptamer characterization strategy, but the requirement of large 
quantities of homogenous RNA makes the ITC-based method difficult to scale for the 
characterization of many RNA-ligand pairs. Here, we describe a rapid, label-free, and 
flexible aptamer characterization strategy based on surface plasmon resonance (SPR). We 
utilized a sensor surface modified with a DNA linker to capture the RNA aptamer that 
contains a complementary sequence to the DNA linker through hybridization. The small 
molecule ligand in free solution is injected over the RNA-hybridized surface to monitor 
binding interactions in real time. The rate of SPR signal change is fit to mathematical 
models to obtain associated thermodynamic and kinetic parameters. We validated the 
SPR-based method on several previously characterized RNA aptamers. Our SPR-based 
strategy requires little sample consumption and can be quickly tailored to qualitatively 
screen or quantitatively characterize many small molecule-RNA pairs. 
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5.1 Introduction  
 Aptamers are nucleic acid sequences that are capable of binding molecular 
ligands with high affinities (1). RNA aptamers are typically generated de novo through an 
iterative in vitro selection strategy or SELEX (Systematic Evolution of Ligands by 
EXponential enrichment) (2,3) or obtained from naturally-occurring sequences (4-6). 
RNA aptamers have been generated through in vitro selection strategies to many small 
molecule ligands, including alkaloids, amino acids, and oligosaccharides (1). By 
incorporating appropriate counterselection cycles in the selection process, aptamers have 
been selected in vitro to discriminate between structurally similar molecules. In one 
example, an aptamer selected to theophylline exhibits a 10,000-fold lower affinity for 
caffeine, which differs from theophylline by a single methyl group (7).  
 Binding affinities of small molecule RNA aptamers are typically determined by 
isocratic elution (8,9) or equilibrium filtration (7,9-11). Both methods require labeling of 
molecules (RNA or small molecule, respectively) and provide a low-throughput process 
for obtaining binding affinities. More recently, a label-free analytical method, isothermal 
titration calorimetry (ITC), has been used to characterize small molecule aptamers by 
measuring heat generation or absorption associated with the binding interactions (5,12). 
However, the ITC-based method requires large quantities of homogenous RNA, which 
limits its ability to be applied to the characterization of many RNA-small molecule pairs. 
In addition, all of these methods are limited to thermodynamic analysis of binding 
interactions, whereas for many applications information on binding kinetics are also 
desired.  
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Progress in biosensor technologies has led to the development of platforms based 
on surface plasmon resonance (SPR), which allows for the real-time, label-free detection 
of biomolecular interactions (13). The SPR-based biosensor platform involves 
immobilization of one molecule (ligand) on a sensor surface and monitoring its 
interaction with another molecule (analyte) in solution. The association or dissociation of 
the ligand-analyte complex results in a change in the refractive index, which is associated 
with the local mass density, near the sensor surface. The refractive index change is 
converted into an SPR signal, which is expressed in resonance units (RU). The rate of 
SPR signal change is fit to a mathematical model to acquire thermodynamic and kinetic 
parameters, including binding affinities, association rates, and disassociation rates. One 
of the pioneering SPR platforms, Biacore, has been applied to characterize 
thermodynamic and kinetics properties of diverse biomolecular interactions, including 
protein-protein (14), nucleic acid-protein (15), small molecule-nucleic acid (16), and 
small molecule-protein (17,18) interactions. In addition, the Biacore platform utilizes a 
microfluidic-based flow system that requires small sample volumes, thereby presenting a 
significant advantage over the ITC-based method.  
 Small molecule binding interactions have been challenging for the SPR-based 
methods to characterize due to the small local mass density change (19). The maximum 
expected SPR binding response is proportional to the ligand immobilization level on the 
sensor surface, analyte-to-ligand molecular weight ratio, and number of available binding 
sites on the ligand (20). Researchers have previously chosen to immobilize small 
molecule ligands on the sensor surface, such that binding of the corresponding RNA 
analyte resulted in a large binding response due to the large analyte-ligand molecular 
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weight ratio (16,21-24). However, this strategy requires the small molecule ligands to 
have or be modified with appropriate functional groups, such as the amine, thiol, 
maleimide, or aldehyde groups, for the conjugation chemistry to attach the ligand to the 
sensor surface and is therefore not scalable to the characterization of many diverse RNA-
small molecule pairs. In addition, such conjugation strategies may impact functional 
groups that play a role in the ligand binding interactions and thus impact measured ligand 
binding properties. 
We describe a rapid, quantitative aptamer characterization strategy based on the 
Biacore biosensor platform. An efficient strategy was developed for capturing RNA 
aptamers to the sensor surface, by appending a common binding sequence to the 5’ end of 
each RNA aptamer sequence and covalently coupling a DNA linker sequence to the 
sensor surface, which serves to capture the modified aptamer sequences through 
programmed hybridization interactions. Small molecule analytes in solution were injected 
over the sensor surface to monitor binding interactions in real time. An efficient 
regeneration strategy was developed to remove the captured RNA from the sensor surface 
upon completion of the assay to allow for characterization of multiple RNA-small 
molecule pairs on the same sensor surface. We validated the SPR-based aptamer 
characterization strategy by measuring the binding properties of theophylline, citrulline, 
and arginine aptamers and compared the measured values to those determined by 
isocratic elution or equilibrium filtration. Our SPR-based strategy supports the rapid 
characterization of binding properties for RNA aptamers to small molecule ligands, 
thereby providing a powerful characterization tool for functional RNA design. 
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5.2 Results 
5.2.1 Development of a SPR-based binding assay to characterize RNA-small 
molecule binding interaction  
 We developed a capture-based binding assay by indirectly immobilizing RNA 
through hybridization to a DNA linker sequence which is covalently coupled to the 
sensor surface (Figure 5.1). By capturing RNA to the sensor surface, small molecule 
analytes can be directly diluted in solution and injected over the sensor surface, thereby 
avoiding limitations associated with conjugating the small molecule to the sensor surface. 
The sensor surface for the binding assay is generated by covalently coupling a 24-mer 
poly-T DNA linker with an amino modification on the 5’ end to a dextran-based sensor 
surface through an EDC-mediated amine coupling reaction. Each sensor surface includes 
two flow cells (FC1 and FC2), and both FCs were modified with the poly-T DNA linker. 
FC1 is used as a reference flow cell to correct for bulk refractive index changes, matrix 
effects, nonspecific binding, injection noise and baseline drift (25). The DNA linker 
allows the capture of RNA containing a 24-mer poly-A tail, which is appended to the 3’ 
end of the RNA sequence to FC2 through hybridization. It is expected that the poly-A 
sequence interferes minimally with the native aptamer structure.  
The DNA linker is coupled at high density (~4000 RU) to the sensor surface to 
increase the amount of RNA captured and therefore increase the small molecule binding 
signal. For a typical small molecule (>150 Da) binding assay, the capture of a 30 kDa 
RNA to ~1500 RU is sufficient to generate a reliable and measurable binding signal (>5 
RU). The small molecule analyte at a particular concentration is subsequently injected 
over the sensor surface, and the SPR signal change associated with the binding 
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interaction is monitored. Since the capture of the RNA aptamer to the sensor surface is 
based on hybridization interactions with the DNA linker, a nucleic acid denaturant, such 
as 25 mM NaOH, can be injected to remove the RNA from the surface, thereby allowing 
reuse of the sensor surface to measure the binding signal at varying analyte 
concentrations. 
 
 
Figure 5.1 Schematic of the SPR-based RNA-small molecule binding assay. The sensor 
surface is generated by covalently linking a 5’ amino-modified poly-T DNA strand to the 
carboxymethyl dextran sensor surface via an EDC-mediated amine coupling reaction. 
RNA, with a poly-A sequence at its 3’end, is hybridized to the DNA linker, followed by 
the injection of small molecule analyte to monitor binding interactions in real time. The 
surface is regenerated with 25 mM NaOH for the next assay. 
 
5.2.2 Validation of the SPR-based aptamer binding assay 
We applied our SPR-based method to measure the binding properties of three 
aptamer sequences that have been extensively characterized through different methods: 
the theophylline, citrulline, and arginine aptamers (7,9) (Figure 5.2). The theophylline 
aptamer has been characterized to have a binding affinity of 0.2-0.4 M by equilibrium 
filtration (7) and fluorescence stopped-flow methods (26). The citrulline and arginine 
aptamers have been characterized by both isocratic elution and equilibration filtration 
methods to have a binding affinities of 62-68 and 56-76 M, respectively (9). We 
performed the SPR-based binding assays on these three aptamer sequences at a series of 
analyteRNA-(A)
DNA-(T)
sensor
RNA-capturing binding assay regeneration
188 
 
concentrations that span ~10-fold above and below the expected binding affinities for 
proper analysis (Figure 5.3). As proper formation of RNA tertiary structure can be 
dependent on MgCl2 concentrations, the ligands were directly dissolved in the binding 
characterization buffer (10 mM HEPES, 150 mM NaCl, 5 mM MgCl2, and 0.05% P20 
surfactant, pH7.4) comprising the same MgCl2 concentration as that used in the buffers 
used in the in vitro selection of these aptamers (26). The binding characterization buffer 
was also used as the Biacore running buffer to equilibrate the instrument. 
 
A Theophylline aptamer B Citrulline aptamer C Arginine aptamer 
 
 
   
 
Figure 5.2 Predicted secondary structures of RNA aptamers with a 24-mer poly-A tail 
appended to the 3’ end. The secondary structures of (A) theophylline, (B) citrulline, and 
(C) arginine aptamers were generated using Nupack by setting the temperature to 25ºC 
(27). The sequence for each aptamer is provided in Supplementary Table S5.1.  
 
For the characterization of the theophylline aptamer, three independent replicated 
binding assays were performed. Each binding assay consists of multiple assay cycles, and 
each cycle includes an RNA-capture, theophylline-injection, and regeneration steps. For 
each assay cycle, ~10-50 ng/l of RNA was captured onto the sensor surface for 2 
minutes at a flow rate of 2 l/min, resulting in an ~1700-2000 RU of RNA-capture level. 
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The RNA-capture levels were highly consistent within each replicate, with a coefficient 
of variation (CV) less than 0.46%. Varying concentrations of theophylline were injected 
over the sensor surface in random orders (0.56, 1.67, 0.19, 5, 0.06, and 0 M) (Figure 
5.3A). In between each injection of theophylline, the captured RNA was removed by an 
injection of 25 mM NaOH for 30 seconds at a flow rate of 30 l/min, and new RNA was 
re-captured onto the sensor surface prior to the injection of next theophylline sample.  
The sensorgrams from FC2 were referenced first by subtracting the corresponding 
sensorgrams from FC1 to correct for bulk refractive index changes, matrix effects, 
nonspecific binding, injection noise and baseline drift (25). The reference-subtracted 
sensorgram (FC2-FC1) was double-referenced by subtracting the sensorgram associated 
with the blank injection (0 M) to account for any systematic drift over the course of the 
injection (Figure 5.3A). The double-referenced sensorgram was fit to a 1:1 kinetic 
binding model (Supplementary Figure S5.1) and a steady-state affinity model 
(Supplementary Figure S5.2). The association (1.46×10
5 
± 7.32×10
3
 M
-1
s
-1
) and 
dissociation (6.31×10
-2 
± 4.72×10
-3 
s
-1
) rates were determined for the theophylline 
aptamer. The binding affinity (433 ± 37.8 nM) obtained from calculating the ratio of the 
dissociation over association constants was in close agreement with that obtained from 
the steady-state affinity model (324 ± 22.9 nM).  
Similar binding assays and analyses were performed on the citrulline 
(Supplemental Figure S5.3) and arginine (Supplemental Figure S5.4) aptamers. For the 
characterization of citrulline and arginine aptamers, the RNA-capture level ranged from 
~2200-2300 RU and ~1900-2100 RU, respectively. Varying concentrations of 
citrulline/arginine were injected over the sensor surface in random orders (0.56, 1.67, 
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0.19, 5, 0.06, and 0 M) (Figure 5.3B and C). Kinetic analysis for the citrulline and 
arginine aptamers was not possible because the fast kinetic rates exceeded the machine 
detection limit (association rate: 10
3
-10
7
 M
-1
s
-1
; dissociation rate: 10
-5
-0.1 s
-1
). Binding 
affinities for the citrulline (23.2 ± 0.21 M) and arginine (15.9 ± 0.32 M) aptamers were 
obtained from the steady-state affinity model. For the arginine aptamer, the assay 
performed at 500 M arginine was excluded from the analysis due to non-specific 
binding to the reference flow cell (Figure 5.3C and Supplementary Figure S5.4). The 
measured affinities for the three aptamers were in close agreement with those obtained by 
the more traditional methods, thus validating our SPR-based binding assay.  
 
A Theophylline aptamer 
 
 
 
 
 
-10
-5
0
5
10
15
20
0 20 40 60 80 100 120 140 160
Adjusted sensorgramRU
R
e
s
p
o
n
s
e
 (
0
 =
 b
a
s
e
li
n
e
)
sTim e (0 = baseline)
0
0.06
0.19
0.56
1.67
5
191 
 
B Citrulline aptamer 
 
 
C Arginine aptamer 
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Figure 5.3 Biacore response (RU) as a function of time (s). Representative Biacore 
sensorgrams for (A) theophylline, (B) citrulline, and (C) arginine aptamers are shown 
here. The sensorgrams were double-referenced by the reference flow cell (FC1) and the 
blank injection as described in the main text. The indicated concentrations are in M. 
 
5.3 Discussion 
  We developed a rapid, flexible SPR-based aptamer characterization strategy that 
can be applied for the characterization of many aptamer-small molecule ligand binding 
interactions. By appending a common hybridization sequence to the RNA aptamer, we 
can capture different RNA sequences to the same sensor surface, thereby presenting a 
more cost-effective strategy than direct coupling of the RNA sequence to the sensor 
surface (23). A similar RNA-capture strategy has been previously employed for the 
characterization of RNA-protein binding interactions by immobilizing a biotin-modified 
DNA linker to a streptavidin-based sensor surface (28). Although the streptavidin-biotin 
binding interaction is essentially irreversible, with a dissociation constant of ~1 fM, the 
protein-based sensor surface is less resilient to the harsh denaturant (25 mM NaOH) used 
in our strategy to regenerate the surface. We chose to covalently immobilize the DNA 
linker to the dextran-based sensor surface, as the dextran is highly resistant to harsh 
chemicals, thereby increasing the stability of the characterization surface for many 
binding assays. In addition, for the Biacore system used in our strategy the dextran-based 
surface offers more reactive sites than the protein-based sensor surface for the 
immobilization of DNA linker. Therefore, by using a dextran-based sensor surface higher 
RNA-capture levels can be achieved, allowing a higher small molecule binding signal. 
We demonstrated that our method is quantitative and yields similar values for 
thermodynamic binding properties as those obtained through the more traditional 
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methods based on equilibrium filtration or isocratic elution. Our SPR-based strategy 
allows measurements of kinetic parameters in addition to equilibrium parameters and 
requires little sample volume due to its microfluidic-based flow system, thereby 
providing a significant advantage over the ITC-based method. One limitation to our assay 
is in the possibility of non-specific interactions between the small molecule analyte and 
the sensor surface, particularly at high analyte concentrations. However, the extent of 
non-specific interactions may be eliminated or reduced by optimizing the characterization 
buffer. 
By developing a flexible and rapid capture-based assay method, our strategy can 
be readily coupled to in vitro aptamer selection strategies to allow for: (i) screening of 
enriched aptamer libraries for qualitative (yes/no) binding; (ii) ranking of functional 
aptamer sequences based on their affinities; (iii) identifying consensus sequences through 
systematic truncation of functional aptamer sequences; and (vi) screening for specificities 
against a family of molecules that share structural similarities. Furthermore, our strategy 
can be applied to characterize binding interactions between nucleic acids (DNA, RNA) 
and diverse molecules (small molecules, DNA, RNA, proteins), or further extended to 
monitoring binding to more complex RNA molecules, such as synthetic RNA devices 
(29). Thus, the described SPR-based strategy provides a versatile and powerful tool for 
advancing functional RNA design. 
 
 
 
 
194 
 
5.4 Materials and Methods 
5.4.1 In vitro transcription of RNA aptamers 
DNA synthesis was performed by Integrated DNA Technologies (Coralville, IA) 
or the Protein and Nucleic Acid Facility (Stanford, CA). Aptamers with the poly-A 
sequence were prepared through a T7 transcription reaction using PCR products 
amplified from templates using forward and reverse primers Biacore-fwd (5’-
TTCTAATACGACTCACTATAGG) and Biacore-rev (5’-TTTTTTTTTTTTTTTTTTTT 
TTTTGGGG), respectively. All described aptamer template sequences are summarized in 
Supplementary Table S5.1. A total of 1-2 g of PCR product was transcribed in a 25 l 
reaction, consisting of the following components: 1×RNA Pol Reaction Buffer (New 
England Biolabs, Ipswich, MA), 2.5 mM of each rNTP, 1 l RNaseOUT (Invitrogen, 
Carlsbad, CA), 10 mM MgCl2, and 1 l T7 Polymerase (New England Biolabs). After 
incubation at 37°C for 2 hr, NucAway Spin Columns (Ambion, Austin, TX) were used to 
remove unincorporated nucleotides from the transcription reactions according to the 
manufacturer’s instructions.  
 
5.4.2 Biacore sensor chip surface generation 
Biosensor experiments were performed on a Biacore X100 instrument (Biacore, 
Uppsala, Sweden) at 25ºC. A CM5 sensor chip (Biacore) was docked in the Biacore 
X100 and equilibrated with the HBS-P buffer (Biacore) (10 mM HEPES, 150 mM NaCl, 
pH 7.4, 0.05% Surfactant P20) supplemented with 5 mM MgCl2. The DNA linker strand 
(5’-TTTTTTTTTTTTTTTTTTTTTTTT), with an amino modification on the 5’ end, was 
immobilized to the chip surface via standard amine-coupling chemistry. Briefly, the 
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carboxymethyl surface of the CM5 chip was activated for 7 min at a flow rate of 5 l/min 
using a 1:1 volume ratio of 0.4 M 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
(Biacore) and 0.1 M N-hydroxysuccinimide (Biacore). A molar ratio of 1:60 of DNA 
strand to cetyl trimethylammonium bromide (Amresco, Solon, OH) was diluted in 10 
mM HEPES buffer (Sigma, St. Louis, MO) to a final concentration of 10 M and 0.6 
mM, respectively, and injected over the activated surface for 10 min at a flow rate of 5 
l/min. Excess activated groups were blocked by an injection of 1 M ethanolamine 
(Biacore), pH 8.5, for 7 min at a flow rate of 5 l/min. The immobilization reaction was 
performed sequentially on both flow cells (FC1, FC2), where FC1 was used as a 
reference cell to correct for bulk refractive index changes, matrix effects, nonspecific 
binding, injection noise and baseline drift (25). Approximately 3000 RU of the DNA 
strand was immobilized using this protocol. 
 
5.4.3 SPR-based aptamer binding assays  
The Biacore X100 instrument was primed three times with the running buffer 
(HBS-P + 5 mM MgCl2) prior to all binding assays. For each assay, five startup cycles 
were performed to stabilize the sensorgram baseline. For each startup cycle, the 
transcribed aptamer construct (~10-50 ng/l) was captured onto the reaction flow cell 
(FC2) for 2 min at a flow rate of 2 l/min (~1700~2300 RU), followed by an injection of 
25 mM NaOH for 30 sec at a flow rate of 30 l/min over both flow cells to regenerate the 
sensor surface. Dilution series of the ligand were made up in the running buffer and 
injected in random orders. Each concentration sample was injected over both flow cells 
for 60 sec at a flow rate of 30 l/min, followed by a 90-sec dissociation phase during 
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which the running buffer flows over the sensor surface. The remaining RNA was 
removed by an injection of 25 mM NaOH for 30 sec at a flow rate of 30 l/min over both 
flow cells, and RNA can be re-captured onto the sensor surface for the next assay cycle.  
Data processing and analysis were performed using Biacore X100 Evaluation 
Software v2.0 (Biacore). A double-referencing method was performed to process all 
datasets (30). In brief, data from the reaction flow cell (FC2) was referenced first by 
subtracting data from the reference flow cell (FC1) to correct for bulk response due to 
differences in sample compositions. The reference-subtracted data (FC2-FC1) was 
referenced again by a blank injection (running buffer) to account for any systematic drift 
over the course of the injection. The double-referenced data was fit to the default 1:1 
binding model for kinetic analysis (Supplementary Figure S5.2) or steady-state affinity 
model for thermodynamic analysis (Supplementary Figure S5.3). Reported values are the 
mean of at least three independent experiments.  
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5.5 Supplementary Information 
 
 
 
Conc. (µM) RNA (RU) ka (1/Ms) kd (1/s) KD (M) RI (RU) 
0.56 1994 1.54E+05 0.06077 3.96E-07 0.123 
1.67 1993 Rmax (RU) tc Chi² (RU²) -0.6335 
0.19 1996 15.05 3.58E+10 0.0938 0.2921 
5 1991    -1.048 
0.06 1988       0.364 
Mean 1992 CV 0.14%   
      
 
Supplementary Figure S5.1 Biacore 1:1 kinetic binding model for the theophylline 
aptamer sequence. The double-referenced sensorgrams for theophylline binding assays 
were fit to a 1:1 kinetic binding model (A+B↔AB): dA/dt = (tc*flow rate^(1/3))*(Conc-
A) - (ka*A*B - kd*AB); dB/dt = - (ka*A*B - kd*AB); dAB/dt = (ka*A*B - kd*AB); 
Total response = AB + RI, with initial values A[0] = 0; B[0] = Rmax (maximum binding 
signal); AB[0] = 0. A, B, and AB represents the small molecule analyte concentration 
(Conc), unbound RNA, and small molecule-RNA complex. The model was fit to the 
sensorgrams to obtained tc (mass transfer constant), ka (association constant), kd 
(dissociation constant), Rmax, and RI (residuals). One representative fitted replicate is 
shown here. Small Chi
2
 values indicate that the fitted values are close to the observed 
values. 
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KD (M) Rmax (RU) offset (RU) Chi² (RU²) 
3.37E-07 13.29 0.3887 0.0145 
 
 
Supplementary Figure S5.2 Biacore steady-state affinity model for the theophylline 
aptamer sequence. The double-referenced sensorgrams for theophylline binding assays 
were fit to a steady-state affinity model: Conc*Rmax/(Conc+KD)+offset. The model was 
fit to the sensorgrams to obtained KD (binding affinity), Rmax (maximum binding 
signal), and offset (residuals). One representative fitted replicate is shown here. The top 
sensorgram shows the steady state RU taken for the affinity analysis. The bottom 
sensorgram shows the fitted curve against the experimental values. Small Chi
2
 values 
indicate that the fitted values are close to the observed values. 
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KD (M) Rmax (RU) offset (RU) Chi² (RU²) 
2.51E-05 9.242 -0.3783 0.00514 
 
    
Supplementary Figure S5.3 Biacore steady-state affinity model for the citrulline 
aptamer sequence. The sensorgrams from the citrulline binding assays were fit to a 
steady-state affinity model as described in Supplementary Figure S5.2. 
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KD (M) Rmax (RU) offset (RU) Chi² (RU²) 
1.17E-05 4.281 -0.7322 0.00444 
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Supplementary Figure S5.4 Biacore steady-state affinity model for the arginine aptamer 
sequence. (A) The sensorgrams from the arginine binding assays were fit to a steady-state 
affinity model as described in Supplementary Figure S5.2. (B) The assay performed at 
500 M arginine was excluded from the analysis due to non-specific binding to the 
reference flow cell. The non-specific binding was observed by the difference between the 
response curve and the dashed line. 
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Supplementary Table S5.1 Sequences of aptamers used in this work. The T7 promoter 
region is indicated in bold and the poly-A linker sequence is indicated in italics. 
 
Aptamer Sequence 
Theophylline TTCTAATACGACTCACTATAGGGAAGTGATACCAGCATCGT
CTTGATGCCCTTGGCAGCACTTCCCCCAAAAAAAAAAAAAAAAAA
AAAAAA 
Citrulline TTCTAATACGACTCACTATAGGGACGAGAAGGAGTGCTGGT
TATACTAGCGGTTAGGTCACTCGTCCCCCAAAAAAAAAAAAAAA
AAAAAAAAA  
Arginine TTCTAATACGACTCACTATAGGGACGAGAAGGAGCGCTGGT
TATACTAGCAGGTAGGTCACTCGTCCCCCAAAAAAAAAAAAAAA
AAAAAAAAA 
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Chapter 6. 
Conclusions 
  
208 
 
 
Living systems rely on the precise control of gene expression to affect appropriate 
phenotypic responses over different temporal and spatial scales, and therefore maintain 
proper cellular function. Increased understanding of natural biological systems, in 
addition to advances in nucleic acid and protein engineering, have inspired researchers to 
construct synthetic genetic systems and catalyze the emerging field of synthetic biology 
(1). Recent advances in the field of RNA synthetic biology led to the development of a 
modular platform from which ligand-responsive ribozyme-based gene-regulatory devices 
can be assembled (2,3). The ability to construct user-specified ribozyme devices tailored 
to diverse applications depends on the development and integration of several enabling 
technologies. Specifically, high throughput technologies that enable the efficient de novo 
generation of new sensor functions and tailoring of device regulatory properties for 
specific cellular applications are needed to broaden the utility of these genetic control 
devices. 
The ribozyme device platform offers two distinct advantages in advancing our 
ability to generate new ligand-responsive RNA control devices with tailored regulatory 
properties. First, the modular composition framework of the device platform supports 
direct interchange of functional RNA components, including sensors, transmitters, and 
actuators, to program devices with user-specified regulatory activities. Second, the 
mechanism of action of the ribozyme component is independent of cell-specific 
machinery, allowing transport of the resultant ribozyme devices to in vitro or diverse 
cellular environments. These two advantages allow direct generation and optimization of 
the individual RNA component activities within the device platform through in vitro 
and/or in vivo strategies, thereby allowing the development of a scalable framework from 
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which ribozyme devices with tailored ligand responsiveness and regulatory properties can 
be efficiently generated. 
We developed a high-throughput and quantitative two-color FACS-based strategy 
that allows rapid generation and optimization of component activities in the cellular 
environment. Our fluorescence-based screening strategy provides an advantage in that the 
device output (GFP) can be normalized by an internal standard (mCherry) across cell 
populations, whereas cell-based screening and selection strategies based on enzyme 
activities (i.e., motility, colorimetry, viability) are more prone to gene expression noise 
that is not normalizable (4-6). Our two-color screening approach can be extended beyond 
RNA device tailoring. As an example, our screening approach can be applied toward 
direct enzyme evolution in cellular environments. In this instance, an enzyme library is 
transformed into a cell host, which harbors an integrated biosensor in the form of an RNA 
control device responsive to the product of the enzyme-catalyzed reaction in the two-
color screen construct. The RNA device can respond to the intracellular accumulation of 
the enzymatic product and translate this information to increased cellular fluorescence 
levels. As the fluorescence levels are normalized by the internal standard, enzyme 
variants that exhibit enhanced activities can be efficiently isolated, increasing the 
sensitivity of the biosensor to small changes in enzyme activity. Thus, our two-color 
FACS-based screen can provide a powerful strategy that allows programming of diverse 
biological components. 
Scalable generation of biological components is currently a rate-limiting step in 
the process of building new genetic control devices. Generation of new component 
functions, such as ones that exhibit new sensing functions, requires searching large 
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sequence space (~10
14
-10
15
 variants), exceeding the capacity of any existing cell-based 
selection or screening strategies. We proposed a solution-based in vitro selection strategy 
based on the modular ribozyme device platform. Large device libraries are generated by 
randomizing the sensor component within the device platform. The selection strategy 
links ligand binding to ribozyme cleavage activity and therefore does not require 
conjugation of target ligand to a solid support (i.e., column). As such, the solution-based 
selection process can be applied to a complex ligand pool in which mixtures of ligand 
targets are simultaneously presented to the RNA library to generate multiple sensing 
functions. We described a dual selection process, optimized by mathematical modeling, 
based on magnetic bead separation to facilitate partitioning of the library members. 
Future efforts will be directed to validating our selection strategy initially on a small 
control library to recover existing functional sequences and ultimately on a large library 
to generate new sensing functions. 
The enrichment efficiencies of our in vitro cleavage-based selection and in vivo 
FACS-based screening strategies are closely associated with the device regulatory 
dynamic range. Our current platform design is based on conformational switching 
facilitated by a strand-displacing transmitter sequence. Previous modeling studies of 
riboswitch function have predicted that slow conformational switching rates may limit 
the device dynamic range, resulting in small changes in the output signal in response to 
changing concentrations of the target ligand (7). This limitation has a more pronounced 
impact on the enrichment efficiency of the in vitro selection. In contrast to the in vivo 
FACS-based screen, where library members exhibiting desired activities can be 
specifically sorted, the proposed in vitro cleavage-based selection collects all the cleaved 
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library members in the supernatant. As such, library members exhibiting similar cleavage 
rates relative to the target member will also be carried over into the next selection round, 
resulting in poor enrichment of the target member. To address this limitation, early 
efforts may be directed toward developing a transmitter design that allows for faster 
conformational switching. One potential strategy is to reduce the random walk step size, 
a measure of the number of base pairs that need to be broken or formed between two 
conformations. As an example, a more compact strand displacement-based transmitter 
sequence (with fewer nucleotides) will be designed through rational or evolutionary 
strategies to facilitate faster conformational switching. Alternative transmitter 
architectures, such as design based on a helix-slipping mechanism (8), may also be 
considered for the development of a next-generation device platform.  
By developing enabling technologies based on the same ribozyme-based platform, 
we will ultimately be able to integrate our in vitro solution-based selection and in vivo 
two-color FACS-based screening strategies into one seamless integrated process. The in 
vitro selection strategy can be performed initially on a large device library (~10
14
-10
15
 
variants) to enrich for sequences that exhibit desired cleavage activities. The in vitro-
enriched libraries can be directly transformed into a cell host (~10
6
-10
7 
clones for yeast) 
and further enriched and optimized by the in vivo two-color FACS-based screen. To 
integrate the resulting devices into biological networks, the regulatory activities of the 
devices can be readily tailored by the same two-color screen to meet application-specific 
performance requirement. Collectively, progress in this thesis will aid in the scalable 
construction and programming of RNA control devices for diverse cellular engineering 
applications and further advance our ability to interact with and program biology. 
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